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Superparamagnetic iron oxide nanoparticles (SPIONs) are very useful for biomedical 
applications, such as magnetic resonance imaging (MRI), hyperthermia for cancer 
therapy, cell targeting, drugs or gene delivery. However, once introduced into blood, 
SPIONs will be captured by the macrophages and then rapidly cleared out from 
circulation which can drastically reduce the efficiency of SPIONs-based diagnosis and 
therapy. Therefore, the bio-interfaces of SPIONs are crucial for their biomedical 
applications. The overall aim of this thesis is to modify SPIONs with different 
polymers for potential cell targeting, MRI and cancer therapy applications. In the first 
project, SPIONs were coated with either poly(DL-lactic acid-co-malic acid) (PLMA) 
or poly(ethylene glycol)-conjugated PLMA (PLMA-PEG) to modulate uptake by 
macrophages. PLMA-SPIONs are readily taken up by macrophages but the extent of 
uptake can be reduced by increasing the PEG content of the PLMA-PEG coating. In 
the second project, SPIONs were coated with either poly(glycidyl methacrylate) or 
poly(glycidyl methacrylate-co-poly(ethylene glycol) methyl ether methacrylate) 
combined with a targeting ligand, folic acid, to attain high selectivity in targeting 
cancers with minimal uptake by macrophages. All these nanoparticles have low 
cytotoxicity and exhibit higher MRI contrast effects than commercial agents. Finally, 
SPIONs-loaded, cisplatin-conjugated polymeric nanoparticles were synthesized for 
potential application against bladder cancer. These nanoparticles show 
mucoadhesiveness, a sustained release of cisplatin over 4 days and can effectively 
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Figure 2-1  Magnetic domains in a bulk material.
   
Figure 2-2  Schematic magnetization curves of (a) ferromagnetic nanoparticles 
and (b) superparamagnetic nanoparticles. 
   
Figure 2-3  In vivo behavior of nanoparticles in blood vessels. The EPR effect 
of nanoparticles is greatest at tumors.
   
Figure 2-4  Size effects of SPIONs on magnetism and MR contrast effects.
   
Figure 2-5  Color maps of T2-weighted MR images of cancer cells implanted 
mice at different temporal points after intravenous injection of 
Herceptin-conjugated SPIONs. An immediate (5 min) color change 
at the tumor site is evident.
   
Figure 2-6  A hypothetical magnetic drug delivery system shown in cross-
section: a magnet is placed outside the body in order that its 
magnetic field gradient might capture magnetic carriers flowing in 
the circulatory system.
   
Figure 2-7  Illustration of bladder permeability barrier established by uroplakin 
covered umbrella cells of bladder epithelium (urothelium) and 
GAG layer that prevents adhesion.
   
Figure 3-1  (a) Schematic representation of PLMA synthesis and (b) 1H NMR 
spectra of (i) PLMA-1, (ii) PLMA-2, and (iii) PLMA-3. 
   
Figure 3-2  FT-IR spectra of (a) PLMA-1, (b) PLMA-1-PEG-1, (c) PLMA-1-
PEG-2, and (d) PLMA-1-PEG-3.
   
Figure 3-3  TEM images of (a) pristine SPIONs from high temperature 
decomposition synthesis, (b) ~12 nm SPIONs after seed-mediated 
growth of (a), and (c) PLMA-2-SPIONs. 
   
Figure 3-4  FT-IR spectrum of ~12 nm SPIONs.
   
Figure 3-5  XPS C 1s core-level spectra of (a) pristine SPIONs and (b) PLMA-
2-SPIONs. 
   
Figure 3-6  Schematic representation of the synthesis of PLMA-1-PEG-
SPIONs. Site and extent of amide band formation between H2N-
PEG and PLMA-1 are shown for illustration purpose only. TEM 
images of (a) pristine SPIONs from high temperature 
decomposition synthesis, (b) ~12 nm SPIONs from seed-mediated 




Figure 3-7  XPS C 1s core-level spectra of (a) pristine SPIONs, (b) PLMA-1-
SPIONs and (c) PLMA-1-PEG-3-SPIONs.
   
Figure 3-8  Images of macrophages incubated for 2 h (a) without PLMA-2- 
SPIONs, and (b) with PLMA-2-SPIONs at an iron concentration of 
0.5 mM, after staining with Prussian Blue. 
   
Figure 3-9  Uptake of PLMA-2-SPIONs by macrophages (a) as a function of 
incubation time at incubated iron concentration of 0.5 mM and (b) 
as a function of incubated iron concentration for an incubation 
period of 4 h. Inset is the image of macrophages incubated with 
PLMA-2-SPIONs at an iron concentration of 2.0 mM for 4 h after 
staining with Prussian Blue. 
   
Figure 3-10  Effect of PEG content in the surface coating of SPIONs on uptake 
by macrophages as a function of (a) incubation time ([Fe]=0.5 
mM) and (b) incubated iron concentration at an incubation time of 
4 h. 
   
Figure 3-11  Viability of macrophages incubated with (a) nanoparticles with 
different coatings at an iron concentration of 0.5 mM for 24 h and 
(b) PLMA-1-SPIONs and PLMA-1-PEG-3-SPIONs at different 
iron concentrations for 24 h. Viability is expressed as a percentage 
relative to the result obtained with the non-toxic control 
(macrophages incubated without nanoparticles). 
   
Figure 3-12  Field dependent magnetization at 25°C for (a) pristine SPIONs, (b) 
~12 nm SPIONs after seed-mediated growth, (c) PLMA-2-
SPIONs, and (d) PLMA-1-PEG-3-SPIONs. 
   
Figure 3-13  Relaxation rates 1/T1 (s-1) and 1/T2 (s-1) in water as a function of 
the iron concentration of (a) PLMA-2-SPIONs and (b) PLMA-1-
PEG-3-SPIONs (for all plots, correlation coefficient R2 > 0.97). 
Relaxometric measurements were performed by MRI. 
   
Figure 3-14  MR images of phantoms containing (a) macrophages without 
nanoparticles at a cell density of 200×103 cells/mL, and PLMA-2-
SPIONs-labeled macrophages at a cell density of (b) 6.3×103, (c) 
12.5×103, (d) 50×103 and (e) 200×103 cells/mL. 
   
Figure 3-15  Dependency of R2* and R2 on PLMA-2-SPIONs-labeled cell 
concentration in phantoms (for both plots, correlation coefficient 
R2 > 0.97). 
 








Figure 4-2 A. XPS wide scan spectra of (a) oleic acid-stabilized SPIONs, (b) 
initiator-coated SPIONs, (c) SPIONs-PGMA, and (d) SPIONs-
PGMA-NH2; B. XPS C 1s core-level spectra of (a) SPIONs-
PGMA and (b) SPIONs-PGMA-NH2. 
  
Figure 4-3 FT-IR spectra of (a) oleic acid-stabilized SPIONs, (b) initiator-
coated SPIONs, (c) SPIONs-PGMA, (d) SPIONs-PGMA-NH2, (e) 
SPIONs-PGMA-FA-1, and (f) free folic acid.
  
Figure 4-4 TEM images of (a) oleic acid-stabilized SPIONs dispersed in 
hexane and (b) SPIONs-PGMA-FA-1 dispersed in DI water. 
  
Figure 4-5 Field dependent magnetization at 25oC for (a) oleic acid-stabilized 
SPIONs and (b) SPIONs-PGMA-FA-1.
  
Figure 4-6 A. T2-weighted MRI images (3T, spin-echo sequence: TR=3000 
ms, TE=36.8 ms) of SPIONs-PGMA-FA-1 in water; B. Relaxation 
rates (a) 1/T2 and (b) 1/T1 at a magnetic field of 3T as a function of 
iron concentration (mM) of SPIONs-PGMA-FA-1 in water. 
  
Figure 4-7 (a) Intracellular uptake of SPIONs-PGMA-NH2 and SPIONs-
PGMA-FA-1 by KB cells as a function of incubation time; (b) 
intracellular uptake of SPIONs-PGMA-FA nanoparticles with 
different FA surface densities by different cell lines after 
incubation of 4 h. Nanoparticle concentration in medium was 0.2 
mg/mL. (*) denote significant differences between each pair 
indicated (P < 0.05).
  
Figure 4-8 Viability of 3T3 fibroblasts, macrophages, and KB cells as a 
function of SPIONs-PGMA-FA-1 concentration in medium. 
Incubation period was 24 h.
  
Figure 5-1 Schematic representation of the synthesis of SPIONs-P(GMA-co-
PEGMA)-FA.
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pristine SPIONs.
  
Figure 5-3 XPS C 1s core-level spectra of (a) SPIONs-P(GMA-co-PEGMA), 
(c) SPIONs-P(GMA-co-PEGMA)-N3, and (e) SPIONs-P(GMA-co-
PEGMA)-FA-3. XPS N 1s core-level spectra of (b) SPIONs-
P(GMA-co-PEGMA), (d) SPIONs-P(GMA-co-PEGMA)-N3, and 
(f) SPIONs-P(GMA-co-PEGMA)-FA-3.
  
Figure 5-4 FT-IR spectra of (a) SPIONs-P(GMA-co-PEGMA), (b) SPIONs-






Figure 5-5 FT-IR spectra of (a) SPIONs-P(GMA-co-PEGMA)-FA-1 (b) 
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intracellular uptake of SPIONs-P(GMA-co-PEGMA)-FA-3 by 
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Nanotechnology is one of the critical technologies of the 21st century, and it has 
greatly enabled the design of advanced functional nanomaterials of dimensions of 1-
1000 nm in the biomedical field (Gupta and Gupta 2005). Among the different types 
of nanomaterials, magnetic iron oxide nanoparticles are of intense current interest and 
have been successfully used for clinical applications, for example, molecular imaging.  
 
Magnetic iron oxide nanoparticles smaller than 100 nm are normally applied in 
biomedical applications. In the case of magnetic iron oxide nanoparticles with 
diameters less than 20 nm, the so-called superparamagnetic iron oxide nanoparticles 
(SPIONs), these nanoparticles often show superparamagnetic behavior at room 
temperature (Hao et al. 2010). SPIONs have many advantages, such as a high constant 
magnetic moment with a fast response to applied magnetic field, as well as no 
remnant magnetization in the absence of external magnetic field due to zero 
randomization of magnetic moments by thermal agitation. Owing to these unique 
features, SPIONs are very attractive and ideal for a broad range of biomedical 
applications, such as magnetic resonance imaging (MRI) contrast enhancement, 
drug/gene delivery, and hyperthermia in cancer treatment.  
 
However, there are several problems for the application of pristine SPIONs in vivo. 
Firstly, SPIONs synthesized by high-temperature decomposition method are 
hydrophobic and intrinsically unstable over time in a biological environment, due to 
their large surface-to-volume ratio (Oh and Park 2011). Moreover, the adsorption of 
plasma proteins (e.g. immunoglobulins and fibronectin) on the surfaces of SPIONs 
 Chapter 1 
3 
leads to a non-specific uptake by the reticuloendothelial system (RES), e.g. 
macrophages, resulting in a rapid elimination of SPIONs from the blood. The short 
blood circulation time drastically reduces the efficiency of SPIONs-based diagnostics 
and therapeutics. In addition, specific accumulation of SPIONs in target organs is also 
required for cancer therapy via SPIONs-based drug delivery or hyperthermia, in order 
to reduce the systemic toxicity associated with serious side-effects. Therefore, surface 
coating of SPIONs to attain colloidal stability, prolonged blood circulation time, and 
site-specific accumulation in target organs is crucial for SPIONs-based biomedical 
applications. 
 
1.2 Research Objectives and Scopes 
The overall aim of this thesis is to develop various functional polymers as surface 
coatings of SPIONs for potential cell targeting, MRI, and cancer therapy applications. 
This thesis consists of seven chapters. In Chapter 1, a general introduction of the 
current problems for SPIONs-based biomedical applications, the objectives and scope 
of this study is provided while Chapter 2 gives an overview of the related literature. 
Chapter 3 describes the research on the use of biocompatible and biodegradable 
polymer coatings, poly(DL-lactic acid-co-malic acid) (PLMA) and poly(ethylene 
glycol)-conjugated PLMA (PLMA-PEG), for the modulation of uptake of SPIONs by 
macrophages. In Chapter 4, the focus is on SPIONs which can target cancers while 
evading uptake by macrophages. The SPIONs are first coated with poly(glycidyl 
methacrylate) (PGMA) via surface-initiated atom transfer radical polymerization 
(ATRP). After ring-opening reaction with ethylenediamine, different amounts of 
tumor-targeting ligand, folic acid (FA) are conjugated on the surface to attain high 
 Chapter 1 
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selectivity in targeting cancer cells. Chapter 5 gives an alternative method for 
synthesizing FA-conjugated SPIONs for minimizing uptake by macrophages and 
enhancing the selectivity in targeting of cancer cells. ATRP of GMA and 
poly(ethylene glycol) methyl ether methacrylate (PEGMA) from the surface of 
SPIONs was first carried out, followed by ‘click’ chemistry to conjugate FA with 
controlled surface densities. In Chapter 6, the preparation of nanoparticles 
incorporating SPIONs and drug for potential bladder cancer therapy is described. 
Amphiphilic poly(ε-caprolactone)-b-poly(propargyl methacrylate-click-
mercaptosuccinic acid-co-poly(ethylene glycol) methyl ether methacrylate) (PCL-b-
P(PMA-click-MSA-co-PEGMA)) are synthesized via the combination of reversible 
addition-fragmentation chain transfer (RAFT) polymerization and thiol-yne reaction. 
This polymer was used to encapsulate SPIONs and coordinate cisplatin. The resulting 
nanoparticles are mucoadhesive and provide sustained drug release. Finally, the 
















































The rapid growth of nanotechnology over the past decade provides exciting 
possibilities for synthesis, characterization, and functionalization of nanoscale 
materials for biomedical applications and diagnostics (Schladt et al. 2011). Among 
the variety of promising nanoscale materials, SPIONs have gained significant 
attention due to their great potential for various biomedical applications, including 
MRI for cell targeting and monitoring, drug/gene delivery, hyperthermia for cancer 
treatment, etc. In addition, in contrast to other inorganic nanoparticles, SPIONs are 
biocompatible, since the iron from degraded SPIONs can be incorporated in the 
natural iron stores of the body, such as hemoglobin (Veiseh et al. 2011). 
 
2.1.1 Basic Properties of SPIONs 
Bulk ferromagnetic materials, which exhibit a permanent magnetization (M) in the 
absence of a magnetic field, contain multi domains (Figure 2-1). Due to the different 
alignment of atomic magnetic moments within the domain, the overall magnetization 
decreases. Under an external magnetic field H, M of the ferromagnetic materials 
increases with H until a saturation magnetization Ms is reached. When H is decreased 
to zero, a remnant magnetization (Mr) is present. A hysteresis loop can be observed in 
the magnetization curve of ferromagnetic materials as shown in Figure 2-2a. 
 
As the size of a ferromagnet decreases, a critical size will be reached such that the 
particle contains a single domain with all the spins uniformly aligned in the same 
direction (Lu et al. 2007). For a single domain particle, an energy barrier of KV has  to 
be overcome in order to reverse the directions of magnetization, where K is the 
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effective anisotropy constant and V is the particle volume (Lu et al. 2007). When the 
particle size is decreased, the thermal energy KBT, where KB is the Boltzman constant 
and T is the temperature, exceeds the energy barrier KV, leading to randomization of 
the magnetization in any direction (Crooks 1979). This phenomenon is called 
superparamagnetism. No hysteresis loop is present in the magnetization curve of 
superparamagnetic particles (Figure 2-2b). On the other hand, when the temperature 
decreases until KBT < KV, the particle undergoes a transition from a 
superparamagnetic to a so-called blocked state. The temperature at which KBT = KV is 
called blocking temperature TB. 
 
 




Iron oxide nanoparticles at diameter smaller than around 20 nm often display 
superparamagnetic behavior at room temperature. Due to the zero net magnetization 
as a result of thermal agitation after removal of an external magnetic field, 
aggregation concerns resulting from magnetic interaction are minimized. Therefore, 





Figure 2-2 Schematic magnetization curves of (a) ferromagnetic nanoparticles and 
(b) superparamagnetic nanoparticles (Frey et al. 2009). 
 
 
2.1.2 Synthesis of SPIONs 
In the last few decades, numerous synthetic routes have been developed to obtain 
shape-controlled and high-quality SPIONs, such as co-precipitation, thermal 
decomposition, microemulsion, hydrothermal synthesis, and sol-gel reactions. Instead 
of compiling all these synthetic methods, only the widely used methods are presented 
in the following sections.    
 
2.1.2.1 Co-precipitation 
Co-precipitation is a simple and widely used method to synthesize iron oxide (either 
Fe3O4 or γ-Fe2O3) nanoparticles by the addition of a base to an aqueous mixture of 
Fe3+ and Fe2+ salts under an inert atmosphere. The size, shape, and composition of the 
iron oxide nanoparticles depends on the type of salts (e.g. nitrates, chlorides, sulphates, 
etc.), the ratio of Fe3+ /Fe2+, the reaction temperature, the pH value and ionic strength 
of the medium.  
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The formation of magnetite (Fe3O4) is expected to proceed according to the following 
reaction:   
2 Fe3+ + Fe2+ + 8 OH- → Fe3O4 + 4 H2O 
According to this reaction, complete synthesis of Fe3O4 should be expected at a pH 
between 8 and 14, with a ratio of 2:1 (Fe3+ /Fe2+) under protection from oxygen. 
However, magnetite is not very stable under ambient atmosphere and is easily 
oxidized to maghemite (γ-Fe2O3) in air or in an acid medium (Muller et al. 2008). 
Although γ-Fe2O3 is more chemically stable, Fe3O4 is more preferred due to its higher 
saturation magnetization (Ms) than γ-Fe2O3 (Qiao et al. 2009). 
 
The major advantage of the co-precipitation method is that a large quantity of 
nanoparticles can be synthesized. However, the control of size distribution is limited 
with generation of polydisperse nanoparticles. Since TB depends on particle size, a 
wide size distribution will lead to a wide range of TB, resulting in non-ideal magnetic 
behaviour for many applications (Lu et al. 2007). A short burst of nucleation and 
subsequent controlled growth is important to synthesize monodisperse particles. 
Recently, carboxylate anions (such as citric acid) or polyvinyl alcohol (PVA) have 
been added as stabilization or reducing agents to the reaction to control the 
nanoparticle size. The chelation of these organic ions on the particles surface can 
prevent nucleation and lead to the formation of larger particles. On the other hand, the 
growth of the particles may also be inhibited due to the adsorption of additives on the 
nuclei and the growing crystals, leading to formation of smaller particles. In addition, 
size selection is used to obtain narrow-sized particles. NaCl as an extra electrolyte is 
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added to a stable colloidal solution to precipitate larger particles, resulting in smaller 
and nearly monodisperse particles in the supernatant (Muller et al. 2008).  
  
2.1.2.2 Thermal Decomposition 
Thermal decomposition of organometallic compounds, metal-surfactant complexes, or 
metal salts in high-boiling organic solvents has become the most successful approach 
for producing monodisperse iron oxide nanoparticles. The size and morphology of the 
nanoparticles can be precisely controlled by controlling the reaction temperature, 
reaction time, the concentrations and ratios of the reactants, as well as the addition of 
seeds. The decomposition of FeCup3 (Cup: N-nitrosophenylhydroxylamine) or 
Fe(CO)5 followed by oxidation results in the successful synthesis of monodisperse γ-
Fe2O3 (Rockenberger et al. 1999; Hyeon et al. 2001). The first synthesis of 
monodisperse Fe3O4 using the thermal decomposition method was performed by Sun 
and Zeng (2002). In their method, iron(III) acetylacetonate is decomposed at high 
temperature (up to ~ 300 oC) in the presence of 1,2-hexadecanediol, oleic acid, and 
oleylamine in phenol ether. The synthesized magnetite nanoparticles are 
monodisperse with a narrow size distribution, hence no subsequent size-selection 
procedure is required. Larger Fe3O4 nanoparticles of up to 20 nm can be synthesized 
by seed-mediated growth method using the smaller Fe3O4 as seeds. 
 
Unfortunately, only sub-gram quantities of monodisperse nanoparticles are obtained 
in most reported methods. Thus, several rounds of synthesis are needed to obtain 
sufficient amount for further applications. Recently, the synthesis of ultra-large-scale 
(tens of grams) of monodisperse magnetite nanoparticles has been reported by Park et 
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al. (2004). Monodisperse magnetite nanoparticles (size deviation < 5%) in the size 
range of 5-22 nm can be synthesized by thermal decomposition of iron-oleate 
complex with a constant heating rate to 320 oC. The particle size can be controlled by 
variation of the solvents with different boiling points and aging period.   
 
Besides the synthesis of size-controlled monodisperse magnetite nanoparticles using 
thermal decomposition, shape-controlled nanoparticles can also be produced by using 
fatty acid salts as stabilizers instead of oleic acid (Kovalenko et al. 2007). By 
adjustment of the stabilizer composition and the reaction temperature, monodisperse 
spherical, cubic, and bipyramidal Fe3O4 can be obtained. 
 
2.1.3 Challenges of SPIONs for Biomedical Applications 
The dispersibility and stability of SPIONs in biological medium is crucial for their 
biomedical applications. Once introduced into a physiology environment, pristine 
SPIONs tend to interact with plasma proteins, such as fibronectin and 
immunoglobulins, and form aggregates, due to their large surface area. This process is 
called opsonization, and it results in rapid recognition and non-specific uptake by the 
RES or mononuclear phagocytic system (MPS), which is the body’s defense system 
comprising highly phagocytotic cells derived from bone marrow, such as tissue 
macrophages (e.g. Kupffer cells in the liver) and blood monocytes (Kumar et al. 2005; 
Qiao et al. 2009). As a result of the opsonization effect, SPIONs are quickly cleared 
from the blood circulation. The rapid sequestration of intravenously injected particles 
by the RES is potentially efficient for targeting and visualizing tissues that are rich in 
macrophages (such as liver and spleen) or for diagnosing diseases with macrophage 
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activity (such as atherosclerosis, tuberculosis, and rheumatoid arthritis, etc.) (Kamat et 
al. 2010). On the other hand, for delivering particles to target tumors, a long blood 
circulation time with macrophage evasion is important and required, since the rapid 
removal of the nanoparticles from the blood circulation system will lead to a much 
reduced efficiency in SPIONs-based diagnostics and therapeutics.    
 
The size and surface properties of SPIONs play an important role in the interaction 
and clearance by cells. In general, nanoparticles larger than 200 nm are sequestered 
by the spleen and liver as a result of mechanical filtration; while particles below 10 
nm are rapidly removed by extravasation and renal clearance (Tsourkas et al. 2006). 
Apart from the particle size, the surface properties of particles are also important. 
Hydrophilic surface prevents interaction of nanoparticles with macrophage-based 
RES and increases the circulation time. On the other hand, hydrophobic surface leads 
to increasing opsonization and rapid removal of particles from circulation (Kumar et 
al. 2005). In addition, ionic surface leads to a higher uptake than a neutral surface, and 
the extent of phagocytosis is increased with increasing charge density. The rapid 
clearance of cationic particles may be due to the non-specific electrostatic interaction 
between the positively charged particles and the negatively charged cells. However, 
anionic particles also present significant uptake by macrophages due to their strong 
and non-specific adsorption on the plasma membrane which precedes the 
internalization step (Wilhelm et al. 2009). Therefore, in order to inhibit non-specific 
adsorption of plasma proteins and prolong blood circulation time, poly(ethylene 
glycol) (PEG) and its derivatives are introduced to the surface of particles to create 
non-fouling surface, resulting in an increase in the blood circulation time by several 
orders of magnitude (Danhier et al. 2010). 
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Besides colloidal stability and long blood circulation time, site-specific accumulation 
of SPIONs is also required for tumor targeting and therapy. Long-circulating 
nanoparticles can passively target tumors through the enhanced permeability and 
retention (EPR) effect. Due to the leaky tumor capillary fenestrations and inefficient 
lymphatic drainage, particles of 1-500 nm can leak into tumors over time (Figure 2-3) 
(Maeda 2001). However, the heterogeneous structures of tumors (such as 
vascularization, lymphatic drainage rate, and blood flow) as well as the in vivo 
barriers (such as blood-brain barrier) can prevent passively targeted particles from 
reaching the tumors, resulting in the limitation of the EPR effect (Danhier et al. 2010). 
Therefore, targeting ligands have been coupled on the surface of particles to 
specifically direct particles to tumors. The targeting ligands can recognize and bind to 
the receptors that are upregulated on cancer cells but not expressed by normal cells. 
Active targeting is particular useful for the delivery of drugs to reduce off-site toxicity 
and enhance anti-tumor efficacy due to improved uptake by cancer cells via receptor-
mediated endocytosis. 
 
Targeting ligands include antibodies, aptamers, peptides, proteins, and small 
molecules. Herceptin as a humanized Immunoglobulin G (IgG) monoclonal antibody 
can target breast cancer cells with over-expressed human epidermal growth factor 
receptor 2 (HER-2) which is a readily accessible surface receptor and has been widely 
researched for selective immunotargeting of tumor cells (Liu et al. 2008b). Due to its 
large hydrodynamic size, the antibody-conjugated particles may suffer from 
inefficient diffusion through biological barriers as well as rapid uptake by the RES. 
Small molecules have become more attractive than antibodies due to their small size 
and good stability. Folic acid is a small tumor-targeting molecule which has high 
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affinity for folate receptors (FRs) that are aggressively expressed in various types of 
cancers, including ovary, endometrium, breast, kidney, and myeloid cells of 
hematopoetic lineage (Xia and Low 2010). The FRs are generally absent in most 
normal human tissues except for placenta, lung, choroid plexus, kidney, and thyroid 
(Moghimi et al. 2001).  
 
Figure 2-3 In vivo behavior of nanoparticles in blood vessels. The EPR effect of 
nanoparticles is greatest at tumors (Jun et al. 2008). 
 
 
2.2 Surface Functionalization of SPIONs 
Although superparamagnetic iron oxide nanoparticles synthesized by high-
temperature decomposition method are monodisperse, they are typically coated with 
hydrophobic ligands, such as oleic acid and oleylamine. As such, they cannot be 
dispersed and are not stable without aggregation in a biological environment. Along 
with the need for colloidal stability, site-specific targeting is a critical requirement for 
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SPIONs in biomedical applications. Therefore, it is necessary to surface functionalize 
SPIONs to improve their stability and minimize biological non-specific adsorption.  
 
2.2.1 Materials for Surface Modification of SPIONs  
The stability of SPIONs results from the equilibrium between attractive and repulsive 
forces. When attractive interaction (such as Van Der Waals force, dipole-dipole 
interaction) dominates, Brownian motion leads to irreversible aggregation of the 
nanoparticles (Majewski and Thierry 2007). Stabilization of SPIONs can be achieved 
by playing on repulsive forces: electrostatic and steric repulsion. Electrostatic 
repulsion can be achieved in the presence of an electrical double layer while steric 
repulsion is provided by adsorption or grafting of polymers on the nanoparticles. 
However, electrostatic repulsion is influenced by salt concentration. Electrical double 
layer around the charged nanoparticles will be suppressed when the ion strength of the 
aqueous media is increased, leading to eventual agglomeration of the nanoparticles. 
Therefore, steric stabilization is preferred because it is less sensitive to the ionic 
strength of the dispersion medium, and can be achieved in both polar and non-polar 
medium. The materials used for steric stabilization of SPIONs are normally organic 
monomer stabilizers, organic polymer stabilizers, and inorganic stabilizers.  
 
2.2.1.1 Monomer Stabilizers  
Low molecular weight stabilizers that consist of one high affinity anchor group can be 
bound to the surface of SPIONs to tailor their dispersibility in aqueous media. 
Dopamine, a derivative of the amino acid DOPA which is abundantly present in the 
mussel adhesive protein (Waite and Tanzer 1981), has been widely used as a high 
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affinity binding group for stabilizing SPIONs in water and physiological media 
(Reimhult et al. 2009). Xu et al. (2004) reported that dopamine serves as a robust 
anchor on the surface of iron oxide nanoparticles to attain exceptional stability of 
nanoparticles under heating and high salt concentration. The mechanism for the strong 
affinity of dopamine for magnetic nanoparticles was investigated by Chen et al. (2002) 
using a spectroscopic method. They reported that the enediol groups of dopamine 
convert the under-coordinated Fe surface sites back to a bulk-like lattice structure 
with an octahedral geometry for oxygen-coordinated iron. Moreover, each dopamine 
molecule has one amino group that can be used as a functional site for further 
immobilization of functional groups on the surface of SPIONs. However, dopamine 
can be oxidized to form dopamine quinine, which is highly reactive and is suggested 
to be cytotoxic (Carpenter et al. 2007). 
 
Carboxylates, such as citric acid, dimercaptosuccinic acid, and galactaric acid, can 
also stabilize SPIONs in an aqueous dispersion. It was reported that the carboxyl 
group interacts with a Fe3+ ion located on the surface by forming a bridge with the 
two oxygen atoms (Hatton and Lattuada 2007; Muller et al. 2008). This leaves at least 
one carboxylic acid group exposed to the solvent, which would be responsible for 
improving the hydrophilic properties of the SPIONs. Hatton and Lattuada (2007) have 
exploited this method to prepare monodisperse, water-soluble magnetic nanoparticles. 
In addition, carboxylates can be effectively used to tune the particles size (Ishikawa et 
al. 1993). For example, Bee et al. (1995) reported that the average diameter of citrate-
coated nanoparticles can be varied from 3 to 8 nm by decreasing the concentration of 
citrate ions. However, the stability is strongly dependent on pH and the concentration 
of adsorbed acids.  
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2.2.1.2 Polymer Stabilizers  
Polymeric coating materials can be divided into synthetic and natural. Polymers based 
on PEG, poly(lactic-co-glycolic acid) (PLGA), poly(N-isopropylacrylamide) 
(PNIPAAm), poly(amido amine) (PAMAM) dendrimers, etc. are typical examples of 
synthetic polymers. Chitosan, dextran, gelatin, phospholipids, etc. are the most 
common natural polymers. Dextran and PEG as the typical and representative 
polymeric stabilizers are discussed in detail in the following section. 
 
Dextran is a polysaccharide polymer and consists of a great number of α–D-
glucopyranosyl units with various degrees of chain branching and length (Muller et al. 
2008). Dextrans of different molecular weights (between 40-70 kDa) have many 
advantages, such as biocompatibility, good water solubility, high stability due to the 
glucosidic bonds, and the presence of numerous reactive hydroxyl groups that allow 
further conjugation of functional molecules (Maitra and Bisht 2009). They have been 
widely used to coat magnetic nanoparticles. Dextran or its derivatives (e.g. 
carboxymethyl dextran) coated SPIONs have been approved by the US Food and 
Drug Administration (FDA) as MRI contrast enhancement agents. For example, 
Ferumoxtran-10 consists of monocrystalline iron oxide core coated with a thick 
dextran layer, and it shows prolonged blood residence time (half-life of 25-30 hours). 
Hence, it can be used as an intravenous contrast agent for MR imaging of tumors or 
macrophages located in deep and pathologic tissues, such as kidney, brains, and 




PEG is a hydrophilic, water-soluble, biocompatible polymer. PEG-coated SPIONs 
exhibit excellent solubility and stability in aqueous medium as well as in 
physiological medium. Moreover, PEG can be used to create a non-fouling surface to 
prevent non-specific adsorption, leading to increased blood circulation time and 
reduced uptake by phagocytic cells like macrophages. Many investigations have 
reported the utilization of PEG to increase the biocompatibility of the iron oxide 
nanoparticles and blood circulation times (Zhang et al. 2006b; Sun et al. 2007a; 
Labhasetwar et al. 2010). The non-fouling property of PEG may be attributed to its 
numerous ethylene oxide groups, which give rise to a large hydration volume, and 
also to the osmotic repulsion generated by the polymer chains which inhibit protein 
adsorption (Majewski and Thierry 2007). As a result of their resistance to non-
specific protein adsorption, PEGylated nanoparticles have been successfully used for 
drug delivery (Zhang et al. 2006a; Labhasetwar et al. 2010). 
 
2.2.1.3 Inorganic Stabilizers  
A drawback of polymer stabilizers is the relatively low intrinsic stability of the 
coating at higher temperature (Lu et al. 2007). Therefore, silica and gold are used for 
protecting magnetic nanoparticles against deterioration. These nanoparticles have an 
inner iron oxide core with an outer metallic shell of inorganic materials. Silica has 
been exploited as a coating material for magnetic nanoparticles (Tartaj et al. 2002; 
Hyeon et al. 2006; Korgel et al. 2008). The Stöber method is a well-known and 
prevailing approach for coating magnetic nanoparticles, a process in which silica is 
formed in situ through the hydrolysis and condensation of a sol-gel precursor (e.g. 
tetraethyl orthosilicate (TEOS)). The coating thickness can be controlled by changing 
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the amount of TEOS. The silica coatings have several advantages due to their ability 
to protect the magnetic cores and to prevent aggregation via variation of the shell 
thickness. Moreover, the presence of surface silanol groups can enable the covalent 
attachment of functional ligands (Ulman 1996). For example, amino groups or 
fluorescent groups have been introduced on the surface of silica-coated magnetic 
nanoparticles by hydrolysis and condensation of 3-aminopropyltriethyoxysilane 
(APTES) or fluorescein isothiocyanate-linked APTES on the surface of magnetic 
nanoparticles, respectively (Wang et al. 2011). Recently, mesoporous silica shell-
coated magnetic nanoparticles obtained after acid etching have been applied for 
controlled drug release (Haam et al. 2008; Nel et al. 2008). 
 
Gold (Au) is another inorganic coating which is appropriate for protecting the iron 
core against oxidation. Since gold can form strong bonds with sulfur, the gold shell 
also allows facile conjugation with a variety of biomolecules, making these 
composites useful in biomedical applications. For example, gold-coated magnetic 
nanoparticles with thiolated PEG masks them from the intravascular immune system 
(Williams and Latham 2006). Moreover, gold nanocrystals exhibit an absorption band 
in the visible region due to its surface plasmon phenomenon, allowing the gold-coated 
magnetic nanoparticles to be used for optical applications (Daniel and Astruc 2004; 
Lee et al. 2008). It was suggested that gold-coated magnetic nanoparticles could be 




2.2.2 Methods for Surface Modification of SPIONs  
There are two general strategies for surface functionalization of SPIONs for 
biomedical applications: the “one-pot” and post-synthesis methods. “One-pot” 
approaches involve nanoparticles that are simultaneously synthesized and coated with 
suitable macromolecules. Polysaccharides such as dextran or citric acid have been 
widely used to stabilize SPIONs synthesized via the co-precipitation method and there 
are commercial products such as ferumodextran which are prepared by this method 
(Majewski and Thierry 2007). SPIONs synthesized by thermal decomposition 
methods are usually coated with oleic acid and oleylamine, but Li and co-workers 
reported the synthesis of water-soluble and biocompatible PEGylated nanoparticles by 
thermal decomposition of iron(III) acetylacetonate in presence of mPEG-COOH (Gao 
et al. 2005; Gao et al. 2006). The post-synthesis strategies include physical adsorption 
or chemical grafting of macromolecules. Some of the common post-synthesis 
methods are summarized in this section.   
 
2.2.2.1 Self-assembly 
One type of self-assembly based on hydrophobic interaction between hydrophobic 
SPIONs and amphiphilic copolymers enables the generation of core-shell micellar 
nanoparticles in aqueous solution. The hydrophobic core serves as a carrier for oleic 
acid-stabilized SPIONs or hydrophobic anticancer drugs which are physically 
encapsulated in the micellar particles, while the hydrophilic shell renders the particles 
stable in aqueous media. Targeting ligands can then be attached to the surface of these 




Polyester-based hydrophobic polymers prepared by ring-opening polymerization, 
such as poly(lactic acid) (PLA), poly(ε-caprolactone) (PCL) and PLGA, have been 
intensely investigated due to their biocompatibility and biodegradability. For example, 
Hu et al. (2009) synthesized a well-controlled PLA-b-PPEGMA amphiphilic 
copolymer via a combination of ring-opening polymerization of lactide and atom 
transfer radical polymerization (ATRP) of PEGMA. The copolymer self-assembled in 
the presence of SPIONs and was further functionalized with folic acid for cancer cell 
targeting. Huh and co-workers (2007) reported the use of a well-defined COOH-
terminated PLGA-b-PEG amphiphilic block copolymer to encapsulate hydrophobic 
SPIONs and doxorubicin (DOX). The resulting core-shell nanoparticles were further 
functionalized with an antibody for ultra-sensitive targeted detection by MRI and 
these nanoparticles showed synergistic effect for the inhibition of tumor growth. 
Folate-conjugated PCL-b-PEG copolymer developed by Shuai et al. (2008) were self-
assembled to encapsulate SPIONs and DOX and the resulting nanoparticles can 
efficiently transport anticancer drugs to tumors. Other amphiphilic copolymers, such 
as Pluronic F127 (Lai et al. 2010) and lipid (Bronstein et al. 2007), have also been 
used to encapsulate SPIONs and chemotherapeutic agents, for potential chemotherapy 
and MRI detection of cancers. 
 
Another type of self-assembly generates polyelectrolyte capsules from electrostatic 
layer-by-layer (LBL) self-assembly, which is based on electrostatic interaction 
between SPIONs and anionic or cationic polymers. The LBL technique was first 
applied to assemble oppositely charged polyelectrolytes, and then be rapidly extended 
to other systems such as polymeric nanocrystals, metal and semiconductor 
nanoparticles (Ai 2011). LBL self-assembly is now recognized as one of the 
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nanotechnologies that advanced the applications of MRI and drug delivery, since LBL 
capsules can be designed for encapsulation of SPIONs or drugs. The oppositely 
charged polyelectrolytes can be selected either from synthetic or natural polymers, 
such as poly-L-lysine, poly-L-glutamic acid, poly-L-aspartic acid, hyaluronic acid, 
heparin, and chitosan. For example, cationic SPIONs were modified with a bilayer 
composed of polystyrene sulfonate sodium salt and FA-functionalized PAMAM 
dendrimers via LBL assembly (Wang et al. 2007). The resulting multifunctional 
magnetic nanoparticles can target cancer cells and can be used in MRI. Recently, Liu 
et al. (2011b) reported the synthesis of magnetic-targeted and pH-sensitive drug 
delivery system based on LBL self-assembly of polyelectrolytes (oligochitosan as the 
polycation and sodium alginate as the polyanion) onto the cores composed of SPIONs 
and drugs.  
 
However, it is difficult for the non-covalently attached polymeric surface coatings to 
maintain the stability of the functionalized SPIONs in biological environments, since 
the stability is influenced by ionic strength of the medium, the coating structure and 
the amount of coating. Thus, SPIONs have also been modified via the covalent 
attachment of functionalized polymers.   
 
2.2.2.2 Surface-initiated Controlled Polymerization 
Covalent attachment of functionalized polymers is commonly carried out via two 
techniques: “grafting to” and “grafting from”. In the “grafting to” technique, end-
functionalized polymers react with the surface groups of SPIONs. The drawback of 
this method is the low grafting density due to the steric hindrance posed by already 
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attached polymers which restrict access to the reactive surface sites. This drawback 
can be overcome by using the “grafting from” method (also called surface-initiated 
polymerization), in which polymer chains grow in situ from the surface of SPIONs. 
Higher grafting density can be obtained because it is easier for the smaller monomers 
to gain access to the active initiation sites. 
 
Recently, “living”/controlled radical polymerizations, such as ATRP, nitroxide-
mediated radical polymerization, and reversible addition-fragmentation chain transfer 
(RAFT) polymerization, have been successfully used in surface-initiated 
polymerization to  precisely control the molecular weight and composition of polymer 
chains (Lu et al. 2010). In particular, ATRP that is catalyzed by transition metal 
complexes and uses halogen-containing initiators has gained much interest, as it offers 
good control of the mass distribution, homogeneous number of grafts, and tolerance 
against impurities (Schmidt et al. 2009). Since the first report of  ATRP of styrene on 
magnetic nanoparticles by Vestal and Zhang (2002), ATRP has been successfully 
applied for a wide range of vinyl monomers, acrylates, and methacrylates to modify 
magnetic nanoparticles, generating linear and various branched polymeric shells 
(Neugebauer et al. 2011).  
 
PEGylated magnetic nanoparticles with a dense layer of PEGMA by surface-initiated 
ATRP has been synthesized by Hu and co-workers (2006). In this approach, a silane 
initiator was first immobilized onto the magnetic nanoparticles surface, and then 
PEGMA was grafted onto the surface of magnetic nanoparticles via copper-mediated 
ATRP. The grafted PEGMA chains are stable and enable the modified magnetic 
nanoparticles to disperse well in aqueous solutions. The resulting PEGylated magnetic 
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nanoparticles are macrophage-evading, as the uptake of these nanoparticles by 
macrophages is greatly reduced from 158 pg/cell to < 2 pg/cell over a five days period 
after grafting with PEGMA. Moreover, the pendant hydroxy groups of the polymer 
brushes could serve as reactive sites for the conjugation of functional groups.  
 
SPIONs coated with thermo-responsive polymeric shells have been synthesized via 
ATRP of NIPAAm (Wuang et al. 2006; Liu et al. 2011a). It is well-known that the 
PNIPAAm experiences a coil-to-globule phase transition from hydrophilic, water-
swollen state to a hydrophobic, globular state in aqueous solution when heated to 
above its lower critical solution temperature (LCST) of 32 oC. Since PNIPAAm 
expels its liquid contents at a temperature near that of the human body, the 
PNIPAAm-coated thermo-sensitive magnetic nanoparticles could be designed for the 
potential applications in targeted and controlled drug delivery. 
 
2.3 Biomedical Applications of SPIONs 
2.3.1 MRI 
Molecular imaging, such as optical imaging, MRI, and positron emission tomography 
(PET), is a very useful non-invasive diagnostic technique that offers the ability to 
monitor cell behavior in vivo (Noth et al. 2008). This non-invasive technique is 
repeatable without irreversible tissue removal procedures. Among the different 
molecular imaging modalities, MRI is one of the best imaging modalities in both 
research and clinical fields for injury and disease diagnosis as it offers high spatial 
and temporal information with excellent resolution. 
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The fundamental mechanisms of MRI are based on computer-assisted imaging of 
relaxation signals of hydrogen nuclei, which are abundant in water and lipids of 
tissues, excited by radiofrequency waves in a strong magnetic field. According to 
different pathways of the relaxation, MRI can be classified into longitudinal 
relaxation time (T1)- and transverse relaxation time (T2)-weighted images. Due to the 
intrinsic different T1 and T2 times of different parts of the tissues, magnetic resonance 
(MR) signal intensities are changed, resulting in an imaging contrast (Qin et al. 2007). 
MRI contrast agents have been applied to further enhance the contrast by shortening 
the T1 or T2 where they are accumulated. T1 contrast agents (such as manganese or 
gadolinium chelates) generate brighter images, while T2 contrast agents (such as 
SPIONs) produce darker images. SPIONs-based T2 contrast agents are more 
advantageous than gadolinium-based T1 contrast agents, since the effect of SPIONs on 
proton relaxation rates is 10-fold stronger than that of gadolinium. Thus, SPIONs can 
potentially be detected at a much lower concentration (Rogers and Basu 2005).  
 
SPIONs have been used as T2 contrast agents for over 20 years. The degree of the T2 
contrast effect is typically represented by the spin-spin relaxivity R2 (R2=1/T2). The 
higher the R2 values, the greater the contrast effects. By plotting R2 against the 
molarity of magnetic atoms, the relaxivity coefficient r2 is obtained, which is a 
standardized contrast enhancement indicator (Jun et al. 2008). The particle size is an 
important parameter for MRI contrast enhancement by SPIONs. The size dependent 
effect has been well demonstrated by Cheon’s group (Jun et al. 2008). As shown in 
Figure 2-4, mass magnetization values of SPIONs increase from 25 to 102 emu per 
gram Fe with increasing size of SPIONs from 4 to 12 nm, resulting in an increase in r2 
values from 78 to 218 mM-1s-1. The MR contrast is correspondingly changed from 
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light grey to black. In addition, the MR contrast effect relies on the local 
concentration of the contrast agents. The specific high accumulation of SPIONs at the 
targeted sites will lead to an enhanced MR contrast effect with high resolution. 
 
Figure 2-4 Size effects of SPIONs on magnetism and MR contrast effects. 
 
 
Various types of SPIONs-based contrast agents with different biodistribution have 
been developed. The particles that are readily taken up by the RES and accumulate in 
the liver, spleen, and lymph nodes, have been developed for detecting tumors or 
lesions in these organs and for investigating the pathogenesis of disease with 
phagocytes activity by in vivo tracking cell movement. Dextran-coated SPIONs with 
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different sizes have been used clinically as MRI contrast agents, such as Feridex® 
(off production since 2008), Resovist® (off production since 2009), and Combidex® 
(off production since 2008), etc. Resovist®, a carboxydextran-coated SPIONs with 
size ranging between 45 and 60 nm, used to be a commercial liver-specific MR 
contrast agent for the differentiation of malignant versus benign lesions.  Dextran-
coated SPIONs with size smaller than 10 nm are potentially useful to detect lymph 
node metastases. In addition, since macrophages play central roles in mediating a 
broad range of inflammatory and infectious diseases, macrophages-based MRI has 
been applied to visualize organ graft rejection as well as to detect induced 
inflammation and atherosclerotic plaque development. Targeting ligands, such as 
hyaluronic acid (Kamat et al. 2010) and IgG (Weissleder et al. 1991), have been 
conjugated to the surface of SPIONs to enhance the efficiency and selectivity of 
accumulation of SPIONs in macrophages. 
 
On the other hand, long blood circulating contrast agents with minimal non-specific 
uptake by the RES are useful for blood pool and non-phagocytic cells imaging. PEG 
coating is usually used to confer the SPIONs–based contrast agents with the RES-
evading property. Various types of targeting ligands, such as aptamers, peptides, and 
small molecules have been incorporated to improve the detection and specific 
targeting by the nanoparticles. For example, Zhang et al. (2006b) reported the 
synthesis of folic acid-modified PEG-coated SPIONs for in vivo detection of human 
adenocarcinoma HeLa cells by MRI. Herceptin-conjugated water-soluble SPIONs 
have been investigated for in vivo MRI-based detection of human breast cancer cells 





Figure 2-5 Color maps of T2-weighted MR images of cancer cells implanted mice at 
different temporal points after intravenous injection of Herceptin-conjugated SPIONs. 
An immediate (5 min) color change at the tumor site is evident (Huh et al. 2005). 
 
 
2.3.2 Drug/Gene Delivery 
The first concept of using magnetic particles for drug delivery in cancer therapy was 
proposed by Widder, Senyi, and colleagues in the late 1970s (McBain et al. 2008). 
The basic idea is the encapsulation, attachment, or adsorption of therapeutic agents 
(such as drugs, DNA, and siRNA) onto the magnetic particles. These magnetic 
particles may have magnetic cores with a polymer coating. With a combination of an 
external magnetic field and specific targeting ligands, magnetic particles-based 
carriers are effective tools for directing therapeutic agents specifically to disease sites 
(Figure 2-6). Once the magnetic carriers are accumulated at tumors or other targeted 
sites in vivo, the therapeutic agents are then released from the magnetic carriers via 
enzymatic activity or through changes in physiological conditions such as temperature 
or pH. This method is advantageous for reducing dosage and side effects associated 
with non-specific uptake of cytotoxic drugs by healthy tissues (Dobson 2006; Sun et 





A number of studies have demonstrated the advantages of magnetic particles-based 
carriers for drug delivery. Zhang et al. (2006a) developed methotrexate (MTX)-
immobilized PEG-coated SPIONs. MTX is a therapeutic drug that can target cancer 
cells with overexpression of folate receptors. These particles can be specifically 
delivered to tumor cells to induce cellular apoptosis. Recently, a magnetic carrier for 
targeted MRI detection and treatment of breast cancer has been developed by Huh et 
al. (2007). In this system, SPIONs and anticancer drug (doxorubicin) are encapsulated 
with an amphiphilic polymer and Herceptin is conjugated for targeting the breast 
cancer. These particles show excellent inhibition of tumor growth and ultra-sensitive 
targeted detection by MRI in vivo. In addition, PAMAM dendrimers or PEG-PEI 
coated magnetic particles, which allows efficient loading and protection of nucleic 
acids, can be potentially used to advance gene delivery and therapy (Hao et al. 2010).      
 
 
Figure 2-6 A hypothetical magnetic drug delivery system shown in cross-section: a 
magnet is placed outside the body in order that its magnetic field gradient might 





Magnetic carriers-based intravesical drug delivery (IDD) has been used for bladder 
cancer therapy to prolong the residence time of the instilled drug in the bladder. IDD 
involves direct instillation of drug into the bladder via a catheter, which has proved to 
be an effective method to attain high local concentrations of the drug with minimal 
systemic effects (GuhaSarkar and Banerjee 2010). However, IDD also has its 
limitations. One of the limitations is the short residence time of the drug in the bladder, 
due to the periodical voiding of urine from the bladder which flushes out the instilled 
drug solution. Thus, frequent dosage is required. The other limitation is the bladder 
permeability barrier (BPB) which inhibits drug penetration into the bladder wall. The 
main site of BPB is located at the umbrella cells, which are superficial cells in the 
transitional epithelium of the bladder (Figure 2-7). The umbrella cells erect a 
watertight barrier based on scalloped-shaped plaques that are composed of uroplakins, 
and tight junctions joining its apical surface (Tyagi et al. 2006). Furthermore, the 
permeability of urothelium is augmented by the presence of mucin layer on the 
surface of umbrella cells. The mucin layers are composed of hydrophilic 
glycosaminoglycans (GAGs), which can physically block adhesion of instilled drug or 
drug carriers from reaching the underlying tight junctions and cell membranes (Tyagi 
et al. 2006). Therefore, drug-loaded magnetic particles are promising for overcoming 
the limitations of the traditional IDD for bladder cancer therapy. They can be 
localized in tumors by using an external magnet, which provides continuous exposure 
of tumors to high drug concentrations (Shen et al. 2008). It has been reported that 
administration of doxorubicin-loaded magnetic particles in swine bladder followed by 
external magnetic targeting resulted in accumulation of particles in the superficial and 
deep tissues of the magnetic-targeted sites which were retained for at least 44 days 




Figure 2-7 Illustration of bladder permeability barrier established by uroplakin 
covered umbrella cells of bladder epithelium (urothelium) and GAG layer that 
prevents adhesion (Tyagi et al. 2006). 
 
2.3.3 Hyperthermia 
Tumors are more sensitive and susceptible to heat than normal tissues in vivo, since 
their disorganized vascular structure makes it more difficult to dissipate heat. 
Significant cell death can result when the temperature is higher than 41 oC. Therefore, 
hyperthermia based on the generation of heat at the tumor site is a promising cancer 
therapy and is a supplementary treatment to chemotherapy, radiotherapy, and surgery 
(Lu et al. 2007). Traditional hyperthermia treatment refers to temperature in the range 
of 41-46 oC at the cellular and tissue levels, which is differentiated from thermo 
ablation that causes direct tissue necrosis at the temperature > 46 oC (up to 56 oC) 
(Kumar and Mohammad 2011).  
 
The application of magnetic materials for hyperthermia treatment was first proposed 
in 1957 (Gilchrist et al. 1957). In this strategy, magnetic materials are distributed 
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throughout the targeted tumor site, and heat is generated at the tumor site by an 
external alternating current (AC) magnetic field. The mechanism is based on the 
conversion of magnetic energy (generated due to magnetic moment fluctuations) into 
thermal energy via Brownian or Néel relaxation (Fortin et al. 2007). The specific 
absorption rate (SAR) or specific loss power (SLP) is generally used to define the 
transformation of magnetic energy to heat. Higher SLP values (i.e. higher temperature 
enhancement rate) of magnetic materials are desirable since they can generate heat 
efficiently. SLP values generally depend on the structure of the magnetic materials 
(such as size, shape, and crystal structure), magnetic properties (such as magnetic 
anisotropy), and amplitude and frequency of the applied AC magnetic field (Kumar 
and Mohammad 2011). 
 
Compared to conventional hyperthermia treatment such as ultrasound, microwaves, 
radiofrequency, and infrared radiation, SPIONs-based hyperthermia treatment has 
many advantages. SPIONs with conjugated targeting ligands can specifically and 
effectively target tumor site, resulting in generation of heat only at the tumor site with 
minimal damage to the healthy tissues. Furthermore, SPIONs-based hyperthermia can 
also be utilized for controlled drug delivery. For example, the “on-off” release of drug 
from SPIONs-loaded thermal sensitive PNIPAAm hydrogel can be tuned by an 
external oscillating magnetic field (Satarkar and Hilt 2008). The synergistic 
combination of chemotherapy and SPIONs-based hyperthermia treatment provides 
potential opportunity for the development of multi-therapeutic modalities with 
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Macrophages play an important role in clearing foreign materials from blood 
circulation. They also play a pivotal role in the pathophysiology of inflammatory 
neurological disorders, such as Alzheimer’s disease and Parkinson’s disease, which 
are characterized by extensive recruitment of macrophages towards the inflammation 
site (Vyas et al. 2003; Stoll et al. 2004). Moreover, macrophages have been used as 
Trojan horses for drug delivery (Gendelman et al. 2006). Thus, macrophage imaging 
in vivo provides the means for understanding the progression of numerous diseases, 
and evaluating the efficacy of drugs as indicated by the macrophage response. 
However, in other in vivo applications, the non-specific uptake of SPIONs by 
macrophages may pose a serious limitation. The rapid removal of the SPIONs from 
the blood circulation system results in a drastic reduction in their possibility of 
reaching the target organs (Berry and Curtis 2003).  
 
In this Chapter, the formulation of polymeric surface coatings of SPIONs for 
modulation of the uptake by macrophages is described. Since an anionic surface can 
result in a significant uptake by macrophages as discussed in Chapter 2, poly(DL-
lactic acid-co-malic acid) (PLMA) was synthesized and used as a highly efficient 
label for macrophages. PLMA as a surface coating of SPIONs has many advantages, 
such as its biodegradability and biocompatibility. Moreover, the amphiphilic nature of 
PLMA copolymer enables the encapsulation of hydrophobic SPIONs and renders the 
resulting nanoparticles water-soluble and anionic due to the abundance of carboxyl 
groups in the malic acid units. Different compositions of PLMA can be obtained by 
varying the mass ratio of malic acid to lactic acid during synthesis. The PLMA-coated 
SPIONs (PLMA-SPIONs) were assessed for their potential as a high contrast MRI 
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probe from their physical properties, magnetic resonance enhancement effects, 
interaction with macrophages and cytotoxicity. On the other hand, for applications 
where evading macrophages is desired, the PLMA copolymer can be readily modified 
by covalent attachment of H2N-PEG to obtain the PLMA-PEG copolymer, and used 
for coating the SPIONs (PLMA-PEG-SPIONs). PLMA offers an abundance of 
functional groups (i.e. –COOH) for attaching the PEG and the extent of macrophage 
uptake of the PLMA-PEG-SPIONs can be modulated by varying the PEG content of 
the copolymer. This flexibility, together with the favorable physical properties and 
magnetic resonance enhancement effect of the PLMA-SPIONs and PLMA-PEG-













3.2 Materials and Methods 
3.2.1 Materials  
DL-lactic acid (85%), DL-malic acid (98%), iron(III) acetylacetonate (Fe(acac)3) 
(99%), 1,2-hexadecanediol (90%), oleic acid (90%), oleylamine (90%), N,N’-
dicyclohexylcarbodiimide (DCC) (99%), N-hydroxysuccinimide (NHS) (97%) and 
benzyl ether (99%) were purchased from Sigma-Aldrich and used as received. 
Methoxy PEG Amine (H2N-PEG) (MW 2000) was purchased from Jenkem 
Technology. Mouse macrophages (RAW 264.7) were purchased from ATCC. RPMI-
1640 medium, fetal bovine serum, L-glutamine, and penicillin were purchased from 
Sigma-Aldrich. All other solvents and chemicals were purchased from Fisher 
Scientific and used as received.  
 
3.2.2 Preparation of SPIONs   
SPIONs of ~12nm diameter were synthesized by seed-mediated growth according to a 
previously reported method (Sun et al. 2004): Fe(acac)3 (3.532 g, 10 mmol), 1,2-
hexadecanediol (12.922 g, 50 mmol), oleic acid (8.474 g, 30 mmol), oleylamine 
(8.024 g, 30 mmol), and benzyl ether (100 mL) were mixed and magnetically stirred 
under nitrogen protection. The mixture was heated to 200 °C for 2 h and then heated 
to 300 °C for another 1 h. The heating source was removed and the black mixture was 
allowed to cool to room temperature. Under ambient conditions, ethanol (200 mL) 
was added to the mixture, and the black material was precipitated and separated via 
centrifugation (at 6000 rpm for 10 min). The precipitate was dissolved in 80 mL of 
hexane in the presence of oleic acid (2 mL) and oleylamine (2 mL). Centrifugation 
(6000 rpm, 10 min) was applied to remove any undispersed residue. The product, 
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oleic acid-stabilized SPIONs of 8~10 nm, was then precipitated with ethanol and 
collected by centrifugation (6000 rpm, 10 min). The nanoparticles were dried under 
reduced pressure and stored at 4 °C. To produce the ~12 nm SPIONs, 80 mg of 8~10 
nm SPIONs seeds were reacted with Fe(acac)3 (2 mmol) and the diol (10 mmol) under 
the same conditions as described above.  
 
3.2.3 Synthesis of PLMA Copolymers 
40.0 mL of 85% lactic acid solution (0.378 mmol of lactic acid) were poured into a 
100 mL round-bottomed flask. After three rounds of nitrogen replacement, this 
solution was gradually heated to 140 °C under reduced pressure for 8 h to remove the 
water which was formed in the polycondensation process. DL-malic acid at different 
mass ratios (1:1, 2:1 and 3:1) to the obtained viscous oligomer of poly(DL-lactic acid) 
was added under nitrogen protection. This system was kept at 140 °C with magnetic 
stirring under reduced pressure for another 24 h. The resulting PLMA was dissolved 
in tetrahydrofuran (THF), then precipitated with a large amount of ethyl ether, and 
finally dried under vacuum. The polymers synthesized using malic acid : lactic acid 
mass ratios of 1:1, 2:1 and 3:1 are denoted as PLMA-1, PLMA-2, and PLMA-3, 
respectively. 
 
3.2.4 Synthesis of PLMA-PEG Copolymers  
100 mg of PLMA-1 (0.42 mmol of carboxyl groups) were dissolved in 20 mL of dry 
THF, and then DCC, NHS and H2N-PEG were added. The molar ratios of PEG to 
carboxyl groups in PLMA-1 used were 0.2:1, 0.5:1 and 0.8:1. The mixture was stirred 
overnight at room temperature and then filtered. The filtrate was precipitated by ethyl 
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ether and dried under vacuum. The product is denoted as PLMA-1-PEG-1, PLMA-1-
PEG-2, and PLMA-1-PEG-3, for the reactant ratio of PEG to carboxyl groups of 
PLMA-1 of 0.2:1, 0.5:1, and 0.8:1, respectively. 
 
3.2.5 Preparation of PLMA-SPIONs and PLMA-PEG-SPIONs 
40.0 mg of PLMA (three different compositions were used) or PLMA-1-PEG (three 
different compositions were used) was dissolved in 15 mL of THF, and 10.0 mg of 
the ~12 nm oleic acid-stabilized SPIONs were dissolved in 15 mL of chloroform. The 
two solutions were then mixed together and continuously stirred overnight at room 
temperature. The solvent was removed under reduced pressure with mild heating; and 
the resulting black viscous material was dispersed in 10 mL acetone, and then added 
dropwise into 50 mL of DI water under vigorous stirring. After evaporation of acetone, 
the product was centrifuged at 20000 rpm for 10 min and washed with DI water, and 
then dried using a lyophilizer. The obtained nanoparticles are denoted as PLMA-
SPIONs (i.e. PLMA-1-SPIONs, PLMA-2-SPIONs, and PLMA-3-SPIONs) and 
PLMA-PEG-SPIONs (i.e. PLMA-1-PEG-1-SPIONs, PLMA-1-PEG-2-SPIONs, and 
PLMA-1-PEG-3-SPIONs), respectively. 
 
3.2.6 In Vitro Quantification of Nanoparticles Uptake by Macrophages  
Mouse macrophages (RAW 264.7) were routinely cultured in RPMI-1640 medium, 
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 IU/mL penicillin 




For quantification of the intracellular uptake of the nanoparticles, the cultured cells 
were seeded in 24-well culture plates at a density of 105 cells/well in 1 mL medium 
for 24 h before the medium was replaced with fresh medium containing various 
concentrations of PLMA-SPIONs or PLMA-PEG-SPIONs. In the control experiment, 
the cells were seeded and cultured in the same manner but without nanoparticles.  
After pre-determined incubation periods, the cells were washed with PBS to remove 
the loosely attached and free nanoparticles in the medium, and then detached with 
trypsin-EDTA solution (0.25% trypsin). After counting with a hemocytometer, the 
cells were collected by centrifugation, and the cell pellet was dissolved in 37% HCl at 
60 °C for 2 h. The iron concentration was determined using the HP 7500a inductively 
coupled plasma mass spectrometry (ICP-MS) (Agilent Technologies). Three 
replicates were measured, and the results were averaged.  
 
Prussian Blue staining was used to qualitatively assess the cellular uptake of 
nanoparticles. The PLMA-SPIONs labeled cells were washed three times with PBS to 
remove nanoparticles which were loosely attached to the cells, and then were fixed in 
5% formaldehyde in PBS for 15 min. The cells were then washed with water and 
incubated for 30 min with a mixture of 5% potassium ferrocyanide and 5% 
hydrochloric acid in equal volumes. Finally, the cells were washed with water, 
counterstained with Nuclear Fast Red for 5 min and washed with water. A Leica 




3.2.7 Cytotoxicity Assay of Nanoparticles  
The cytotoxicities of PLMA-SPIONs and PLMA-PEG-SPIONs were evaluated by 
determining the viability of macrophages after incubation in medium containing the 
nanoparticles. Cell viability testing was carried out via the reduction of the MTT 
reagent (methylthiazolyldiphenyl-tetrazolium bromide). The MTT assay was 
performed in a 96-well plate following the standard procedure with minor 
modifications (Mosmann 1983). Control experiments were carried out using the 
complete growth culture medium (non-toxic control). Cells were first seeded at a 
density of 104 cells/well in 100 μL medium for 24 h before the medium was replaced 
with one containing the nanoparticles at determined iron concentration. The cells were 
then incubated at 37 °C and 5% CO2 for 24 h. The culture medium from each well 
was removed and 90 μL of medium and 10 μL MTT solution (5 mg/mL in PBS) were 
then added to each well. After 4 h of incubation at 37 °C and 5% CO2, the medium 
was removed and the formazan crystals were solubilized with 100 μL dimethyl 
sulfoxide (DMSO) for 15 min. The optical absorbance was then measured at 570 nm 
on a microplate reader (Tecan GENios). The results were expressed as percentages 
relative to the results obtained with the non-toxic control. The results obtained with 
the various samples and the controls were analyzed statistically using the two-sample 
t-test and the differences observed were considered significant for P<0.05. 
 
3.2.8 MRI Experiments 
MRI experiments were performed at 25 °C in a clinical magnetic resonance scanner 
(Siemens Trio; 3T). PLMA-SPIONs or PLMA-PEG-SPIONs at different iron 
concentrations were suspended in tubes of water (20 mL). The tubes were placed into 
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a standard human head coil, singly for gradient-echo sequences or all together for 
spin-echo sequences, to obtain an image of a circular central slice (4 mm thickness; 
‘coronal’ review) for each tube. T2 relaxation times for PLMA-SPIONs were 
determined from a multi-echo spin-echo sequence (32 echoes; repetition time (TR): 
3000 ms; echo times (TE): 9.2–294.4 ms with 9.2 ms interval). T2 relaxation times for 
PLMA-PEG-SPIONs were determined from a multi-echo spin-echo sequence (32 
echoes; TR: 1600 ms; TE: 8–160 ms). T2* relaxation times were determined for each 
tube independently using a multi-echo gradient-echo sequence (8 echoes; TR: 1600 
ms; TE: 4, 8, 12, 16, 20, 24, 40, 80 ms) and great care was taken to place the imaged 
slice at the centre of the contents of each tube. T1 relaxation times were determined 
from a saturation recovery experiment using spin-echo images obtained with a 
number of TRs (7 TRs; TR: 25–6400 ms; TE: 9 ms). T1 and T2 spin-echo sequences 
(10 repetitions for R2 while 4 repetitions for R1 sequences) were repeatedly obtained 
over a period of 12 h while the samples remained in the scanner to assess the stability 
of the nanoparticles in solution under prolonged exposure to a magnetic field. The 
relaxation rates (R1, R2, R2*) for each sample were computed using the MATLAB 
V7.1 software by non-linear least squares fitting of appropriate exponential functions 
to plots of signal against TE or TR. Relaxivities (r1, r2, r2*) were computed using 
linear regression analysis (Microsoft EXCEL) to fit relaxation rates and molar Fe 
concentrations. 
 
For the MRI experiments with PLMA-SPIONs labeled macrophages, the 
macrophages were cultured and labeled with PLMA-SPIONs at iron concentration of 
0.5 mM for 4 h as described above. The cells were then washed, counted, and 
centrifuged (2500 rpm, 5 min). The cells were resuspended in 1% agarose at cell 
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densities of 6.3×103, 12.5×103, 50×103, and 200×103 cells/mL, and transferred to 
individual plastic bottles (15 mL per bottle). The bottles were imaged with a clinical 
3T magnetic resonance system (Siemens Trio). The same spin-echo T2 sequences as 
reported above for determination of nanoparticle relaxivity were run on the cell 
samples using the same hardware. T2* images were acquired independently for each 
tube placed in a human wrist coil instead of the head coil. The wrist coil’s greater 
signal to noise ratio allowed the depiction of cell clusters with an acquisition period of 
approximately 35 minutes. A multi-echo 3D gradient echo sequence (TR:1600 ms; TE: 
5, 10, 14, 20, 28, 40, 60, 80 ms) was used to produce 20 transverse slices (of 1mm 
thickness within a 20 mm slab) with a 20 mm field of view and in-plane voxel 
dimensions of 300m300m. A central slice (number 10) with the region of interest 
specified to be 15mm15mm was selected for calculation of relaxation rates and 
relaxivities which were computed as reported above for the tubes of nanoparticle 
suspensions. 
 
3.2.9 Characterization  
1H NMR spectra were recorded on a Bruker DMX-300 with tetramethylsilane as the 
internal standard and d6-acetone as the solvent. Gel permeation chromatography (GPC) 
was performed on a Waters Breeze GPC equipped with a Waters 1515 isocratic 
HPLC pump and a Waters 2414 refractive index detector. THF was used as the eluent 
at a flow rate of 1 mL min-1. Polystyrene standards were used as the reference. FT-IR 
spectra were obtained in a transmission mode on a Bio-Rad FT-IR spectrophotometer 
(Model FTS135) under nitrogen atmosphere. Surface properties of pristine and PLMA 
coated SPIONs were analyzed via X-ray photoelectron spectroscopy (XPS) on an 
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AXIS HSi spectrometer (Kratos Analytical) using a monochromatized A1 Kα X-ray 
source (1486.6 eV photons) at a constant dwell time of 100 ms and a pass energy of 
40 eV. The anode voltage was 15 kV, and the anode current was 10 mA. The pressure 
in the analysis chamber was maintained at 6.7× 10-6 Pa or lower during each 
measurement. The particles were mounted on standard sample studs by means of 
double-sided adhesive tape. The core-level signals were obtained at a photoelectron 
takeoff angle of 90° (with respect to the sample surface). To compensate for surface 
charging effect, all core-level spectra were referenced to the C 1s hydrocarbon peak at 
284.6 eV. In spectral deconvolution, the line width (full-width at half-maximum) of 
the Gaussian peaks was maintained constant for all components in a particular 
spectrum. The peak ratios for various elements were corrected using experimentally 
determined instrumental sensitivity factors. 
 
Thermogravimetric analysis (TGA) data were obtained with a TGA 2050 
thermogravimetric analyzer (TA instruments). Samples weighing between 6 to 15 mg 
were heated from 30 to 1000 °C at a heating rate of 15 °C /min in air. Transmission 
electron microscopy (TEM) images were recorded on a JEOL 2010 transmission 
electron microscope at an accelerating voltage of 200 kV. The TEM specimens were 
made by placing a drop of the nanoparticles suspension on a carbon-coated copper 
grid. Measurement of magnetization was carried out with a DMS vibrating sample 
magnetometer (VSM) (Model 1600). The hydrodynamic size of the nanoparticles was 
determined by dynamic laser light scattering (DLS) measurements performed on a 
dispersion of the nanoparticles in DI water using a 90 Plus Particle Size Analyzer 
(Brookhaven Instruments) at room temperature. Surface charge measurements were 
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performed on a dispersion of the nanoparticles in DI water using a Zetasizer 

















3.3 Results and Discussion  
3.3.1 Characterization of PLMA  
PLMA is a biodegradable and biocompatible polymer (He et al. 2003) and was 
synthesized in the present work via a two-step polycondensation method as shown 
schematically in Figure 3-1a, which is much simpler than the procedure reported 
previously (He et al. 2004). The ratio of the hydrophilic (malic acid) to hydrophobic 
(lactic acid) parts of the PLMA copolymer affects its properties which in turn may 
affect the uptake by macrophages. Hence, different mass ratios (1:1, 2:1, 3:1) of malic 
acid to lactic acid were used to synthesize three different PLMA copolymers (namely 
PLMA-1, PLMA-2, and PLMA-3, respectively). The properties of the corresponding 
PLMA-SPIONs were investigated and the results are described in the subsequent 
sections. 
 
The composition of the PLMA copolymer was first verified by 1H NMR. Figure 3-1b 
shows the 1H NMR spectra of the three PLMA copolymers. The signals at 5.2 and 
1.58 ppm are attributed to CH(1) and CH3 (2) protons of the lactic acid units, 
respectively (Penczek et al. 1998). The signals at 5.6 and 3.0 ppm are assigned to the 
CH (3) and CH2 (4) protons of the malic acid units in the copolymer (Kajiyama et al. 
2004). From the integration of bands (1) and (3), the molar ratio of malic acid to lactic 
acid in the copolymer can be obtained. From Figure 3-1b, it can be seen that this ratio 
increases as the ratio of malic acid to lactic acid in the reactant mixture increases. The 
malic acid molar content of the PLMA copolymers were calculated to be 37.9%, 





Figure 3-1 (a) Schematic representation of PLMA synthesis and (b) 1H NMR spectra 
of (i) PLMA-1, (ii) PLMA-2, and (iii) PLMA-3. 
 
3.3.2 Characterization of PLMA-PEG  
The FT-IR spectra of PLMA-1 and PLMA-1-PEG copolymers are shown in Figure 3-
2. The spectrum of PLMA-1 (Figure 3-2a) shows a strong band at 1750 cm-1 attributed 
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to the O-C=O carbonyl stretch. With increasing PEG content in the PLMA-1-PEG 
copolymer (Figure 3-2b-2d), a new absorption band appears at 1710 cm-1 with 
increasing intensity due to the formation of N-C=O amide linkages between H2N-
PEG and PLMA-1. A strong absorption band at 1100 cm-1 which is the characteristic 
band for C-O-C ether stretching vibration of PEG is also present. Concomitantly, the 
intensity of the O-C=O absorption band at 1750 cm-1 decreases with increasing PEG 
content. Thus, the FT-IR results clearly indicate that PEG was successfully 
conjugated to the PLMA-1 copolymer in increasing amounts as the reactant ratio of 
H2N-PEG to carboxyl groups of PLMA-1 increases. 
 
Figure 3-2 FT-IR spectra of (a) PLMA-1, (b) PLMA-1-PEG-1, (c) PLMA-1-PEG-2, 




The molecular weights of the PLMA-1 and PLMA-1-PEG copolymers are given in 
Table 3-1. From the molecular weight of PLMA-1 (650g mol-1) and the molar 
percentage of malic acid (37.9% from 1H NMR), the theoretical molecular weight of 
PLMA-1-PEG copolymers can be calculated from the reactant ratio assuming 
complete reaction. Conversely, from the experimentally determined molecular weight 
of the copolymers, the molar ratio of PEG to PLMA-1 carboxyl groups can also be 
determined. These values are compared in Table 3-1. It can be seen that the calculated 
ratios of PEG to carboxyl groups of PLMA-1 (0.19:1, 0.45:1 and 0.71:1, for PLMA-1-
PEG-1, PLMA-1-PEG-2, and PLMA-1-PEG-3, respectively) correspond best to the 
ratio of the reactants at the lowest PEG content. With increasing PEG, the calculated 
ratio shows progressively lower values than expected since steric hindrance makes it 
difficult to attach increasingly amounts of the relatively large PEG molecule. 
 
Table 3-1 Molecular weight and PEG content of PLMA-1-PEG copolymers. 
Sample 
 





Mn      Mw/Mn





Molar ratio of 
amino-PEG to 
carboxyl groups of 
PLMA-1 
 based on GPC 
results 
PLMA-1 -       650           1.1 - - 
PLMA-1-PEG-1 0.2:1     1675           1.1 1730 0.19:1 
PLMA-1-PEG-2 0.5:1     3027           1.2 3350 0.45:1 
PLMA-1-PEG-3 0.8:1     4380           1.3 4970 0.71:1 
 
3.3.3 Characterization of PLMA-SPIONs  
The SPIONs prepared by the high temperature decomposition of Fe(acac)3 are 8~10 
nm in diameter (Figure 3-3a). After seed-mediated growth, the nanoparticles have an 
average size of ~12 nm (Figure 3-3b). The FT-IR spectrum of the ~12 nm SPIONs is 
shown in Figure 3-4. The absorption peaks at 2920 cm-1 and 2846 cm-1 are attributed 
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to the asymmetric and symmetric stretch in the methylene groups of oleic acid. The 
absorption peak at 580 cm-1 is the characteristic peak of Fe-O in Fe3O4 while the 
corresponding characteristic peaks in γ-Fe2O3 at 633 cm-1 and 563 cm-1 were absent 
(Li et al. 2009; Zhang et al. 2010), indicating that these SPIONs are Fe3O4.  
 
Figure 3-3  TEM images of (a) pristine SPIONs from high temperature decomposition 






Figure 3-4 FT-IR spectrum of ~12 nm SPIONs. 
 
The three PLMA copolymers were then used to modify the ~12 nm SPIONs to form 
PLMA-1-SPIONs, PLMA-2-SPIONs, PLMA-3-SPIONs, respectively. The lactic acid 
block, as the hydrophobic part of the amphiphilic PLMA copolymer is expected to 
encapsulate the oleic acid-stabilized iron oxide nanoparticles through hydrophobic 
interaction, whilst the malic acid block renders the particles water soluble. The 
properties of the three types of nanoparticles are summarized in Table 3-2. With 
increasing malic acid content in the copolymer, and hence more carboxyl groups, the 
zeta potential of the nanoparticles shows only a small decrease. This may be due to 
the encapsulation of some of the carboxyl groups in the hydrophobic core during 
nanoparticle formation. The size given in Table 3-2 is the hydrodynamic diameter, 
and this parameter decreases with increasing malic acid content. The hydrophilicity of 
the PLMA copolymer is increased with increasing malic acid content, which increases 
the affinity of the copolymer for water, resulting in efficient solvent diffusion to form 
nanoparticles of smaller size. However, the hydrodynamic diameter is significantly 
larger than the size of the individual nanoparticles observed from the TEM image. For 
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example, the hydrodynamic diameter of PLMA-2-SPIONs is 136 nm, but from the 
TEM image, the size of the individual particles is ~12 nm (Figure 3-3c).  The larger 
hydrodynamic size may be due to the partial aggregation of nanoparticles in water and 
the presence of the polymeric shell which does not show up in the TEM image. 
PLMA-2-SPIONs were chosen for the subsequent experiments described below in 
view of its highest iron content and small size.  
 
Table 3-2 Properties of PLMA-SPIONs. 








PLMA-1-SPIONs 37.9% -29.2 ± 0.8 152.8 ± 1.6 0.20 13.1%
PLMA-2-SPIONs 51.7% -30.8 ± 1.3 136.5 ± 1.8 0.14 14.6%
PLMA-3-SPIONs 64.4% -32.9 ± 0.8 130.9 ± 1.0 0.20 10.1%
 
The success of the surface functionalization of SPIONs with PLMA-2 was ascertained 
by XPS. The C 1s core-level spectra of pristine SPIONs and PLMA-2-SPIONs are 
compared in Figure 3-5. The C 1s core-level spectrum of the oleic acid-stabilized 
SPIONs consists of two peak components with binding energy at about 284.6 and 
288.6 eV, which are attributed to the C-C/C-H and O-C=O species of oleic acid, 
respectively. After modification with PLMA-2, the C 1s core-level spectrum of 
PLMA-2-SPIONs shows significantly enhanced peaks at 286.2 and 288.8 eV, which 
are attributed to the C-O and O-C=O species of PLMA-2, respectively. The area ratio 
of O-C=O to C-O is calculated to 1.51 : 1, consistent with the theoretical value of 
1.52 : 1 for PLMA-2 which has a malic acid content of 51.7% (mole basis) as inferred 




Figure 3-5 XPS C 1s core-level spectra of (a) pristine SPIONs and (b) PLMA-2-
SPIONs. 
 
3.3.4 Characterization of PLMA-PEG-SPIONs  
The three PLMA-1-PEG copolymers were used to modify the ~12 nm SPIONs to 
form PLMA-1-PEG-1-SPIONs, PLMA-1-PEG-2-SPIONs, and PLMA-1-PEG-3-




Figure 3-6 Schematic representation of the synthesis of PLMA-1-PEG-SPIONs. Site 
and extent of amide band formation between H2N-PEG and PLMA-1 are shown for 
illustration purpose only. TEM images of (a) pristine SPIONs from high temperature 
decomposition synthesis, (b) ~12 nm SPIONs from seed-mediated growth of (a), and 
(c) PLMA-1-PEG-3-SPIONs. 
 
The properties of the PLMA-PEG coated SPIONs are summarized in Table 3-3. The 
zeta potential of the nanoparticles increases with increasing ratio of H2N-PEG to 
PLMA-1. This is consistent with the decrease in carboxyl groups of the PLMA-1 
copolymer as a result of amide bonds formed with H2N-PEG. With increasing PEG 
content, the hydrophilicity of the PLMA-1-PEG copolymer is increased, which results 
in more efficient solvent diffusion and less aggregation of the nanoparticles. At the 
same time, the thickness of the hydrated shell also increases. The combination of 
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these two effects results in the variation in the hydrodynamic size shown in Table 3-3. 
The hydrodynamic diameter given in Table 3-3 is larger than the size observed from 
the TEM image for the same reason discussed in Section 3.3.3. 
 
Table 3-3 Properties of PLMA-1-PEG-SPIONs. 





PLMA-1-PEG-1-SPIONs -27.5 ± 0.1 118.4 ± 0.5 0.20 
PLMA-1-PEG-2-SPIONs  -17.5 ± 0.9 65.7  ± 1.2 0.22 
PLMA-1-PEG-3-SPIONs -10.8 ± 0.9  94.4  ±  2.2 0.22 
 
The success of the surface modification of SPIONs with PLMA-1-PEG was further 
ascertained by XPS. The C 1s core-level spectra of pristine SPIONs, PLMA-1-
SPIONs and PLMA-1-PEG-3-SPIONs are compared in Figure 3-7. For PLMA-1-
SPIONs (Figure 3-7b), the area ratio of O-C=O (at 288.8 eV) to C-O (at 286.5 eV) is 
calculated to be 1.38:1, consistent with the theoretical value of 1.38:1 for PLMA-1 
having a molar percentage of malic acid of 37.9% as inferred from the 1H NMR result. 
Compared with the C 1s core level spectrum of PLMA-1-SPIONs (Figure 3-7b), the C 
1s core-level spectrum of PLMA-1-PEG-3-SPIONs (Figure 3-7c) shows an increase 
in the intensity of the C-O peak at about 286.2 eV and a greatly diminished O-C=O 
peak at 288.8 eV, due to the increase in C-O bonds from the conjugated NH2-PEG. 
The small shift in the binding energy of the C-O peak in PLMA-1-PEG-3-SPIONs 
with respect to that of PLMA-1-SPIONs is due to the different chemical environments 
of the C-O bonds in PLMA-1 and PEG. The appearance of C-N and N-C=O peaks at 
285.8 and 287.3 eV respectively is due to the amine groups of the H2N-PEG as well 




Figure 3-7 XPS C 1s core-level spectra of (a) pristine SPIONs, (b) PLMA-1-SPIONs 
and (c) PLMA-1-PEG-3-SPIONs. 
 
3.3.5 Uptake of PLMA-SPIONs by Macrophages 
The stability of PLMA-2-SPIONs in cell culture medium at 37oC was first established 
before the cell uptake experiments. The absorbance of the PLMA-2-SPIONs 
suspension at a concentration of [Fe] = 2 mM was monitored at 350 nm over a 4 h 
period. A change in absorbance would indicate aggregation and precipitation of the 
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nanoparticles. The absorbance after 4 h was 96% of the initial value, and hence it can 
be concluded that the PLMA-2-SPIONs are stable in cell medium.   
 
The uptake of PLMA-2-SPIONs by macrophages was first investigated using Prussian 
Blue staining and optical microscopy after the cells were incubated in a medium with 
the nanoparticles at iron concentration of 0.5 mM (equivalent to ~0.2 mg/mL of 
nanoparticles) for 2 h. The efficacy of the macrophages in internalizing the PLMA-2-
SPIONs present at this low concentration within the 2 h period is clearly indicated by 
the presence of many blue particles in the cells incubated with PLMA-2-SPIONs 
(Figure 3-8b) since no blue particle was seen in the unlabeled cells (Figure 3-8a). The 
clear cell edge and good differentiation between the nucleus and the Prussian Blue-
stained cytoplasm in Figure 3-8b indicate that during the washing process, free 
nanoparticles were removed, and a significant amount of nanoparticles remained 
inside the cells rather than on the cell surface.  
 
Figure 3-8 Images of macrophages incubated for 2 h (a) without PLMA-2-SPIONs, 





Quantification of iron uptake by macrophages as a function of incubation time and 
iron concentration in the medium using ICP-MS is shown in Figure 3-9. PLMA-2-
SPIONs were rapidly internalized into the cells at an iron concentration of 0.5 mM, 
and the amount internalized by the macrophages reached 5.3 pg Fe/cell after just 30 
min. This value is higher than that obtained with citrate-coated superparamagnetic 
anionic nanoparticles at four times higher iron concentration for the same incubated 
period (uptake ~4 pg Fe/cell) (Wilhelm et al. 2009).  
 
Increasing the incubation time results in increased uptake by the macrophages and 
after 4 h, there is still no evidence of saturation (Figure 3-9a). Using an incubation 
time of 4 h, increasing the iron concentration in the medium also results in a 
significant increase of cellular iron uptake (Figure 3-9b). A factor of 8 increases in 
iron concentration from 0.25 to 2.0 mM resulted in more than one order of magnitude 
increase in uptake (from 3.6 to 52.1 pg Fe/cell). The high uptake observed at an iron 
concentration of 2.0 mM is clearly indicated by Prussian Blue staining of the cells 
(inset image of Figure 3-9b). The amount of iron internalized by the macrophages 
after 4 h in the medium with 2.0 mM of [Fe] is almost 30% higher than that obtained 
with citrate-coated superparamagnetic anionic nanoparticles for the same conditions 
(~40 pg Fe/cell) (Wilhelm et al. 2009). Furthermore, the cellular iron uptake is higher 
than that obtained with ferucarbotran at nearly the same iron concentration in the 
medium (1.8 mM) after a much longer incubation period (uptake of 43.7 pg/cell after 
24 h) (Liu et al. 2008a). The high efficiency of cellular uptake of anionic 
nanoparticles has been attributed by Wilhelm et al. (2009) to the strong and non-
specific adsorption of these nanoparticles on the plasma membrane which precedes 




Figure 3-9 Uptake of PLMA-2-SPIONs by macrophages (a) as a function of 
incubation time at incubated iron concentration of 0.5 mM and (b) as a function of 
incubated iron concentration for an incubation period of 4 h. Inset is the image of 
macrophages incubated with PLMA-2-SPIONs at an iron concentration of 2.0 mM for 






3.3.6 Uptake of PLMA-PEG-SPIONs by Macrophages 
PEG has been widely used to modify the SPIONs surface to reduce uptake by 
macrophages. The ethylene glycol functional group in the PEG is known to interact 
well with water molecules and so these PEG chains can confer a hydrophilic surface 
on the nanoparticles to improve their stability in aqueous media (Photos et al. 2003). 
The PEG shell also inhibits hydrophobic or electrostatic interactions of nanoparticles 
with plasma proteins to prevent adsorption of the proteins that mediate macrophage 
recognition and subsequent clearance from the blood. Compared with the common 
methods of PEGylation of SPIONs by grafting the PEG chains via surface anchors 
such as silane (Sun et al. 2006), dopamine (Amstad et al. 2009) or citric acid 
(Lattuada and Hatton 2007) which form a monolayer on the SPIONs surface, PLMA 
offers an abundance of functional groups for attaching the PEG. The present method 
also avoids the use of toxic agents such as the copper chloride or copper bromide 
catalyst used for grafting of PEG derivatives (i.e. PEGMA) via ATRP.  
 
Figure 3-10a shows the macrophage uptake of the PLMA-1-SPIONs and PLMA-1-
PEG-SPIONs at an iron concentration [Fe] of 0.5 mM as a function of incubation time. 
For all four types of SPIONs, macrophages uptake increases with increasing 
incubation time. However, it is evident that with increasing PEG surface density, the 
uptake of the nanoparticles decreases. For example, the uptake of PLMA-1-SPIONs at 
2 h was 6.1 pg Fe cell-1, while the corresponding values for PLMA-1-PEG-1-SPIONs, 
PLMA-1-PEG-2-SPIONs and PLMA-1-PEG-3-SPIONs were reduced to 3.2, 1.96 and 
1.45 pg Fe cell-1, respectively. This decrease in the uptake of the nanoparticles is 
attributed to a combination of the hydrophilic and non-fouling nature of the PEG 
chains and the decrease in the nanoparticles’ surface negative charge with increasing 
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PEG content (Table 3-3) since negatively charged nanoparticles have been reported to 
result in high cell uptake (Luciani et al. 2009). The cellular uptake of PLMA-1-PEG-
3-SPIONs at 12 h (7.13 pg Fe cell-1) is higher than that reported in a previous study on 
SPIONs surface-grafted with poly(PEGMA) (< 2 pg Fe cell-1) (Fan et al. 2007) and 
this may be attributed to the residual negative charges of the former.  
 
Figure 3-10 Effect of PEG content in the surface coating of SPIONs on uptake by 
macrophages as a function of (a) incubation time ([Fe]=0.5 mM) and (b) incubated 
iron concentration at an incubation time of 4 h. 
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Figure 3-10b shows how the uptake of the nanoparticles varies as a function of the 
iron concentration for an incubation time of 4 h. While increasing PEG surface 
density is effective in reducing macrophage uptake, the nanoparticles concentration 
has a strong effect on macrophage uptake. At an iron concentration of 2.0 mM, the 
macrophage uptake of all four types of SPIONs is about 10 times more than at 0.25 
mM. The concentration dependent uptake is consistent with previous observations 
(Xie et al. 2007). Figure 3-10 illustrates the versatility of the PLMA copolymer for 
coating SPIONs. In applications where a high uptake is desired, e.g. labeling and 
tracking of macrophages for understanding their relationship to disease pathogenesis 
(Beduneau et al. 2009), the PLMA-SPIONs would be suitable. On the other hand, for 
applications where a long blood circulation time is desired, e.g. tumor targeting 
(Moghimi et al. 2001; Moghimi and Szebeni 2003), the PLMA-PEG coated SPIONs 
can be used. 
 
3.3.7 Cytotoxicity of Nanoparticles 
Accumulation of excess iron in cells can be a cause for concern, as it has been 
reported that free iron can cause toxicity (Berry 2009). Previous studies have reported 
that an increase in oxidative stress and iron-driven free radical oxidation due to iron 
overload may lead to cytotoxicity and cell death (Minotti 1993; Emerit et al. 2001). 
The cytotoxicity assay of PLMA-SPIONs and PLMA-PEG-SPIONs was carried out 
by incubating the macrophages with PLMA-SPIONs or PLMA-PEG-SPIONs at iron 
concentration of 0.25, 0.50, 1.0, and 2.0 mM for 24 h. The viability of macrophages 
after labeling with nanoparticles was assessed relative to cells in the control 
experiment (without nanoparticles) using the MTT assay. Since the absorbance of 
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nanoparticles at the highest concentration of [Fe]=2 mM in DMSO was less than 1% 
of the absorbance obtained in the MTT assay, the nanoparticles would not interfere 
with the optical absorbance reading. From Figure 3-11, it can be seen that the 
viabilities of the macrophages after labeling with different iron concentrations for 24 
h are nearly the same as that in the control experiment, even at high iron concentration. 
These results indicate that both PLMA-SPIONs and PLMA-PEG-SPIONs are non-
cytotoxic. 
 
Figure 3-11 Viability of macrophages incubated with (a) nanoparticles with different 
coatings at an iron concentration of 0.5 mM for 24 h and (b) PLMA-1-SPIONs and 
PLMA-1-PEG-3-SPIONs at different iron concentrations for 24 h. Viability is 
expressed as a percentage relative to the result obtained with the non-toxic control 
(macrophages incubated without nanoparticles). 
 
 
3.3.8 Magnetic Properties of Nanoparticles and MR Relaxometry 
Figure 3-12 shows the magnetization curves of as-synthesized SPIONs before and 
after seed-mediated growth method, PLMA-2-SPIONs, and PLMA-1-PEG-3-SPIONs. 
The saturation magnetization (Ms) value of pristine SPIONs seed (8~10 nm) is 44 
emu/g at 25°C; after seed-mediated growth, the Ms of ~12 nm SPIONs is 56 emu/g. 
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The iron oxide content of both types of nanoparticles is similar (~80% from TGA). 
Thus, the 27% increase in Ms after seed-mediated growth is due to a size effect 
consistent with the observation reported in a previous study (Goya et al. 2003). After 
surface modification of the ~12 nm SPIONs with PLMA or PLMA-PEG, the Ms of 
PLMA-2-SPIONs and PLMA-1-PEG-3-SPIONs decreased to 13.8 emu/g and 12.1 
emu/g, respectively. However, on the basis of Fe content, there is no significant 
difference among the Ms values of the SPIONs (96.7 emu/g Fe), PLMA-2-SPIONs 
(94.5 emu/g Fe), and PLMA-1-PEG-3-SPIONs (95.3 emu/g Fe). The Ms of PLMA-2-
SPIONs or PLMA-1-PEG-3-SPIONs is deemed sufficient for bioapplications as Ms of 
7-22 emu/g is usually adopted (Fan et al. 2007). Since neither remainance nor 
coercivity is observed, the as-synthesized nanoparticles can be considered to be 
superparamagnetic at room temperature.  
 
Figure 3-12 Field dependent magnetization at 25°C for (a) pristine SPIONs, (b) ~12 





The inverse relaxation times (1/T1= R1, 1/T2 =R2) of PLMA-2-SPIONs and PLMA-1-
PEG-3-SPIONs in water as a function of the iron molar concentration are shown in 
Figure 3-13. The largest standard deviation (SD) of the calculated relaxation times 
was 5.5% of the mean value. The longitudinal relaxivity r1 and transverse relaxivity r2, 
which are rates of proton relaxation, were determined according to the following 
equation (Bloembergen et al. 1948): 
1/Ti=1/Ti,0 + ri [Fe], where i=1, 2 
1/Ti is the observed solvent relaxation rate in the presence of the contrast agent, while 
1/Ti,0 is the relaxation rate of the pure solvent without the contrast agent. For a T2 
contrast agent, the higher the r2/r1, the better the contrast efficacy. The r1 values of 
PLMA-2-SPIONs and PLMA-1-PEG-3-SPIONs in water were found to be 0.38 mM-
1s-1 and 0.26 mM-1s-1, which are much smaller than that of Resovist (4.6 mM-1s-1) and 
Endorem (4.1 mM-1s-1) at the same magnetic field strength (Rohrer et al. 2005). The 
r2 values of PLMA-2-SPIONs and PLMA-1-PEG-3-SPIONs were found to be 196 
mM-1s-1 and 162.7 mM-1s-1, which are higher than the corresponding values of 
Resovist (143 mM-1s-1) and Endorem (93 mM-1s-1) (Rohrer et al. 2005). Hence, r2/r1 
of PLMA-2-SPIONs and PLMA-1-PEG-3-SPIONs were calculated to be 516 and 626, 
which are more than an order of magnitude higher than those of Resovist (r2/r1 of 31) 
and Endorem (r2/r1 of 23). From these results, it can be inferred that PLMA-2-SPIONs 
and PLMA-1-PEG-3-SPIONs can be expected to significantly enhance MR contrast 
efficacy. The stability of PLMA-2-SPIONs in the 3T magnetic field was also studied 
by comparing the relaxation rates after various periods in the magnetic field (Figure 
3-13a). The r1 values obtained at the start of the experiment and after 18 hours in the 
magnetic field are very similar. The r2 value obtained after 18 hours was 178 mM-1s-1, 
compared to the initial value of 196 mM-1s-1. Since the r2 value changed by only 9%, 
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it can be concluded that the PLMA-2-SPIONs have a high degree of stability in water. 
The stability of PLMA-1-PEG-3-SPIONs in the 3T magnetic field was also studied by 
comparing the relaxation rates after various periods in the magnetic field. The r2 value 
obtained after 12 hours was 159.5 mM-1s-1, compared to the initial value of 162.7 
mM-1s-1. Thus, PLMA-PEG-3-SPIONs are also highly stable in water.  
 
Figure 3-13 Relaxation rates 1/T1 (s-1) and 1/T2 (s-1) in water as a function of the iron 
concentration of (a) PLMA-2-SPIONs and (b) PLMA-1-PEG-3-SPIONs (for all plots, 




The hierarchical hydrophobic-hydrophilic structure of the PLMA or PLMA-PEG 
polymer coating is hypothesized to play a dual role in increasing the T2 relaxation rate 
and decreasing the T1 relaxation rate of the PLMA-SPIONs and PLMA-PEG-SPIONs. 
The large r2 relaxivity is attributed to the presence of “ice-like” water in the 
hydrophilic blocks (malic acid) of the PLMA or PLMA-PEG copolymer (Hardy and 
Henkelman 1989). The “ice-like” water results from the restriction in the mobility of 
the water molecules due to hydrogen bonding with the malic acid blocks. The r2 value 
can also be increased due to the clustering of the T2 contrast agents (Gao et al. 2005). 
The substantially larger hydrodynamic size of the nanoparticles as compared to the 
size observed from the TEM image indicates that some aggregation of the 
nanoparticles in water is possible. On the other hand, the hydrophobic part (lactic acid) 
of the PLMA or PLMA-PEG copolymer hinders the contact between the external 
water molecules and the magnetic core, which in turn limits the spin-lattice relaxation 
rate and results in a smaller r1 (Qin et al. 2007). 
 
MR imaging of PLMA-SPIONs-labeled macrophages suspension was carried out with 
macrophages incubated with PLMA-2-SPIONs at an iron concentration of 0.5 mM for 
4 h. Different concentrations of labeled cells in agarose suspension were used in the 
MRI experiments. Compared with the control preparation of agarose medium with the 
unlabeled cells (Figure 3-14a), the images of the labeled cells (Figure 3-14b-14e) 
show a trend of increasing number of spots with increasing density of the labeled cells, 
with the spots getting darker with increasing TE. These spots are clusters of labeled 
cells, and the intracellular iron generates MR contrast to differentiate the labeled cells 
from the control which had a uniform appearance not influenced by the number of 
cells present. Based on these results, the PLMA-2-SPIONs-labeled macrophages at a 
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density of 6.3×103 cells/mL (Figure 3-14b) give rise to sufficient MR contrast to be 
differentiated from the unlabeled cells. Since each image slice was 1.0 mm in 
thickness, it is estimated that the slice shown in Figure 3-14b contained approximately 
2820 cells, indicating a distinct detectable threshold of about 2820 cells. The detection 
threshold can be further lowered if the cells are labeled using higher nanoparticle 
concentration in the medium or longer incubation time. 
 
Figure 3-14 MR images of phantoms containing (a) macrophages without 
nanoparticles at a cell density of 200×103 cells/mL, and PLMA-2-SPIONs-labeled 





The effects of cell labeling with PLMA-SPIONs on R2 and R2* are shown in Figure 3-
15. Both the R2 and the R2* showed a linear relationship with respect to the 
concentration of labeled cells in agarose. The r2* for cell-associated PLMA-2-SPIONs 
was about 8.6-fold higher (1.3 s-1/104 cells/mL) than the r2 (0.15 s-1/104 cells/mL). The 
r2* and the r2 values were also expressed in units of s-1 per millimole of Fe (calculated 
from the cell concentration and cellular iron uptake) for comparison with the 
relaxivities of free nanoparticles (Table 3-4). 
 
Figure 3-15 Dependency of R2* and R2 on PLMA-2-SPIONs-labeled cell 
concentration in phantoms (for both plots, correlation coefficient R2 > 0.97). 
 
Table 3-4 Relaxivities of cell-associated and free nanoparticles. 
Sample r2* (mM-1s-1) r2 (mM-1s-1) 
Cell-associated nanoparticles 834.1 96.6 




The cell-associated PLMA-2-SPIONs showed higher r2* values compared with the 
free PLMA-2-SPIONs in water (834.1 mM-1s-1 vs 301.3 mM-1s-1) (Table 3-4). On the 
other hand, r2 measurements were higher for the free nanoparticles than for the cell-
associated nanoparticles (196 mM-1s-1 vs 96.6 mM-1s-1) (Table 3-4). Our finding is 
consistent with the observations of Bremer et al. (2007) and is expected from 
theoretical considerations (Gillis et al. 2002; Rutt et al. 2002). The aggregation of the 
nanoparticles into larger entities within cells would lead to a decrease in r2 at the 
echo-limited regime (Bremer et al. 2007), while an increase in r2* resulted from outer-
sphere inhomogeneities of the magnetic field produced by the non-uniform 
distribution of the nanoparticles within the cells. For clinical applications in vivo, the 
differentiation between cell-associated and free nanoparticles would be especially 
desirable, and it has been reported that high sensitivity for the detection of low 
amounts of labeled cells can be attributed to the significantly greater R2* effects 
compared with R2 effects (Bremer et al. 2007). Our results support this finding and 












PLMA, a copolymer of lactic acid and malic acid, can be used to coat SPIONs to 
obtain nanoparticles which are highly stable in aqueous medium. The anionic nature 
of PLMA results in a high degree of internalization by macrophages. Covalent 
attachment of increasing amount of PEG on the PLMA confers macrophage-evading 
properties on the nanoparticles. Hence, a wide range of cellular iron uptake by 
macrophages can be achieved via varying the PEG content in the PLMA-based 
coating, incubation time and concentration of nanoparticles. The PLMA-coated 
nanoparticles with and without incorporation of PEG are highly stable in aqueous 
medium, do not result in significant cytotoxicity, and exhibit high magnetic resonance 
enhancement. Hence, they are potentially good T2 contrast agent either for labeling 
macrophages for use in MRI monitoring of disease associated with high macrophage 

















CHAPTER 4 SURFACE MODIFIED SUPERPARAMAGNETIC 
IRON OXIDE NANOPARTICLES FOR HIGH EFFICIENCY 


















The focus in this Chapter is on designing SPIONs for tumor targeting in a biological 
environment. To achieve tumor targeting, the surface coatings of SPIONs should be 
able to evade macrophages and have a high density of functional groups for 
conjugation with targeting ligands. The functions and examples of the targeting 
ligands to achieve tumor-specific targeting are given in Section 2.1.3. Although 
PLMA-PEG-SPIONs (Chapter 3) showed macrophage-evading properties, their 
ability to further conjugate targeting ligands is limited, due to the low density of 
carboxylic groups remaining after conjugation of NH2-PEG as well as steric 
hindrance which makes it difficult for the carboxylic groups located in the inner 
polymeric shell to react with targeting ligands. 
 
Herein, we describe a strategy for surface modification of SPIONs using 
poly(glycidyl methacrylate) (PGMA) to achieve active tumor targeting. PGMA is a 
well-known polymer for biomedical applications because it is inexpensive, 
biocompatible, and nontoxic (Dong et al. 2010). In addition, PGMA has been shown 
to be easily modifiable by changing the reactive epoxy groups to a variety of 
functional groups (e.g. –NH2, –COOH and –OH), which makes them suitable for the 
immobilization of DNA, enzyme, and drug for biomedical applications (Sha et al. 
2007). SPIONs encapsulated within PGMA microspheres have been prepared by 
dispersion polymerization method for bioseparation applications (Horak and Shapoval 
2000; Ma et al. 2005; Wang et al. 2008; Dong et al. 2010; Horak et al. 2010). 
However, the relatively large size of the particles (in the micron size range) does not 
facilitate in vivo applications. In addition, a proportion of the functional groups are 
buried in the core of PGMA microspheres resulting in a low surface density of 
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functional groups. In our strategy, the surface modification of SPIONs with PGMA 
was carried out via ATRP. Compared with dispersion polymerization method, the 
PGMA-functionalized SPIONs (SPIONs-PGMA) obtained via ATRP are much 
smaller with a higher surface density of functional groups. Moreover, with ATRP, the 
polymer chain length, and thus the amount of the surface functional groups, can be 
easily varied by varying the reaction time or the monomer to initiator ratio. The 
functional groups of PGMA can then be used for conjugation of FA. Compared with 
previously reported PEG-coated SPIONs where FA was conjugated to the terminal 
functional groups of PEG (Chen et al. 2008; Zhang et al. 2009), the PGMA coating 
offers a higher density of functional groups which would facilitate FA conjugation. In 
this work, we demonstrate that surface modification of SPIONs with PGMA via 
ATRP and subsequent conjugation of FA resulted in uptake by cancer cells which is 










4.2 Materials and Methods 
4.2.1 Materials  
Iron chloride (FeCl3·6H2O, 98%) and sodium oleate (95%) were purchased from 
Tokyo Chemical Industry (Tokyo, Japan). Ethylenediamine (EDA) (≥ 99.5%) was 
purchased from Fluka (Buchs, Switzerland). Oleic acid (90%), 1-octadecene (90%), 
N-hydroxysuccinimide (NHS) (97%), 1-ethyl-3-(3-dimethylamino)-propyl 
carbodiimide (EDAC), FA (≥ 97%), 2-bromoisobutyryl bromide (98%), aminopropyl 
triethoxysilane (APS, 99%), copper(I) bromide (CuBr, 99%), 2,2’-bipyridine (Bpy, 
99%) were purchased from Sigma-Aldrich (St. Louis, USA) and used as received. 
GMA (97%) was purchased from Sigma-Aldrich and used after removal of the 
inhibitors by passing through a silica gel column. Toluene and triethylamine (TEA) 
were purified by distillation from CaH2 before use. KB cells, mouse macrophage cells 
(RAW 264.7), and 3T3 fibroblasts were chosen as our model cancer, phagocytic and 
normal cell lines, respectively, and were purchased from American Type Culture 
Collection (ATCC). Folic acid-deficient Dulbecco’s modified Eagle’s medium 
(DMEM), fetal bovine serum, L-glutamine, and penicillin were purchased from 
Sigma-Aldrich. Folic acid-deficient RPMI-1640 medium was purchased from 
Invitrogen (California, USA). All other solvents were purchased from either Sigma-
Aldrich or Fisher Scientific (Leicestershire, UK) and used as received. 
 
4.2.2 Preparation of SPIONs  
SPIONs were prepared according to a previously reported method (Park et al. 2004): 
FeCl3·6H2O (5.4 g, 20 mmol) and sodium oleate (18.3 g, 60 mmol) were dissolved in 
a solvent mixture of 40 mL ethanol, 30 mL distilled (DI) water and 70 mL hexane. 
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The resulting solution was heated to 70 oC and kept at that temperature for 4 h. After 
reaction, the upper organic layer was washed three times with 15 mL DI water in a 
separatory funnel. The iron-oleate complex was obtained after evaporation of hexane. 
For synthesis of monodisperse SPIONs with a particle size of ~12 nm, the iron-oleate 
complex (18 g, 20 mmol) and oleic acid (2.8 g, 10 mmol) were dissolved in 1-
octadecene (100 g). The mixture was heated to 320 oC at a heating rate of 3.3 oC min-1, 
and kept at that temperature for 30 min under a blanket of argon. After the reaction, 
the solution was cooled to room temperature, and ethanol (250 mL) was added to the 
mixture to precipitate the nanocrystals. The nanoparticles (1.8 g, ~ 80% conversion of 
the Fe in the iron-oleate complex) were obtained after separation by centrifugation 
(6000 rpm, 10 min) and drying under reduced pressure. The nanoparticles were stored 
at 4 oC. 
 
4.2.3 Synthesis of Initiator 
2-bromoisobutyryl bromide (3.2 mL, 25 mmol) was added dropwise to a cold solution 
of APS (4.7 mL, 20 mmol) in 30 mL dry toluene with TEA (3.5 mL, 25 mmol) at 0 oC 
under argon protection. The mixture was magnetically stirred for 3 h at 0 oC under 
argon protection and then allowed to react overnight at room temperature. At the end 
of the reaction period, the mixture was first filtered to remove the salts, and the 
solvent and unreacted TEA was then evaporated under reduced pressure. 7.1 g of the 
initiator was obtained as a viscous liquid and stored at 0-4 oC. 
1H NMR (300 MHz, CDCl3), (δ, ppm): 0.62-0.67 (2H, t, SiCH2), 1.20-1.29 (9H, t, 
CH3CH2OSi), 1.62-1.72 (2H, m, CH2), 1.90-1.96 (6H, q, CH3C), 3.25-3.31 (2H, t, 
CH2NH), 3.78-3.86 (6H, t, CH3CH2OSi), 6.9 (1H, s, NH). 
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4.2.4 Synthesis of Initiator Coated SPIONs 
200 mg of SPIONs were dispersed in 100 mL dry toluene with acetic acid (98.6 μL). 
The initiator (318 mg, 0.86 mmol) was added and the mixture was stirred for 72 h at 
room temperature under the protection of argon. The resulting product was 
precipitated by ethanol and washed three times with ethanol to remove the excess 
initiator. After drying under reduced pressure, 130 mg of the nanoparticles were 
obtained and stored at 4 oC. 
 
4.2.5 Surface Initiated ATRP on SPIONs  
The initiator-coated SPIONs (100 mg) were first dispersed in 2 mL THF in a 10 mL 
round-bottom flask containing a magnetic stirring bar to form a transparent brownish 
solution. The GMA monomer (504 mg, 3.5 mmol) was then added. The solution was 
purged with argon for 15 min, and CuBr (10.2 mg, 0.07 mmol) and Bpy (33.2 mg, 
0.21 mmol) were added. After purging with argon for another 10 min, the flask was 
sealed. The mixture was stirred at 35 oC for 4 h. The reaction mixture was then diluted 
with THF and was centrifuged at 4000 rpm for 4 min to remove the Cu(II) precipitate. 
The supernatant was precipitated with ethanol, and the precipitate was re-dispersed in 
THF and centrifuged at a speed of 2000 rpm for 2 min to further remove the 
remaining Cu(II) precipitate and any agglomerates. The resulting nanoparticles 
(SPIONs-PGMA) were precipitated three times with ethanol, and after drying under 




4.2.6 Chemical Modification of Epoxy Groups with EDA 
SPIONs-PGMA (200 mg) was added to a 50 mL flask containing 10 mL THF and 10 
mL EDA. The mixture was stirred at 50 oC for 24 h under the protection of argon. The 
mixture was then cooled to room temperature and dialyzed against DI water for 5 
days using a membrane with molecular weight cutoff of 12000 g/mol to remove the 
excess EDA and solvent. The product was then dried using a lyophilizer, and the 
obtained particles (150 mg) were denoted as SPIONs-PGMA-NH2.  
 
4.2.7 Folic Acid Conjugation  
SPIONs-PGMA-NH2 (30 mg) was first dispersed in 15 mL of DI 
water/dimethylsulfoxide (DMSO) (v/v, 1:1). NHS and EDAC (molar ratio of NHS : 
EDAC : FA = 2.2 : 1.1 : 1) were then added and the mixture was placed in an 
ultrasonic bath for 10 min. Different amounts of FA (0.5, 1.0, and 2.0 mL of 0.01 M 
FA in DMSO) were then added to prepare nanoparticles with different surface 
densities of FA. The reaction was allowed to take place overnight at room temperature 
protected from light. The solution was then dialyzed against DI water for 5 days in a 
dialysis bag with a cutoff molecular weight of 12000 g/mol, with replacement of 
water every 12 h. The final product was lyophilized and denoted as SPIONs-PGMA-
FA-1, SPIONs-PGMA-FA-2 and SPIONs-PGMA-FA-3, corresponding to the volume 
of the FA reagent of 0.5 mL, 1.0 mL and 2.0 mL, respectively. The amount of FA 
conjugated on the surface of nanoparticles was quantified using UV-vis spectroscopy 
according to the method described in the literature (Chen et al. 2008). SPIONs-
PGMA-NH2 and SPIONs-PGMA-FA were dispersed in DI water at the same iron 
concentration and the absorbance of the solutions at 280 nm were measured. Using a 
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calibration curve obtained by measuring the absorbance of different concentrations of 
free folic acid in water at 280 nm, the folate content on the surface of nanoparticles 
was calculated.  
 
4.2.8 Cell Culture  
KB cells and macrophages (RAW 246.7) were cultivated in folic-deficient RPMI-
1640 medium while 3T3 fibroblasts were cultured in folic-deficient DMEM medium.  
All culture media were supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 100 U mL-1 penicillin. Cells were cultivated in the medium at 37 oC in a 
humidified environment of 5% CO2. 
 
4.2.9 In Vitro Evaluation of Uptake of Nanoparticles  
KB cells were seeded in 12-well polystyrene dishes at a concentration of 105 cells/mL 
for 24 h. The medium was then replaced with one containing either SPIONs-PGMA-
NH2 or SPIONs-PGMA-FA at a concentration of 0.2 mg/mL. After incubation at 37 
oC for prescribed time periods (1, 2, and 4 h), the culture medium was removed and 
the cells were washed thrice with PBS to remove the free nanoparticles. The cells 
were then detached with trypsin-EDTA solution and counted with a hemocytometer. 
The cells were collected by centrifugation, and the cell pellet was dissolved in 37% 
HCl at 60 oC for 2 h. The iron concentration was determined using ICP-MS. The 
uptake of the SPIONs-PGMA-FA by macrophages and 3T3 fibroblasts after 4 h of 
incubation was evaluated at the same cell concentration in a similar manner.  
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4.2.10 Cytotoxicity Assay  
The cytotoxicity of SPIONs-PGMA-FA was evaluated by determining the viability of 
KB cells, macrophages, and 3T3 fibroblasts after incubation with the medium 
containing the nanoparticles. Cell viability was determined by the MTT assay. The 
cells were first seeded in a 96-well plate at a density of 104 cells/well. After 24 h, the 
medium was replaced with one containing the nanoparticles at 0.1, 0.2, 0.5, and 1.0 
mg/mL. Control experiments were carried out using the growth culture medium 
without nanoparticles (non-toxic control). The cells were incubated at 37 oC in the 
presence of 5% CO2 for 24 h and the MTT assay was conducted according to Section 
3.2.7. 
 
4.2.11 MRI Experiments 
MRI experiments to obtain the relaxation rates and the relaxivities of SPIONs-
PGMA-FA in water were performed according to the procedures described in Section 
3.2.8. 
 
4.2.12 Characterization  
Surface compositions of the nanoparticles were analyzed via XPS. The XPS 
measurements were performed on a Kratos AXIS UltraDLD spectrometer (Shimadzu 
(Asia Pacific), Singapore) with an Al Kα X-ray source (1486.6 eV), using procedures 
described previously (Huang et al. 2010). TEM images were taken on a JEOL 2100F 
transmission electron microscope (TEM, Tokyo, Japan) at an accelerating voltage of 
200 kV. The determination of hydrodynamic size and surface charge of the 
nanoparticles was performed on a dispersion of the nanoparticles in DI water using a 
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Zetasizer nanosystem (Malvern Instrument, Worcestershire, UK). An average of 4 
readings (every reading comprising 10 scans) was calculated and the results were 
reported as average ± standard deviation. The stability of SPIONs-PGMA-FA in 
aqueous medium with a wide range of salt concentration (up to 1 M) and pH (4-12), 
and in cell culture medium was assessed by measuring the hydrodynamic size over a 
24 h period. UV-vis spectroscopy measurements were performed on a UV-1601 
(Shimadzu (Asia Pacific), Singapore). 1H NMR, TGA and VSM measurements were 
carried out according to the procedures described in Section 3.2.9.  
 
4.2.13 Statistical Analysis  
Three replicates were measured per time point in each cell experiment. The results are 
reported as mean ± standard deviation and were assessed statistically using one-way 
analysis of the variance (ANOVA) post-hoc Tukey test. Statistical significance was 








4.3 Results and Discussion 
4.3.1 Synthesis of SPIONs-PGMA-FA 
The steps for the synthesis of SPIONs-PGMA-FA are shown schematically in Figure 
4-1. The ATRP initiator was synthesized via the reaction of γ-aminopropyl 
triethoxysilane (APS) with 2-bromoisobutyryl bromide (BIB). The initiator was 
immobilized on the surface of SPIONs via a combination of ligand exchange and 
condensation of the triethoxysilane. The initiator first hydrolyzed to silanol and 
replaced the adsorbed oleic acid on the surface of SPIONs, after which condensation 
of the silanol groups formed a surface Si-O-Si network (De Palma et al. 2007).  
 
       Figure 4-1 Schematic representation of the synthesis of SPIONs-PGMA-FA. 
 
XPS was used to verify the success of the surface functionalization steps. By 
comparing Figure 4-2A (a) and 2A (b), it can be seen that after the initiator was 
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immobilized on the SPIONs, the characteristic signals for nitrogen (N 1s at 401 eV) 
and bromide (Br 3p at 184 eV and Br 3d at 72 eV) are present in the wide scan 
spectrum. The Br moiety was used to initiate the ATRP of GMA. After surface-
initiated ATRP of GMA, the increase in the O 1s signal which arises from PGMA and 
the disappearance of the characteristic signals of the initiator in the wide scan (Figure 
4-2A (c)) can be observed, indicating that the thickness of the grafted PGMA shell 
has exceeded the sampling depth of the XPS technique (~7.5 nm) (Tan et al. 1993). 
The epoxy functional groups of PGMA can be modified in a number of ways via the 
ring-opening reaction. In this work, EDA was used to react with the epoxy groups to 
form amino groups which were utilized to immobilize the targeting ligand. After 
reaction with EDA, the presence of the N 1s signal at a binding energy of 400 eV in 
the wide scan spectrum (Figure 4-2A (d)) can be observed. The success of the surface 
modification of SPIONs via ATRP and subsequent ring-opening reaction can also be 
seen from the XPS C 1s core-level spectra. The C 1s core-level spectrum of SPIONs-
PGMA (Figure 4-2B (a)) consists of three peaks with binding energy at 284.6, 286.3, 
and 288.6 eV, which are attributed to C-C/C-H, C-O, and O-C=O respectively. The 
area ratio of C-C/C-H, C-O, and O-C=O is calculated to be 3.7:3:1 while the 
theoretical ratio in PGMA is 3:3:1. The higher than expected proportion of C-C/C-H 
is attributed to possible carbon contamination in the analysis chamber. Thus, it can be 
concluded that the SPIONs have been successfully modified with PGMA via ATRP. 
After ring-opening reaction, the C 1s core-level spectrum of SPIONs-PGMA-NH2 
(Figure 4-2B (b)) shows a new peak at 285.8 eV which corresponds to the C-N groups, 
indicating SPIONs-PGMA has been successfully modified by EDA. The 
immobilization of FA on the surface of the nanoparticles cannot be confirmed by XPS 
since the wide scan spectrum of SPIONs-PGMA-FA shows the same three prominent 
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signals for C, N and O as SPIONs-PGMA-NH2. Thus FT-IR was used to verify the 
synthesis of SPIONs-PGMA-FA. 
 
Figure 4-2 A. XPS wide scan spectra of (a) oleic acid-stabilized SPIONs, (b) initiator-
coated SPIONs, (c) SPIONs-PGMA, and (d) SPIONs-PGMA-NH2; B. XPS C 1s 
core-level spectra of (a) SPIONs-PGMA and (b) SPIONs-PGMA-NH2. 
 
 
The FT-IR spectra of the pristine SPIONs and initiator-coated SPIONs are shown in 
Figure 4-3a and 4-3b. The pristine SPIONs are stabilized by oleic acid, and the 
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characteristic bands around 1540 cm-1 and 1450 cm-1 corresponding to the COO- 
groups of oleic acid coordinated with SPIONs can be observed (Fan et al. 2007). The 
strong bands at 2846 cm-1 and 2920 cm-1 are attributed to the symmetric and 
asymmetric stretch of CH2 groups in the oleic acid (Fan et al. 2007). After the initiator 
was immobilized on the SPIONs, the N-C=O bond at 1645 cm-1 and 1533 cm-1, and 
the absorption band around 1000 cm-1 which corresponds to Si-O-Si vibrations can be 
observed. These changes attest to the silanization of the SPIONs (Sun et al. 2007b). 
After surface-initiated ATRP (Figure 4-3c), the characteristic bands of PGMA, C=O 
groups at 1720 cm-1, oxirane ring symmetrical expansion and contraction vibrations at 
1260 cm-1, and oxirane ring asymmetric expansion and contraction vibrations at 841 
cm-1 and 903 cm-1 can be observed (Wang et al. 2008). Reaction of SPIONs-PGMA 
with EDA results in new bands around 1636 cm-1 and 1500 cm-1 (Figure 4-3d) 
attributed to the vibrations of –NH2 and –NH, respectively (Ma et al. 2005). Lastly, 
after conjugation of FA on the surface of nanoparticles, all the characteristic 
vibrational bands associated with FA such as C-H stretching at 2930 and 2842 cm-1, 
aromatic ring stretch of the pyridine and p-amino benzoic acid moieties in the 1180-
1604 cm-1 range are present (comparing Figure 4-3e and 4-3f) (Setua et al. 2010). 
These results confirm the successful conjugation of FA. Based on the UV 
spectrophotometry method of FA quantification, the amount of FA conjugated on the 
nanoparticles was calculated to be 27, 48 and 76 mg (g·nanoparticles)-1 for SPIONs-
PGMA-FA-1, SPIONs-PGMA-FA-2 and SPIONs-PGMA-FA-3, respectively. 
Analysis of the reproducibility of the FA conjugation experiment shows that the 
difference between the amounts of FA conjugated in repeated experiments was less 





Figure 4-3 FT-IR spectra of (a) oleic acid-stabilized SPIONs, (b) initiator-coated 
SPIONs, (c) SPIONs-PGMA, (d) SPIONs-PGMA-NH2, (e) SPIONs-PGMA-FA-1, 
and (f) free folic acid. 
 
4.3.2 Size and Zeta Potential of Nanoparticles 
The TEM image of the oleic acid-stabilized SPIONs synthesized by thermal 
decomposition shows that these nanoparticles are monodisperse with a particle size of 
~12 nm (Figure 4-4a). These nanoparticles can be readily dispersed in organic 
solvents (e.g. hexane or toluene) but not in water. On the other hand, SPIONs-PGMA-
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FA dispersed well in aqueous solution and the solution can be stored at 4 oC for 
months without significant precipitation. The hydrodynamic sizes of SPIONs-PGMA-
FA-1, SPIONs-PGMA-FA-2 and SPIONs-PGMA-FA-3 were 111.5 ± 3.4, 134.1 ± 1.0 
and 145.9 ± 2.8 nm, respectively. With increasing amount of conjugated FA on the 
surface of the nanoparticles, the hydrodynamic size increases. The hydrodynamic 
sizes of these nanoparticles are larger than those observed from the TEM images 
(Figure 4-4b) which are comparable to that of the pristine SPIONs. The possible 
explanations for the hydrodynamic size being substantially larger than the particle 
size as shown in Figure 4-4b are partial aggregation of the nanoparticles in water, 
crosslinking between nanoparticles induced by EDA as well as the presence of a 
polymeric shell which was not discernible by TEM due to the lack of contrast 
between the polymer shell and the background. In our preliminary experiments, we 
have found that interparticle crosslinking is inhibited in the presence of excess EDA. 
Thus, a molar ratio of EDA to epoxy groups of ~160:1 was used in the preparation of 
SPIONs-PGMA-NH2. Before the ring-opening reaction, SPIONs-PGMA is 
hydrophobic and cannot disperse in water. After modification with EDA, amino 
groups were generated on the surface of nanoparticles (SPIONs-PGMA-NH2), 
resulting in a positive zeta potential (25.2 ± 2.2 mV) and dispersibility in water. After 
FA conjugation, the zeta potentials for SPIONs-PGMA-FA show a decrease (16.1 ± 
1.9, 12.8 ± 0.6, and 10.7 ± 1.3 mV for SPIONs-PGMA-FA-1, SPIONs-PGMA-FA-2 
and SPIONs-PGMA-FA-3, respectively) due to amide bond formation and the 
presence of the carboxyl groups of FA. These SPIONs-PGMA-FA nanoparticles are 
highly stable in aqueous medium and are resistant to aggregation even under high salt 
concentration (up to 1000 mM). In addition, the nanoparticles also show no sign of 




Figure 4-4 TEM images of (a) oleic acid-stabilized SPIONs dispersed in hexane and 
(b) SPIONs-PGMA-FA-1 dispersed in DI water. 
 
4.3.3 Magnetic Properties  
The magnetization curves of the as-synthesized SPIONs and SPIONs-PGMA-FA as a 
function of applied magnetic field at room temperature are shown in Figure 4-5. No 
hysteresis loop was observed, confirming the superparamagnetic behaviour of the 
nanoparticles at room temperature. The Ms values of pristine oleic acid-stabilized 
SPIONs (Figure 4-5a) and SPIONs-PGMA-FA-1 (Figure 4-5b) at 25 oC are 41 and 
8.5 emu/g, respectively. The decrease of Ms is due to the decrease in iron oxide 
content of the SPIONs-PGMA-FA-1 nanoparticles as compared to the pristine oleic 
acid-stabilized SPIONs. When the magnetization values are expressed in “per unit 
weight of Fe”, the values for SPIONs (Fe3O4 content of 69% based on TGA result) 
and SPIONs-PGMA-FA-1 (Fe3O4 content of 15% based on TGA result) are 82 and 78 
emu/(g Fe), respectively. The slight decrease in Ms value after surface modification 
may be due to the electron exchange between the polymer coating and the SPIONs 
surface atoms which could disorder the spins and quench the magnetic moment 
(Zhang et al. 2009). Since 7-22 emu/g is usually adopted for bioapplications (Fan et al. 
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2007), the Ms for SPIONs-PGMA-FA-1 is deemed sufficient. The different Ms values 
of pristine SPIONs reported in Chapter 3 and Chapter 4 may be due to different 
degree of diamagnetic contribution from the surfactant coatings (oleic acid and 
oleylamine in Chapter 3 while oleic acid in Chapter 4) which is directly related to the 
sample preparation method (Morales et al. 1999; Woo et al. 2004).  
 
Figure 4-5 Field dependent magnetization at 25oC for (a) oleic acid-stabilized SPIONs 
and (b) SPIONs-PGMA-FA-1. 
 
Nanoparticles with superparamagnetic property are used as T2 contrast agents which 
generate dark contrast in MRI. Figure 4-6A shows the MR signal-enhancing property 
of SPIONs-PGMA-FA-1 in water as a function of iron concentration. With increasing 
iron concentration (i.e. nanoparticle concentration), the T2-weighted images become 
increasingly darker. The longitudinal (1/T1) and transverse (1/T2) relaxation rates of 
protons in water solutions of SPIONs-PGMA-FA-1 measured in a 3T magnetic field 
as a function of the iron molar concentration are shown in Figure 4-6B. From the 
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slope of these plots, the r1 value of SPIONs-PGMA-FA-1 in water was calculated to 
be 1.95 mM-1s-1, while the r2 value was 191.4 mM-1s-1. Comparing with MRI contrast 
agents Feridex (r2 = 93 mM-1s-1) (Rohrer et al. 2005) and Resovist (r2 = 143 mM-1s-1) 
(Rohrer et al. 2005) at the same magnetic field strength, the higher r2 value exhibited 
by SPIONs-PGMA-FA-1 would afford better T2 contrast for MRI. The r2/r1 ratio of 
SPIONs-PGMA-FA-1 was calculated to be 98, which is four times higher than that of 
Feridex (r2/r1 ratio of 23) and three times higher than that of Resovist (r2/r1 ratio of 
31). For a T2 contrast agent, the higher the r2/r1, the better the contrast efficacy. Hence, 
SPIONs-PGMA-FA-1 can be a highly efficient T2 contrast agent. 
 
Figure 4-6 A. T2-weighted MRI images (3T, spin-echo sequence: TR=3000 ms, 
TE=36.8 ms) of SPIONs-PGMA-FA-1 in water. B. Relaxation rates (a) 1/T2 and (b) 
1/T1 at a magnetic field of 3T as a function of iron concentration (mM) of SPIONs-
PGMA-FA-1 in water. 
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The stability of SPIONs-PGMA-FA-1 in water in the 3T magnetic field was 
investigated by comparing the relaxivities after various periods in the magnetic field.  
After 10 h, the r2 value was found to be 191.2 mM-1s-1, which is very similar to the 
initial value. Since r2 will change if there is aggregation of the nanoparticles, this 
result confirms that the SPIONs-PGMA-FA-1 is highly stable in water.  
 
4.3.4 Cellular Uptake of Nanoparticles 
The specific interaction between folic acid-conjugated SPIONs and the folate receptor 
in vitro is demonstrated by comparing the extent of uptake of SPIONs-PGMA-NH2 
and SPIONs-PGMA-FA by the KB cells which express a high level of folate receptor 
(approximately an order of magnitude higher than those occurring in carcinoma tumor 
explants and in other carcinoma cell lines (Ross et al. 1994)). Figure 4-7a shows that 
for both types of nanoparticles, the cellular uptake increases with increasing 
incubation time, but the uptake of folic acid-functionalized SPIONs-PGMA-FA-1 was 
about five times higher than that of the non-targeting nanoparticles (SPIONs-PGMA-
NH2) over the 4 h incubation period. The cellular content of SPIONs-PGMA-FA-1 
reached ~20 pg Fe/cell after 4 h even though the nanoparticle concentration in the 
medium is only 0.2 mg/mL. The presence of folic acid on the SPIONs-PGMA-FA 
enables the nanoparticles to rapidly bind to the folate receptors on the KB cells, and 
the receptor-mediated endocytosis is much more efficient than the non-specific 
binding/penetration process which is responsible for the uptake of the nanoparticles 




Figure 4-7 (a) Intracellular uptake of SPIONs-PGMA-NH2 and SPIONs-PGMA-FA-1 
by KB cells as a function of incubation time; (b) intracellular uptake of SPIONs-
PGMA-FA nanoparticles with different FA surface densities by different cell lines 
after incubation of 4 h. Nanoparticle concentration in medium was 0.2 mg/mL. (*) 
denote significant differences between each pair indicated (P < 0.05). 
 
 
The effect of FA surface density on receptor-mediated endocytosis and non-specific 
binding/penetration process is shown in Figure 4-7b. The cellular uptake of the 
nanoparticles with different FA densities by 3T3 fibroblasts was not significantly 
different (P > 0.05). On the other hand, with increasing FA density, the cellular 
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uptake by macrophages shows significant differences between SPIONs-PGMA-FA-1 
and SPIONs-PGMA-FA-3 (P = 0.0003), as well as between SPIONs-PGMA-FA-2 
and SPIONs-PGMA-FA-3 (P = 0.01). For the KB cells, significant difference can be 
observed between SPIONs-PGMA-FA-1 and SPIONs-PGMA-FA-3 (P = 0.003), but 
not between either SPIONs-PGMA-FA-1 and SPIONs-PGMA-FA-2 (P = 0.1), or 
between SPIONs-PGMA-FA-2 and SPIONs-PGMA-FA-3 (P = 0.06). The result 
obtained with the KB cells is consistent with Bae and Kataoka’s (2009) research on 
FA-functionalized polymer micelles which indicates that the amount of FA does not 
significantly affect receptor recognition unless the FA content is more than 10 wt%. 
The FA content of the SPIONs-PGMA-FA nanoparticles in the present work is 
estimated to range from 3 to 10% of the total polymer weight (excluding the iron 
oxide nanoparticle). Regardless of the FA surface density, the uptake of the FA-
functionalized nanoparticles by the KB cells was about a factor of 5-6 times higher 
than that of non-targeting nanoparticles (comparing Figure 4-7a and 7b). 
 
In addition to the importance of achieving a high uptake of the SPIONs by the cancer 
cells, another key factor for the in vivo application of SPIONs as a contrast agent for 
cancer imaging is evasion of uptake by cells of the RES. The rapid removal of 
nanoparticles from blood circulation will result in a drastic reduction in their 
capability to reach the targeted organs (Huang et al. 2010). In a number of previous 
investigations on the targeting ability of FA-functionalized nanoparticles (Dixit et al. 
2006; Kim et al. 2007; Pan and Feng 2009; Liu et al. 2010), normal cells such as 3T3 
fibroblasts were used as a comparison with cancer cells. However, such a comparison 
ignores the problem posed by the phagocytic cells such as macrophages. In the 
present work, the uptake by the cancer cells, normal cells and macrophages was 
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compared. It can be seen from Figure 4-7b that SPIONs-PGMA-FA resulted in a 
much higher uptake by KB cells than 3T3 fibroblasts and macrophages. After 4 h of 
incubation, the cellular uptake of the folic acid conjugated functionalized 
nanoparticles was about five times higher than 3T3 fibroblasts, and about three times 
higher than macrophages.  
 
The surface properties of nanoparticles play a key role in determining the extent of 
uptake by macrophages. Positive surface charges are expected to enhance the cellular 
uptake due to electrostatic interaction between positively charged nanoparticles and 
negatively charged cell membrane. However, it has been reported that negatively 
charged nanoparticles result in a high level of cell internalization while decreased 
phagocytic activity of macrophages was observed with cationic nanoparticles. This in 
turn results in a shorter half-life of negatively charged nanoparticles in blood than 
cationic nanoparticles (Sengupta et al. 2000; Levchenko et al. 2002; Luciani et al. 
2009). This phenomenon may be due to the more extensive binding of opsonin serum 
proteins with negatively charged nanoparticles, which stimulates phagocytosis by 
macrophages (Hernandezcaselles et al. 1993; Bhattacharjee et al. 2010). The size of 
the nanoparticles also affects cellular uptake, and 10-100 nm nanoparticles have been 
deemed optimal for in vivo delivery as the bigger ones (> 200 nm) are quickly 
sequestered by the RES (Shubayev et al. 2009). A very substantial increase in FA 
surface density beyond that in SPIONs-PGMA-FA-3 may further promote receptor 
recognition of nanoparticles by the KB cells but the expected decrease in 
hydrophilicity and increase in hydrodynamic size will likely also increase 
phagocytosis by macrophages. 
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4.3.5 Cytotoxicity Assay  
The toxicity of nanoparticles is an important issue that needs to be addressed prior to 
clinical application. Although SPIONs are metabolized into elemental iron species, a 
high concentration of Fe ions in the cytoplasm can potentially cause toxic effect due 
to generation of reactive oxygen species (Theil 2003; Jun et al. 2008). Therefore, 
three cell lines with different FR expression, 3T3 fibroblasts, macrophages and KB 
cells, were used as the model normal cell line, phagocytic cell line and cancer cell line, 
respectively, to investigate the toxicity of SPIONs-PGMA-FA after incubation in 
medium containing various concentrations of nanoparticles for 24 h (Figure 4-8). No 
significant difference in cytotoxicity can be observed among the three cell lines even 
though the extents of uptake are different. The viabilities of these three types of cells 
were >92% when the incubated nanoparticles concentration was 0.5 mg/mL or less. 
Increasing the nanoparticle concentration to 1.0 mg/mL results in a decrease in 
viability to 86%. Positively charged nanoparticles have been proven to be more 
cytotoxic than neutral and negatively charged nanoparticles due to induced 
intracellular reactive oxygen species (ROS) production (Bhattacharjee et al. 2010). 
Nevertheless, since a low SPIONs-PGMA-FA-1 concentration of 0.2 mg/mL is 
sufficient to achieve an intracellular iron content of ~20 pg Fe/cell in the KB cells, it 





Figure 4-8 Viability of 3T3 fibroblasts, macrophages, and KB cells as a function of 












We have shown that surface-initiated ATRP of GMA on SPIONs followed by 
subsequent reaction with ethylenediamine results in a polymer coating which can 
render the nanoparticles water-dispersible, and at the same time generate functional 
groups for conjugation with folic acid. These nanoparticles are highly stable in 
aqueous medium, have low cytotoxicity, and possess high T2 relaxivity and r2/r1 ratio. 
The combination of surface conjugated folic acid and the hydrophilic polymer coating 
results in rapid and selective internalization of these nanoparticles by KB cells while 
concomitantly minimizing uptake by macrophages and normal cells. Hence, this type 



















CHAPTER 5 COMBINED ATRP AND ‘CLICK’ CHEMISTRY 
FOR DESIGNING LONG-CIRCULATING TUMOR-TARGETING 

















Although the nanoparticles (SPIONs-PGMA-FA) reported in Chapter 4 are 
internalized to a much great extent by KB cells than by 3T3 fibroblasts and 
macrophages, a further reduction in uptake by macrophages would be advantageous 
for in vivo biomedical applications demanding long blood circulating time. Therefore, 
in this Chapter, we report on an improved design and synthesis method of SPIONs 
which have controllable amounts of conjugated FA to target cancer cells, and a stealth 
coating for macrophage evasion. These SPIONs were conferred a coating of 
poly(glycidyl methacrylate-co-poly(ethylene glycol) methyl ether methacrylate) 
(P(GMA-co-PEGMA)) via ATRP, and ‘click’ chemistry was used to achieve different 
surface densities of conjugated FA.  
 
‘Click’ chemistry is an efficient functionalization strategy, and it is preferred  over 
conventional methods for conjugation of biological ligands (De et al. 2008), as the 
reaction tolerates organic and aqueous media, and achieves high chemoselectivity 
with little or no side reactions (De et al. 2008; Hayashi et al. 2009). The combination 
of ATRP and ‘click’ chemistry provides two advantages. Firstly, ATRP enables the 
construction of polymer chains on the surface of nanoparticles and the amount of 
active groups for FA conjugation can be easily varied by varying the reaction 
conditions. In comparison, in the most widely reported method of FA conjugation 
where FA was conjugated to terminal functional groups of the nanoparticle, the 
amount of FA that can be conjugated is limited. Secondly, by using ‘click’ chemistry 
reaction, the FA conjugation process can be well-controlled and carried out efficiently. 
Our group has earlier reported the use of thiol ‘click’ reaction to conjugate FA onto 
the surface of HPG-grafted Fe3O4@SiO2 to target cancer cells (Wang et al. 2011). In 
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this present work, the azide-alkyne reaction was used, since the number of reaction 
steps can be reduced and the reaction conditions do not have to be as stringent as for 
the thiol ‘click’ reaction. The PEGMA segment of the copolymer served as a 
protective layer to increase the stability and blood compatibility of the nanoparticles, 
















5.2 Materials and Methods 
5.2.1 Materials  
PEGMA (475 g/mol) were purchased from Sigma-Aldrich and used after removal of 
the inhibitors by passing through a silica gel column. All other solvents and chemicals 
were similar to those described in Section 4.2.1. 
 
5.2.2 Preparation of SPIONs  
SPIONs were prepared as described in Section 4.2.2 with minor modifications. For 
synthesis of monodisperse SPIONs with a particle size of ~14 nm, the iron-oleate 
complex (18 g, 20 mmol) and oleic acid (2.8 g, 10 mmol) were dissolved in 1-
octadecene (30 g). The mixture was heated to 320 oC at a heating rate of 3.3 oC min-1, 
and kept at that temperature for 1 h under a blanket of argon. After the reaction, the 
solution was cooled to room temperature, and ethanol (250 mL) was added to the 
mixture to precipitate the nanocrystals. The nanoparticles were separated by 
centrifugation (6000 rpm, 10 min), dried under reduced pressure, and stored at 0-4 oC. 
 
5.2.3 Preparation of Initiator-coated SPIONs.  
The initiator-coated SPIONs were prepared as described in Section 4.2.3 and 4.2.4. 
 
5.2.4 Preparation of SPIONs-P(GMA-co-PEGMA) via ATRP  
A series of preliminary experiments were first carried out to establish the optimum 
GMA/PEGMA reactant ratio and reaction time for graft copolymerization on the 
SPIONs. With a high GMA/PEGMA ratio, the copolymer would have a high 
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proportion of GMA groups for conjugation with FA but the water dispersibility of the 
functionalized SPIONs may be compromised. If the reaction time is too short, the 
water dispersibility of the nanoparticles is also poor since the polymer brushes may be 
too short to adequately shield the nanoparticles. However, with a long reaction time, 
the Fe3O4 content, and correspondingly the magnetization, may be too low. The 
procedure described below is for the highest GMA/PEGMA ratio and the optimal 
copolymerization time which resulted in nanoparticles which are highly water 
dispersible. 
 
The initiator-coated SPIONs (100 mg) were first dispersed in 4 mL THF in a round-
bottom flask containing a magnetic stirring bar to form a transparent brownish 
solution. The GMA monomer (120 mg, 0.85 mmol) and PEGMA monomer (940 mg, 
1.98 mmol) were then added. The mixture was degassed by bubbling argon for 15 min, 
and CuBr (10.2 mg, 0.07 mmol) and Bpy (33.2 mg, 0.21 mmol) were added into the 
reaction mixture. After purging with argon for another 10 min, the flask was sealed 
under an argon atmosphere with a rubber stopper. The mixture was stirred at 45 oC for 
4 h. The reaction mixture was then diluted with THF and was centrifuged at 4000 rpm 
for 4 min to remove the Cu(II) precipitate. The supernatant was precipitated with 
ethanol, and the precipitate was re-dispersed in THF and centrifuged at a speed of 
2000 rpm for 2 min to further remove the remaining Cu(II) precipitate and any 
agglomerates. The resulting nanoparticles were precipitated with diethyl ether. This 
dispersion and precipitation procedure was repeated three times followed by drying 




5.2.5 Preparation of SPIONs-P(GMA-co-PEGMA)-N3 
Azide groups on the surface of SPIONs-P(GMA-co-PEGMA) nanoparticles were 
generated through ring-opening reaction of the epoxy groups in the GMA segment of 
the copolymer chain with sodium azide (NaN3). Briefly, 100 mg of SPIONs-P(GMA-
co-PEGMA) was treated with 14.2 mg of NaN3 in the presence of ammonium chloride 
(at the same molar concentration as NaN3) in DMF at 50 oC for 12 h under a blanket 
of argon. After the reaction, the mixture was dialyzed against DI water for 5 days 
using a membrane with molecular weight cutoff of 12000 g/mol to remove the excess 
NaN3 and solvent. The nanoparticles were dried by lyophilization, and denoted as 
SPIONs-P(GMA-co-PEGMA)-N3.  
 
5.2.6 Preparation of Alkyne-functionalized FA  
Alkyne-functionalized FA (propargyl folate) was synthesized according to the method 
previously described in the literature with slight modifications (De et al. 2008; Saeed 
et al. 2011). Folic acid (500 mg, 1.1 mmol) was dispersed in dimethyl sulfoxide 
(DMSO, 10 mL) and the solution was cooled to ~19 oC in a water/ice bath. NHS (130 
mg, 1.2 mmol) and DCC (247 mg, 1.2 mmol) were added, and the resulting mixture 
was stirred for 2 h. Propargylamine (62 mg, 1.1 mmol) was added and the resulting 
mixture was allowed to warm to room temperature and stirred for 24 h protected from 
light. The reaction mixture was filtered to remove the dicyclohexylurea (a white 
precipitate) which was formed as a byproduct, and the filtrate was poured into a large 
amount of water. The orange-yellow precipitate was filtered, washed with acetone, 
and dried under reduced pressure at 30 oC. The analytical data corresponded to that 
reported in the literature for folate derivatives (De et al. 2008; Mindt et al. 2008). 
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1H NMR (500 MHz, DMSO-d6), (δ, ppm): 8.64 (s, 1H, PtC7 H), 8.28 (t, 1H, -
CONHCH2C≡CH), 6.93 (t, 1H, PtC6-CH2NH-Ph), 8.03–8.01 (d, 1H, -
CONHCHCOOH), 7.67–7.63 (d, 2H, Ph-C2H and Ph-C6H), 6.8-7.0 (br, s, 2H, NH2), 
6.65–6.62 (d, 2H, Ph-C3H and Ph-C5H), 4.49–4.48 (d, 2H, PtC6-CH2NH-Ph), 4.32–
4.20 (m, 1H, -CONHCHCOOH), 3.82–3.81 (m, 2H, -CONH-CH2C≡CH), 2.86 (s, 1H, 
-CONH-CH2C≡CH), 2.22–2.14 (m, 2H, -CH2CONH-), 1.99–1.85 (m, 2H, -
CHCH2CH2). (Pt = pteridine).  
 
5.2.7 Preparation of SPIONs-P(GMA-co-PEGMA)-FA  
FA-functionalized nanoparticles was synthesized via ‘click’ reaction of SPIONs-
P(GMA-co-PEGMA)-N3 with propargyl folate. Briefly, 80 mg of SPIONs-P(GMA-
co-PEGMA)-N3 were dispersed in a solution of DMSO (5 mL) and DI water (5 mL). 
CuSO4 and sodium ascorbate (molar ratio of CuSO4:sodium ascorbate:propargyl 
folate = 1:2:1) were then added to the above solution. To prepare nanoparticles with 
different surface density of FA, different amounts of propargyl folate (0.2, 0.7, and 
1.2 mL of 0.03 mM propargyl folate in DMSO) were then added. The resulting 
solution was stirred in the dark at room temperature for 12 h. The solution was then 
dialyzed against DI water for 5 days in a dialysis bag with molecular weight cutoff of 
12000 g/mol, with replacement of water every 12 h. The nanoparticles were obtained 
by lyophilization and denoted as SPIONs-P(GMA-co-PEGMA)-FA-1, SPIONs-
P(GMA-co-PEGMA)-FA-2, and SPIONs-P(GMA-co-PEGMA)-FA-3, corresponding 
to the volume of the propargyl folate reagent used in the ‘click’ reaction of 0.2 mL, 
0.7 mL, and 1.2 mL, respectively. The surface density of FA was quantified with UV-
vis spectrophotometry according to the method described in the literature (Maeng et al. 
2010). SPIONs-P(GMA-co-PEGMA)-N3 (as the control) and SPIONs-P(GMA-co-
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PEGMA)-FA were dispersed in DI water at the same iron concentration and the 
absorbance of the solution at about 280 nm were measured. The folate content on the 
surface of nanoparticles was then calculated (after subtracting out the background 
absorption of the control nanoparticles) from a calibration curve obtained by 
measuring the absorbance of different concentrations of free FA in water at 280 nm. 
 
5.2.8 Cell Culture  
KB cells, macrophages, and 3T3 fibroblasts were cultured as described in Section 
4.2.8. 
 
5.2.9 Cytotoxicity Assay  
The cytotoxicity of SPIONs-P(GMA-co-PEGMA)-FA was evaluated by the MTT 
assay. KB cells, macrophages, and 3T3 fibroblasts were first seeded in a 96-well plate 
at a density of 104 cells/well. After 24 h, the medium was replaced with one 
containing the nanoparticles at 0.1, 0.2, 0.5 and 1.0 mg/mL. Control experiments were 
carried out using the growth culture medium without nanoparticles (non-toxic control). 
After 24 h incubation at 37 oC and 5% CO2, the culture medium from each well was 
then removed and the MTT assay was carried out as described in Section 3.2.7. 
  
5.2.10 In Vitro Evaluation of Folate Receptor Targeting  
The cellular uptake of SPIONs-P(GMA-co-PEGMA)-N3 or SPIONs-P(GMA-co-
PEGMA)-FA-3 by KB cells was carried out as described in Section 4.2.9. for time 
periods of 2 h, 4 h, and 24 h.  
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To investigate the cellular uptake behavior of SPIONs-P(GMA-co-PEGMA)-FA by 
different cell lines, the experiments were repeated with macrophages and 3T3 
fibroblasts. These cells were incubated with SPIONs-P(GMA-co-PEGMA)-FA-3 at a 
concentration of 0.2 mg/mL for prescribed time periods (2, 4, and 24 h) at the same 
cell concentration (105 cells/mL), and the evaluation was carried out in a similar 
manner. The effect of FA density of the nanoparticles on cellular uptake by the 
different cell lines was also investigated. KB cells, macrophages and 3T3 fibroblasts 
were incubated with SPIONs-P(GMA-co-PEGMA)-FA-1, SPIONs-P(GMA-co-
PEGMA)-FA-2, and SPIONs-P(GMA-co-PEGMA)-FA-3 at a concentration of 0.2 




The hydrodynamic size and surface charge of the nanoparticles was determined using 
a Zetasizer nanosystem as described in Section 4.2.12. Hydrodynamic diameter 
measurements were performed on dispersions of the nanoparticles (0.5 mg/mL) in 
either NaCl solution of different concentration (up to 1 M), or PBS at various pH 
(ranging from 4 to 10). 0.1 M HCl and 0.1 M NaOH were used to adjust the pH value 
while 10 M NaCl solution was used to adjust the salt concentration. The 
measurements were performed 20 minutes after the adjustment of the solution 
conditions. The surface charge of the nanoparticles was investigated through zeta 
potential measurements in aqueous solution. Each measurement was repeated at least 
4 times and the results were reported as average ± standard deviation. XPS, TEM. 
UV-vis measurements were as described in Section 4.2.12. Other characterization 
methods, TGA, FT-IR and VSM were carried out as described in Section 3.2.9.  
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5.2.12 Statistical Analysis  


















5.3 Results and Discussion 
The synthesis of SPIONs-P(GMA-co-PEGMA)-FA is shown schematically in Figure 
5-1. GMA and PEGMA were copolymerized on the surface of pristine SPIONs via 
ATRP to attain water dispersibility and macrophage-evading properties. GMA, 
randomly distributed in the copolymer chain, served as reactive sites for conjugation 
of alkyne-functionalized FA via ‘click’ chemistry. The ‘click’ chemistry-mediated 
conjugation enables the preparation of FA-functionalized SPIONs with different FA 
surface density.  
 
Figure 5-1 Schematic representation of the synthesis of SPIONs-P(GMA-co-PEGMA)-
FA. 
 
5.3.1 Surface Characterization of SPIONs-P(GMA-co-PEGMA)-FA 
FA possesses two kinds of carboxyl groups. When FA is linked via its -COOH, its 
FR binding affinity is comparable to free FA. However, its –COOH derivatives are 
not recognized as readily (Wang et al. 1996; Ke et al. 2004). In this work, alkyne-
functionalized FA was synthesized via carbodiimide activation, which has been 
reported to favor linkage with the distal -COOH residue (Dube et al. 2002; Sun et al. 
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2006). The success of the functionalization of the SPIONs with the polymer coating 
and subsequent conjugation with FA was ascertained by XPS. A comparison of the 
XPS wide-scan spectra of the initiator-coated SPIONs and the pristine SPIONs clearly 
shows the presence of Br from the immobilized ATRP initiator in the former (Figure 
5-2).  
 




As shown in Figure 5-3a, the C 1s core-level spectrum of SPIONs-P(GMA-co-
PEGMA) can be curve-fitted with three peaks at binding energies (BEs) of 284.6, 
286.2 and 288.6 eV, which are attributed to C-C/C-H, C-O, and O-C=O, respectively 
(Moulder and Chastain 1992). No nitrogen signal can be observed (Figure 5-3b) since 
there is no nitrogen either in GMA or in PEGMA. After ring-opening reaction with 
sodium azide, a new peak at BE of 285.6 eV in the C 1s core-level (Figure 5-3c) can 
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be observed, corresponding to the C-N group (Moulder and Chastain 1992). 
Furthermore, the characteristic peaks of the azide group (-N=N+=N-) can also be 
observed at BEs of 399.9, 400.6, and 403.9 eV in the N 1s core-level spectrum 
(Figure 5-3d), attributable to the negatively charged N-, imine nitrogen –(N)=, and 
positively charged nitrogen N+, respectively (Collman et al. 2006; Cao et al. 2008). 
The area ratio of the three peaks is about 1:1:1, which is in good agreement with the 
chemical structure of azide groups. Thus, these results indicate that azide groups have 
been successfully generated in the polymer chain. After click reaction with FA, the 
increase in the intensity of the peak at 285.6 eV (assigned to the C-N group) in the C 
1s core-level spectrum of SPIONs-P(GMA-co-PEGMA)-FA-3 (Figure 5-3e) can be 
attributed to the conjugated propargyl folate. The O=C-N peak of the amide group of 
propargyl folate is barely discernible at 287.8 eV. The presence of the conjugated 
propargyl folate is also confirmed by the changes observed in the N 1s spectrum 
(comparing Figure 5-3d and 5-3f). In Figure 5-3f, the peak at 399.7 eV is assigned to 
the C-N group of the propargyl folate, while the peak at 398.3 eV is attributed to the 
imine (-N=) moiety of the triazole ring and the pteridine ring of FA. Since the 
sampling depth of XPS technique is ~7.5 nm (Tan et al. 1993), the disappearance of 
the characteristic peaks of the azide groups indicates that all the azide groups in the 
outer region of the polymer coating of SPIONs-P(GMA-co-PEGMA)-FA-3 have 




Figure 5-3 XPS C 1s core-level spectra of (a) SPIONs-P(GMA-co-PEGMA), (c) 
SPIONs-P(GMA-co-PEGMA)-N3, and (e) SPIONs-P(GMA-co-PEGMA)-FA-3. XPS 
N 1s core-level spectra of (b) SPIONs-P(GMA-co-PEGMA), (d) SPIONs-P(GMA-co-
PEGMA)-N3, and (f) SPIONs-P(GMA-co-PEGMA)-FA-3. 
 
 
The nanoparticles were also characterized by FT-IR to confirm the conjugation of FA 
on the surface of nanoparticles. By comparing Figure 5-4a and 5-4b, it can be seen 
that after ring-opening reaction of GMA with sodium azide, the characteristic 
absorbance peak of –N3 at 2100 cm-1 was present confirming that SPIONs-P(GMA-
co-PEGMA)-N3 was successfully synthesized. After FA conjugation, the FT-IR 
spectrum of SPIONs-P(GMA-co-PEGMA)-FA-3 (Figure 5-4c) displays absorbance 
peaks at 1604 and 1514 cm-1 attributed to aromatic ring stretch of the pyridine and p-
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amino benzoic acid moieties of FA, and the azide band around 2100 cm-1 has almost 
completely disappeared, consistent with the XPS results.  
 
Figure 5-4 FT-IR spectra of (a) SPIONs-P(GMA-co-PEGMA), (b) SPIONs-P(GMA-
co-PEGMA)-N3, and (c) SPIONs-P(GMA-co-PEGMA)-FA-3. 
 
 
On the other hand, with the smaller amount of FA reagent used in the preparation of 
SPIONs-P(GMA-co-PEGMA)-FA-1 and SPIONs-P(GMA-co-PEGMA)-FA-2, the 
FT-IR spectra of these nanoparticles (Figure 5-5) revealed that a portion of the azide 





Figure 5-5 FT-IR spectra of (a) SPIONs-P(GMA-co-PEGMA)-FA-1, (b) SPIONs-
P(GMA-co-PEGMA)-FA-2, and (c) SPIONs-P(GMA-co-PEGMA)-FA-3. 
 
 
The amount of FA conjugated to the nanoparticles was quantified based on the UV 
spectrophotometry method (Maeng et al. 2010). The UV-vis absorption spectra of 
control nanoparticles (SPIONs-P(GMA-co-PEGMA)-N3) and SPIONs-P(GMA-co-
PEGMA)-FA are shown in Figure 5-6. FA has a characteristic absorption band at 
about 280 nm. The control nanoparticles (SPIONs-P(GMA-co-PEGMA)-N3) do not 
exhibit this band. In the absorption spectra of the FA-conjugated nanoparticles, the 
intensity of the band at 280 nm varies with the FA surface density. The FA content 
can be calculated using a calibration curve of free FA by subtracting out the 
background absorption of the control nanoparticles. Thus, the amount of FA 
conjugated on the nanoparticles was calculated to be 19, 62 and 88 mg 
(g·nanoparticles)-1 for SPIONs-P(GMA-co-PEGMA)-FA-1, SPIONs-P(GMA-co-




Figure 5-6 UV-vis absorption spectra of (a) SPIONs-P(GMA-co-PEGMA)-N3, (b) 
SPIONs-P(GMA-co-PEGMA)-FA-1, (c) SPIONs-P(GMA-co-PEGMA)-FA-2, and (d) 
SPIONs-P(GMA-co-PEGMA)-FA-3 in DI water. 
 
5.3.2 Nanoparticle Size and Stability 
TEM images of pristine SPIONs and SPIONs-P(GMA-co-PEGMA)-FA-3 are shown 
in Figure 5-7. As can be seen from Figure 5-7a, the oleic acid-stabilized SPIONs were 
~14 nm with a narrow size distribution. After surface modification, all the three types 
of nanoparticles (SPIONs-P(GMA-co-PEGMA), SPIONs-P(GMA-co-PEGMA)-N3, 
and SPIONs-P(GMA-co-PEGMA)-FA) dispersed well in aqueous solution. The 
hydrodynamic size and zeta potential of these three types of nanoparticles are 
summarized in Table 5-1. With increasing amount of conjugated FA on the surface of 
the nanoparticles, the hydrodynamic size shows an increasing trend. The 
hydrodynamic size is substantially larger than that observed in the TEM image. For 
example, the size of SPIONs-P(GMA-co-PEGMA)-FA-3 observed from the TEM 
image (Figure 5-7b) is comparable to that of the pristine SPIONs (~14 nm, Figure 5-
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7a) but its hydrodynamic diameter is ~132 nm. This difference may be due to the 
presence of the polymeric shell which swells in aqueous medium but is not 
discernible from the TEM image due to the lack of contrast between the polymer shell 
and the background, and/or the slight aggregation of the nanoparticles in water. From 
Table 5-1, it can also be seen that with increasing surface density of FA, the zeta 
potentials of the FA-conjugated nanoparticles show a slight decrease which may be 
due to the presence of a free carboxyl group in each FA moiety (Landmark et al. 
2008). 
 
Figure 5-7 TEM images of (a) pristine oleic acid-stabilized SPIONs dispersed in 
hexane, and (b) SPIONs-P(GMA-co-PEGMA)-FA-3 dispersed in DI water. 
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The stability of SPIONs-P(GMA-co-PEGMA)-FA-3 in aqueous solution with 
different ionic strength and pH is shown in Figure 5-8. The SPIONs-P(GMA-co-
PEGMA)-FA-3 are resistant to flocculation induced by NaCl (up to 1M), as shown in 
Figure 5-8a. Figure 5-8b shows that the SPIONs-P(GMA-co-PEGMA)-FA-3 are 
stable in phosphate buffer over a wide pH range (pH 4-10). Furthermore, an aqueous 
suspension of these nanoparticles can be stored at 4 oC for months without significant 
precipitation, and when the nanoparticles are stored in the solid state, they can be 
readily re-dispersed in aqueous medium. These results indicate that SPIONs-P(GMA-
co-PEGMA)-FA are highly stable.  
 
Figure 5-8 Stability of SPIONs-P(GMA-co-PEGMA)-FA-3 in aqueous solution of 
varying (a) salt concentration, and (b) pH. 
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5.3.3 Magnetic Property  
In the application of SPIONs as targeted contrast agents for MRI, it is critical that the 
SPIONs retain their magnetic properties after coating with polymer. Figure 5-9 shows 
the magnetization of pristine SPIONs and SPIONs-P(GMA-co-PEGMA)-FA-3 versus 
the magnetic field at room temperature. Both types of nanoparticles exhibit 
superparamagnetic behaviour at room temperature. For the SPIONs-P(GMA-co-
PEGMA)-FA-3, based on an Fe3O4 content of 7.8 wt% (from TGA), the Ms is 82 
emu/(g Fe). This value is similar to the Ms of 88 emu/(g Fe) for the pristine SPIONs 
(Fe3O4 content is 70 wt% based on TGA). The reason for a slight decrease in Ms of 
surface-functionalized SPIONs compared to pristine SPIONs has been discussed in 
the Section 4.3.3. The Ms results suggest that the magnetic properties of SPIONs are 
maintained after coating with P(GMA-co-PEGMA)-FA.  
 
Figure 5-9 Magnetization curves of (a) pristine oleic acid-stabilized SPIONs, and (b) 
SPIONs-P(GMA-co-PEGMA)-FA-3 at 25 oC. 
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5.3.4 Cytotoxicity Assay  
The viabilities of KB cells, macrophages, and 3T3 fibroblasts after incubation with 
the nanoparticles were determined by the MTT assay. As can be seen from Figure 5-
10, after 24 h of incubation, the viabilities of these three types of cells were > 90% 
even when the SPIONs-P(GMA-co-PEGMA)-FA-3 concentration in the incubation 
medium was 1.0 mg/mL. Furthermore, no significant difference in cytotoxicity was 
observed among the three cell lines (P > 0.05), even though the extents of cellular 
uptake are different (see below). Thus, these results indicate that SPIONs-P(GMA-co-
PEGMA)-FA have low or no cytotoxicity towards the three types of cells, and can be 
considered as potentially safe for MRI or other in vivo applications. 
 
Figure 5-10 In vitro viabilities of 3T3 fibroblasts, macrophages, and KB cells as a 
function of SPIONs-P(GMA-co-PEGMA)-FA-3 concentration in medium. Incubation 




5.3.5 In Vitro Cellular Uptake  
The specific targeting efficiency of FA-conjugated nanoparticles was investigated 
with SPIONs-P(GMA-co-PEGMA)-N3 (i.e. without FA conjugation) used as the 
negative control. As can be seen in Figure 5-11a, the uptake of SPIONs-P(GMA-co-
PEGMA)-FA-3 into KB cells is about an order of magnitude higher than that of the 
negative control,  indicating the high efficiency of the FA-conjugated nanoparticles in 
targeting cancer cells which overexpress FR. To demonstrate the specificity for cancer 
cells, the uptake of FA-conjugated nanoparticles by KB cells was compared to that by 
3T3 fibroblasts and macrophages. It can be observed from Figure 5-11b that the 
uptake by the three cell lines increased with increasing incubation time, but the uptake 
by KB cells was significantly higher compared to those of the other cell lines. After 
incubation with SPIONs-P(GMA-co-PEGMA)-FA-3 for 24 h, KB cells have the 
highest cellular uptake of about 15 pg Fe/cell, which is five times higher that by the 
macrophages and thirteen times higher that by the 3T3 fibroblasts. Compared with 
SPIONs-PGMA-FA (Chapter 4), SPIONs-P(GMA-co-PEGMA)-FA demonstrates 
enhanced efficiency in targeting KB cells with decreased non-specific uptake by 
macrophages and 3T3 fibroblasts. This improvement is attributed to the hydrophilic 






Figure 5-11 (a) Intracellular uptake of SPIONs-P(GMA-co-PEGMA)-N3 and 
SPIONs-P(GMA-co-PEGMA)-FA-3  as a function of incubation time, (*) denotes 
significant difference as compared to SPIONs-P(GMA-co-PEGMA)-N3 (negative 
control) (P < 0.05); (b) intracellular uptake of SPIONs-P(GMA-co-PEGMA)-FA-3 by 
different cell lines as a function of incubation time, (*) denotes significant difference 
as compared to 3T3 fibroblasts (P < 0.05), (#) denotes significant difference as 
compared to macrophages (P < 0.05); (c) specific uptake index of SPIONs-P(GMA-
co-PEGMA)-FA for different cell lines after incubation of 4 h. The index is calculated 
as the ratio between the cellular uptake of SPIONs-P(GMA-co-PEGMA)-FA and that 
of control nanoparticles (SPIONs-P(GMA-co-PEGMA)-N3), (*) denotes significant 
difference between each pair indicated (P < 0.05). Nanoparticle concentration in 
medium was 0.2 mg/mL. 
 Chapter 5 
120 
To investigate the effect of FA surface density on cellular uptake, the three cell lines 
were incubated for 4 h with FA-conjugated nanoparticles bearing different surface 
density of FA. The results were expressed in terms of specific uptake index (SUI), 
defined as the ratio of cellular uptake of FA-conjugated nanoparticles to that of 
nanoparticles without FA at the same conditions. From Figure 5-11c, it can be seen 
that the SUI value with the three FA-conjugated nanoparticles is >10 for FR-
expressing KB cells, while the corresponding SUI for 3T3 fibroblasts and 
macrophages is ~2, which further demonstrates the specificity and efficiency of these 
FA-conjugated nanoparticles in targeting FR-overexpressing cancer cells. There is no 
significant difference (P > 0.05) in cellular uptake of the three FA-conjugated 
nanoparticles by 3T3 fibroblasts, but the uptake of SPIONs-P(GMA-co-PEGMA)-
FA-3 (FA surface density of 88 mg (g·nanoparticles)-1) by macrophages is 1.3 times 
higher than that of SPIONs-P(GMA-co-PEGMA)-FA-1 (FA surface density of 19 mg 
(g·nanoparticles)-1). The increased phagocytosis may have resulted from the increase 
in nanoparticle size and hydrophobicity with increase in FA surface density. For KB 
cells, there is a corresponding increase of a factor of 1.5. One possible reason for the 
nonlinear relationship between the nanoparticle uptake by KB cells and the FA 
surface density on the nanoparticles is the distribution of the conjugated FA. Due to 
the random distribution of GMA in the copolymer chain, some of the FA may be 
clicked to GMA located inside the polymer coating rather than on the surface, which 
may inhibit the interaction between the conjugated FA and the FR on the cells. The 
other possible explanation is the lack of significant difference in receptor recognition 
unless the FA content is higher than 10 wt% as discussed in Section 4.3.4. The FA 
content of the SPIONs-P(GMA-co-PEGMA)-FA nanoparticles used in the present 
work is estimated to range from 2.1% to 10.6% of the weight of the polymer coating 
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(i.e. excluding the iron oxide nanoparticle). Increasing FA content beyond 10 wt% 
may lead to a significant increase in cellular uptake, as shown by the work of Ke et al. 
(2010) which reported a cellular uptake of ~70 pg Fe/cell after incubation for 6 h with 
nanoparticles with 30 wt% of conjugated FA. However, if the FA content is greatly 
increased to achieve a very high cellular uptake, the dispersibility and RES evasive 
property of the FA-conjugated nanoparticles may be compromised. In this work, 
among the FA-conjugated nanoparticles, SPIONs-P(GMA-co-PEGMA)-FA-3 is 
deemed optimal, since the intracellular uptake by KB cells is the highest while 



















SPIONs-P(GMA-co-PEGMA)-FA nanoparticles which possess the functionalities for 
cancer targeting and macrophage evasion were successfully prepared via the 
combination of ATRP and ‘click’ chemistry. With the incorporation of PEGMA in the 
surface coating, the uptake of the resulting nanoparticles by macrophages is further 
reduced as compared to that of SPIONs-PGMA-FA (Chapter 4). Moreover, SPIONs-
P(GMA-co-PEGMA)-FA have excellent dispersibility and stability in aqueous 
medium and exhibit good biocompatibility. Thus, by virtue of these advantages, 
SPIONs-P(GMA-co-PEGMA)-FA can potentially be a good candidate for targeting 
cancer cells which over-express the folate receptor in bio-imaging, bio-detection and 

















CHAPTER 6 CISPLATIN-CONJUGATED MAGNETIC 


















Bladder cancer is the second most common genitourinary malignancy and ranks ninth 
in worldwide cancer incidence. It is also the most expensive disease to treat from 
diagnosis to death (US data), due to the long-term survival associated with non 
muscle-invasive disease combined with life-long surveillance (Chiong et al. 2008). It 
therefore represents an important public health problem. Most bladder cancers (70-
80%) are superficial or non muscle-invasive cancers and the tumors are confined in 
the urothelial lining (Ploeg et al. 2009; GuhaSarkar and Banerjee 2010). The 
conventional treatment for patients with non-muscle-invasive bladder cancer (NMIBC) 
is surgical transurethral resection of the tumor, along with adjuvant treatment using 
intravesical immunotherapy and chemotherapy, such as Bacillus Calmette-Guerin, 
mitomycin C, paclitaxel, or cisplatin. However, within five years, nearly 80% of these 
patients will develop tumor recurrence, with 20-30% showing progression to more 
aggressive muscle-invasive tumors (Shen et al. 2008). 
 
Treatment failure may be partially due to the short residence time of drugs in the 
bladder. Conventional vehicles used for the intravesical delivery can be adversely 
affected by dilution of instilled drugs by residual urine and failure to provide a 
sustained exposure of drugs inside the bladder, since the drugs are typically 
maintained intravesically for 2 h and they rarely last beyond the first voiding of the 
urine after instillation (Tyagi et al. 2006). The very low permeability of drugs into the 
bladder wall is another hindrance due to the presence of the urothelium (refer to 
Figure 2-7 in Chapter 2). Hence, there is a need for the development of mucoadhesive 
and sustained drug delivery systems to prolong the dwell-time and enhance 
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permeability of the drug leading to less frequent dosing (Smart 2005; Mugabe et al. 
2009). 
 
Polymeric nanoparticles (PNs) formulated from materials such as lipids, biopolymers 
and synthetic biodegradable amphiphilic copolymers, are used as drug carriers for 
controlled drug release to increase the drug residence time. For example, carboxylic 
acid functionalized hyperbranched polyglycerols (HPG) was synthesized to conjugate 
cisplatin for the treatment of NMIBC (Ye et al. 2011). The nanoparticulate cisplatin 
carriers allowed controlled drug release over a period of a few days and effectively 
inhibited proliferation of bladder cancer cells. Furthermore, mucoadhesive materials 
can be used to increase intimacy of contact between the drug-containing polymer and 
the mucous membrane. Mucoadhesive materials are generally natural or synthetic 
hydrophilic molecules containing numerous functional groups such as hydroxyl, 
carboxyl, amine, or sulfidryl that favor adhesion to the mucosal surface by generating 
hydrogen bonds or disulfide bridges (Tyagi et al. 2006; Carvalho et al. 2010). For 
example, chitosan is widely used for enhancing permeability of drugs through the 
urothelium based on electrostatic interactions of their amino groups with negatively 
charged mucin in the mucosal surface (Eroglu et al. 2002; GuhaSarkar and Banerjee 
2010). Another well-known polymer that improves bioadhesion by nonspecific 
interaction of its polymer chains with mucus is PEG (Lele and Hoffman 2000). 
 
A magnetic field can also be used to specifically localize drug-loaded SPIONs to 
tumors, providing continuous exposure to high drug concentrations (Shen et al. 2008; 
Cheng et al. 2009; GuhaSarkar and Banerjee 2010). These SPIONs may also be used 
with an externally applied alternating magnetic field in the treatment of tumors via 
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localized hyperthermia. Thus, anti-cancer drug–loaded SPIONs may enhance the 
effects on tumor ablation by the combination of chemotherapy and hyperthermia. So 
far, few studies have reported the use of SPIONs-loaded polymeric nanoparticles as 
drug delivery vehicles for bladder cancer therapy. 
 
Herein, the aim of this work was to synthesize SPIONs-loaded polymeric 
nanoparticles with pendant dicarboxylic groups for conjugation and release of 
cisplatin as an intravesical agent for bladder cancer therapy. An amphiphilic polymer, 
poly(ε-caprolactone)-b-poly(propargyl methacrylate-co-poly(ethylene glycol) methyl 
ether methacrylate) (PCL-b-P(PMA-co-PEGMA)), was designed to provide a 
hydrophobic core (PCL) for encapsulation of SPIONs, and a hydrophilic shell 
(PEGMA) to attain water-dispersibility. The pendant dicarboxylic groups in the 
hydrophilic shell were used for conjugating cisplatin and also for enhancing the 
mucoadhesiveness of the nanoparticles. Drug release and cytotoxicity of the resulting 
cisplatin-conjugated, SPIONs-loaded polymeric nanoparticles (Pt-Fe-PNs) were 







6.2 Materials and Methods 
6.2.1 Materials 
ε-CL, benzyl alcohol (99%), tin(II) 2-ethylhexanoate (SnOct2), 2-mercaptosuccinic 
acid (MSA, 97%), 4-(dimethylamino)pyridine (DMAP, 99%), 2,2-
azobisisobutyronitrile (AIBN, 98%), 4-cyano-4-(phenylcarbonothioylthio) pentanoic 
acid (>97%), 2,2’-dimethoxy-2-phenylacetophenone (DMPA, 99%), cis-
dichlorodiaminoplatinum (II) (cisplatin, 99.9%), mucin (from porcine stomach) were 
purchased from Sigma-Aldrich (St. Louis, USA). Propargyl methacrylate (PMA, 124 
g/mol), purchased from Sigma-Aldrich and used after removal of the inhibitors by 
passing through a silica gel column. All other chemicals and solvents were similar to 
those described in Section 4.2.1. 
 
6.2.2 Preparation of SPIONs 
The synthesis of SPIONs was carried out as described in Section 5.2.2. 
 
6.2.3 Synthesis of PCL 
ε-CL (5.02 g, 44 mmol), benzyl alcohol (48 mg, 0.45 mmol), and SnOct2 (45.8 mg, 
0.1 mmol) were dissolved in 12 mL toluene and the mixture was stirred at 115 oC for 
24 h under a argon atmosphere. The polymerized mixture was then diluted with 10 
mL CH2Cl2, followed by precipitation in 300 mL cold methanol twice. The precipitate 




6.2.4 Synthesis of PCL-b-P(PMA-co-PEGMA) 
PCL conjugated RAFT chain transfer agent (PCL-CTA) was first synthesized 
according to the method reported in the literature (Krimmer et al. 2011). Briefly, PCL 
(2 g, 0.14 mmol), 4-cyano-4-(phenylcarbonothioylthio) pentanoic acid (195 mg, 0.7 
mmol) and DMAP (27 mg, 0.22 mmol) were dissolved in 20 mL CH2Cl2 and cooled 
to 0 oC. 217 mg of DCC (1.05 mmol) dissolved in 8 mL CH2Cl2 was then added 
dropwise into the mixture, and the mixture was stirred in the dark at room temperature 
overnight. After reaction, the mixture was filtered to remove dicyclohexylurea, and 
the filtrate was precipitated into a large amount of cold methanol. The pink product 
(PCL-CTA) was filtered and dried under reduced pressure. For the RAFT 
copolymerization of PEGMA and PMA, PCL-CTA (600 mg, 0.041 mmol), PEGMA 
(389 mg, 0.82 mmol), PMA (236 mg, 1.9 mmol), and AIBN (2 mg, 0.0082 mmol) 
were dissolved in 5 mL dioxane. The mixture was degassed with argon for 30 min and 
polymerized at 65 oC for 24 h. The mixture was then precipitated into diethyl ether 
three times and the pink product (PCL-b-P(PMA-co-PEGMA)) was obtained after 
drying under reduced pressure. 
 
6.2.5 Synthesis of PCL-b-P(PMA-click-MSA-co-PEGMA) 
The UV-initiated thiol-yne coupling reaction was applied to conjugate MSA to 
alkyne-functionalized PCL-b-P(PMA-co-PEGMA). The pendant dicarboxylic groups 
of the resulting polymer (PCL-b-P(PMA-click-MSA-co-PEGMA)) were subsequently 
used to conjugate cisplatin. In brief, PCL-b-P(PMA-co-PEGMA) (500 mg, 0.021 
mmol), MSA (300 mg, 1.9 mmol), and DMPA (16 mg, 0.063 mmol) were added into 
a single-necked round-bottom flask containing 8 mL dimethylformamide and the 
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mixture was degassed with argon for 30 min. The reaction flask was then sealed and 
subjected to UV irradiation for 2 h in a Riko rotary photochemical reactor equipped 
with a 1000 W high-pressure mercury lamp and a water bath (model RH 400-10W, 
Riko Denki Kogyo of Chiba, Japan). After UV irradiation, the mixture was 
precipitated into diethyl ether thrice and then dried under reduced pressure. 
 
6.2.6 Preparation of SPIONs-loaded PNs 
50 mg of PCL-b-P(PMA-click-MSA-co-PEGMA) and 15 mg of SPIONs were 
dispersed in 7 mL THF. The mixture was added dropwise into 20 mL DI water under 
vigorously stirring. The mixture was stirred overnight to evaporate the organic solvent 
and centrifuged at 3000 rpm for 5 min to remove large aggregates. The supernatant 
was centrifuged at 10000 rpm for 10 min and the resulting precipitate was freeze-
dried to obtain SPIONs-loaded polymeric nanoparticles (Fe-PNs). 
 
6.2.7 Preparation of Cisplatin-conjugated PNs (Pt-Fe-PNs) 
Conjugation of cisplatin to Fe-PNs was conducted according to a procedure reported 
in the literature for the conjugation of cisplatin to polymeric micelles (Huynh et al. 
2011a). 10 mg of cisplatin and 11 mg of silver nitrate (AgNO3) were dissolved in 10 
mL DI water and the solution was stirred in the dark for 4 h at room temperature. The 
mixture was then centrifuged at 9000 rpm for 20 min to remove the precipitated AgCl 
and the supernatant was filtered using a 0.22 μm filter. 15 mg of Fe-PNs dispersed in 
5 mL DI water (pH=7, adjusted using 0.1 M NaOH) was added to the above cisplatin 
aqueous solution and the mixture was left to react overnight in a water bath at 37 oC 
with gentle shaking. After reaction, the mixture was purified by ultrafiltration using 
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centrifugal filter devices with a molecular weight cut-off of 3000 Da and then freeze-
dried to obtain Pt-Fe-PNs. 
 
Fluorescent marker coumarin-6 loaded, cisplatin-coordinated PNs (Pt-C6-PNs) were 
also prepared for visualization of the cellular uptake of the PNs. The Pt-C6-PNs were 
prepared using the same method described for Pt-Fe-PNs except that the polymer 
solution contains 0.05% (w/v) coumarin-6 instead of SPIONs. 
 
6.2.8 In Vitro Cisplatin Release 
Drug release from Pt-Fe-PNs was investigated using the dialysis method. Pt-Fe-PNs 
were dispersed in DI water, PBS or artificial urine at a particle concentration of 1 
mg/mL. Artificial urine was prepared according to the literature (Griffith et al. 1976; 
Stickler and Morgan 2006). 2 mL of the Pt-Fe-PNs dispersion was transferred into the 
dialysis membrane tubing with molecular weight cut-off of 3500 Da and dialyzed 
against 20 mL of DI water, or PBS (10 mM phosphate, 140 mM Cl−, pH=7.4), or 
artificial urine (137 mM Cl−, pH=6.1) in a 37 oC water bath at a shaking speed of 100 
rpm. At predetermined time points, aliquots of 2 mL were taken and treated with aqua 
regia solution at 60 oC for 2 h for the determination of platinum content by ICP-MS. 
The same volume of fresh water, PBS or artificial urine was added to maintain the 
total volume of the release medium. The cumulative release of platinum from Pt-Fe-
PNs was expressed as a percentage of the total amount of platinum in the initial 
sample, and calculated using the equation below: 
                           % release =  
Z
vcVc n nn   10   
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where Z is the initial total amount of platinum in the dialysis bag, cn is the apparent 
concentration of platinum of the nth aliquot taken, V is the total volume of the 
releasing solution,  is the volume of the each aliquot taken.  
 
In order to investigate the effect of temperature on drug release, the temperature of the 
artificial urine release medium was increased to 42 oC after 10 h of release at 37 oC. 
Since clinical hyperthermia treatments are usually limited to 30-60 min, the amount of 
drug release after 1 h of incubation at 42 oC was tested as described above. 
 
6.2.9 Cell Culture 
The human urothelial carcinoma cell line UMUC3 purchased from American Type 
Culture Collection (ATCC, Manassas, USA) was cultivated in McCoy’s Medium 
(Invitrogen, California, USA) supplied with 10% fetal bovine serum (FBS) and 1% 
penicillin-streptomycin (Sigma-Aldrich, St. Louis, USA) at 37 oC in a humidified 5% 
CO2 atmosphere. 
 
6.2.10 Cytotoxicity Evaluation 
Cytotoxicities of free cisplatin, Fe-PNs, and Pt-Fe-PNs towards UMUC3 cells were 
evaluated using the MTT assay. Cells were seeded at a density of 5×103 cells/well in a 
96-well plate and allowed to grow for 24 h. The medium was then replaced with the 
growth medium containing free cisplatin with drug concentration ranging from 0.5 to 
1000 μM, or Fe-PNs or Pt-Fe-PNs with particle concentration ranging from 0.001 to 1 
mg/mL for 2 h. After treatment, the cells were washed thrice with PBS, and 100 μL of 
fresh culture medium was added into each well and cells were allowed to grow for 72 
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h. Control experiments were carried out using the growth culture medium without 
drug or particles (non-toxic control). After incubation, the MTT assay was carried out 
as described in Section 3.2.7. The cell viabilities were presented as the percentage of 
the absorbance of free cisplatin- or particles-treated cells to the absorbance of the non-
toxic control and were plotted against the drug or particles concentration. The half-
maximal inhibitory concentration (IC50) values were determined on the basis of the 
fitted data. 
 
6.2.11 Cellular Uptake 
UMUC3 cells were seeded into a 12-well plate at a density of 105 cells/well and 
allowed to grow for 24 h. Cells were incubated with free cisplatin and Pt-Fe-PNs at 
the same [Pt] (10 μM). After 2 h of incubation, the medium was removed and the cells 
were rinsed with PBS thrice, detached with trypsin-EDTA solution, counted, and 
collected by centrifugation. The cell pellet was dissolved in aqua regia solution at 60 
oC for 2 h to digest the platinum. The platinum concentration was determined using 
ICP-MS. To visualize the cellular uptake, UMUC3 cells were seeded in a 24-well 
plate at a density of 5×104 cells/well and allowed to grow for 24 h at 37 oC with 5% 
CO2. Cells were then incubated with Pt-C6-PNs at [Pt] of 10 μM. After 2 h of 
incubation, the medium was removed and the cells were washed thrice with PBS and 
were then fixed with 4% formaldehyde in PBS for 30 min. The cells were further 
washed with PBS and stained with Hoechst 33258 for 15 min to visualize the cell 
nucleus. The cells were then washed with PBS and observed using a fluorescence 





Mucoadhesive property of Pt-Fe-PNs was evaluated using the mucin-particle method 
according to the literature with minor modifications (Carvalho et al. 2010). This 
method is based on changes in particle size due to interaction between adhesive 
particles and submicron-sized mucin. Briefly, an aqueous suspension of submicron-
sized mucin (0.1% w/v) was mixed with equal volume of Pt-Fe-PNs suspension (0.1% 
w/v), and incubated at 37 oC for 2 h. Pure mucin or nanoparticle suspensions were 
used as controls. Changes in particle size were determined using the Zetasizer 
nanosystem as described in Section 4.2.12. XPS and TEM measurements were 
performed as described in Section 4.2.12. The other characterization methods, 1H 











6.3 Results and Discussion 
Cisplatin, which interacts with DNA to interfere with cell transcription mechanism, 
has been widely used as a powerful anticancer drug (Cheng et al. 2009). Cisplatin 
consists two amines as the permanently bound ligands, and two chlorides as the labile 
leaving ligands (Figure 6-1a) (Huynh et al. 2011b). Cisplatin can be loaded by 
substituting its chloride ligands with carboxylic ligands of drug carriers. Many 
polymers, such as poly(glutamic acid) (Nishiyama et al. 2003), poly(aspartic acid) 
(Nishiyama and Kataoka 2001), and poly(methacrylic acid) (Bontha et al. 2006) have 
been reported to generate cisplatin-polymer complexes. However, cross-linking of 
these polymeric chains occurs as a result of the coordination of cisplatin with two 
carboxylic groups in a nonspecific geometry. Polymers with bidentate dicarboxylic 
ligands have been reported to form chelate rings with cisplatin resulting in structurally 
better defined cisplatin complexes (Figure 6-1b) without crosslinking (Komane et al. 
2008; Huynh et al. 2011a). Therefore, in this work, a polymer with bidentate 
dicarboxylic groups was synthesized via thiol-yne ‘click’ reaction for cisplatin 
conjugation. 
 





6.3.1 Synthesis of PCL-b-P(PMA-click-MSA-co-PEGMA) 
The general synthetic routes employed for the preparation of PCL-b-P(PMA-click-
MSA-co-PEGMA) amphiphilic polymer are shown schematically in Figure 6-2. The 
structures of the as-synthesized polymers were verified by 1H NMR while the 
molecular weights (Mn) of the polymers were further confirmed by GPC and 
summarized in Table 6-1.  
 
Figure 6-2 Synthetic route for PCL-b-P(PMA-click-MSA-co-PEGMA). 
 
PCL as the hydrophobic core was first synthesized by ring-opening polymerization 
(ROP) of ε-CL using the benzyl alcohol as the initiator and SnOct2 as the catalyst. 
The degree of polymerization (DP) of PCL was determined to be 100 by 1H NMR 
(Figure 6-3A) from the integral ratio of peak f (4.1 ppm) to peak a (7.3 ppm), which 
are characteristic signals of PCL repeating units and the phenyl end moiety, 
respectively. Thus, the Mn of PCL was determined to be 14300 g/mol based on 1H 
NMR. The terminal hydroxyl group of the as-synthesized PCL was further modified 
with 4-cyano-4-(phenylcarbonothioylthio) pentanoic acid to serve as the macro-CTA 









 The composition of the PCL-b-P(PMA-co-PEGMA) was estimated using 1H NMR. 
From Figure 6-3B, all resonance signals characteristic of PCL, PMA, and PEGMA 
blocks were clearly visible. The signal at 3.4 ppm (peak i) is assigned to the protons 
of the methoxy end group (-OCH3) of the PEGMA, while the signal at 2.5 ppm (peak 
j) is associated with the proton of (–C≡CH) of the PMA (Agag and Takeichi 2001). 
The DP of PMA  and PEGMA relative to PCL was determined to be 30 and 11, 
respectively, based on the integral ratio of the resonance peaks characteristic of PMA 
(peak j) or PEGMA (peak i) to that of the PCL block (peak f). Thus, the Mn of PCL-b-
P(PMA-co-PEGMA) was calculated to be 23600 g/mol based on 1H NMR result. 
 
For conjugation of cisplatin, thiol-yne ‘click’ reaction between 2-mercaptosuccinic 
acid and the alkyne group of PMA in the polymer was applied to introduce bidentate 
dicarboxylic groups. The conversion was confirmed by the characteristic signals of 2-
mercaptosuccinic in the 1H NMR spectrum as shown in Figure 6-3C. However, since 
the characteristic chemical shift of –C≡CH (DMSO-d6, 3.5-3.6 ppm) (Munteanu et al. 
2008) overlapped with the signals of PEGMA and 2-mercaptosuccinic, the percentage 
of alkyne conversion cannot be verified based on the signal of –C≡CH. Therefore, the 
CH2C≡CH signal was used instead for calculating the conversion of the alkyne groups. 
The protons of the methylene groups of CH2C≡CH are assigned to the signal at 4.64 
ppm (peak l in Figure 6-3B). After thiol-yne reaction, the signal of the methylene 
groups shifts to 4.47 ppm (peak r), while a small bump remains at 4.64 ppm (peak l) 
(Figure 6-3C). Based on the integral ratio of peak r to peak l, the conversion of the 
alkyne groups was determined to be 75%. The Mn of the synthesized PCL-b-P(PMA-




Table 6-1 Molecular weight (g/mol) of polymers 
Sample Mna Mnb Mw/Mnb 









     a Determined from 1H NMR. b Determined from GPC. 
 
FT-IR spectra of PCL-CTA, PCL-b-P(PMA-co-PEGMA), and PCL-b-P(PMA-click-
MSA-co-PEGMA) are shown in Figure 6-4. After RAFT copolymerization of PMA 
and PEGMA, the characteristic absorption bands of –C≡CH at 3300 cm-1 and 2129 
cm-1 were observed (comparing Figure 6-4a and 4b) (Agag and Takeichi 2001). After 
the thiol-yne reaction to form PCL-b-P(PMA-click-MSA-co-PEGMA), these 
characteristic aborption bands of –C≡CH were barely visible (comparing Figure 6-4b 
and 4c), indicating a high conversion of the alkyne groups by the thiol-yne reaction. 
This is consistent with the results obtained by 1HNMR.  
 




6.3.2 Preparation of Fe-PNs and Pt-Fe-PNs 
The oleic acid-stabilized monodisperse SPIONs were first synthesized by the high 
temperature decomposition method. As can be seen from Figure 6-5a, the size of the 
as-synthesized SPIONs is ~14 nm. Using the amphiphilic polymer, PCL-b-P(PMA-
click-MSA-co-PEGMA), SPIONs-loaded polymeric nanoparticles (Fe-PNs) were 
prepared via the nanoprecipitation method. As can be seen from Figure 6-5b, the 
SPIONs were physically encapsulated and present as clusters in the hydrophobic PCL 
core while the hydrophilic shell of P(PMA-click-MSA-co-PEGMA) renders the PNs 
stable in aqueous medium. The hydrodynamic size of Fe-PNs is 281 ± 3.1 nm. The 
zeta potential of Fe-PNs is -34.3 ± 1.1 mV, attributed to high concentration of 
carboxylic groups on the surface. 
 
Figure 6-5 TEM images of (a) pristine oleic acid-stabilized SPIONs, (b) Fe-PNs, and (c) 
Pt-Fe-PNs. 
 
Cisplatin is usually directly added to the aqueous solution of carboxylates to obtain 
cisplatin-polymer complexes (Nishiyama et al. 1999; Zhu et al. 2011). This direct 
conjugation route is reported to require a long reaction time due to the necessity for 
intermediate ligand exchange of cisplatin with water before coordination with 
carboxylates (Huynh et al. 2011a). In order to accelerate this process, AgNO3 is used 
to rapidly shift the intermediate ligand exchange due to the formation of insoluble 
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AgCl (Huynh et al. 2011a; Huynh et al. 2011b). Therefore, in this work, cisplatin was 
first reacted with AgNO3 at room temperature for 4 h. After removal of the AgCl, the 
filtrate was added to the aqueous suspension of Fe-PNs for drug conjugation. 
 
A representative TEM image of the as-synthesized cisplatin-conjugated Fe-PNs (Pt-
Fe-PNs) is shown in Figure 6-5c. After cisplatin-conjugation, no significant change in 
the morphology of the resulting particles can be observed (comparing Figure 6-5b and 
5c). The hydrodynamic size of Pt-Fe-PNs is 295.1 ± 2.1 nm, which is slightly larger 
than that of Fe-PNs. The zeta potential of Pt-Fe-PNs is -9.6 ± 1.5 mV. The increase in 
the zeta potential as compared to that of Fe-PNs is attributed to the coordination of 
cisplatin with the carboxylic groups. 
 
The success of the conjugation of cisplatin with Fe-PNs was ascertained by XPS. 
Figure 6-6 shows the Pt 4f core-level spectra of Fe-PNs and Pt-Fe-PNs. For Fe-PNs, 
no Pt signal was observed as expected (Figure 6-6a). After conjugation of cisplatin, 
the Pt signal was significantly enhanced as shown in Figure 6-6b. The Pt 4f core-level 
spectrum of Pt-Fe-PNs can be curve-fitted into two peak components with binding 
energies at 75.9 eV and 72.6 eV, attributed to the Pt 4f5/2  and Pt 4f7/2, respectively 
(Briggs 1977). The binding energy of Pt 4f7/2 at 72.6 eV indicates the state of the 
platinum to be Pt(II) (Briggs 1977; Onoa et al. 1999). The energy separation of Pt 
4f5/2 and Pt 4f7/2 is 3.3 eV, which is in good agreement with the literature value of 3.33 




Figure 6-6 XPS Pt 4f core-level spectra of (a) Fe-PNs and (b) Pt-Fe-PNs. 
 
The magnetic property of pristine SPIONs and Pt-Fe-PNs is demonstrated in Figure 6-
7. The Ms value of pristine SPIONs is 45 emu/g (Figure 6-7a) at 25 oC while that of 
Pt-Fe-PNs is 7.7 emu/g (Figure 6-7b). Since iron oxide (Fe3O4) accounts for 12.7% of 
the Pt-Fe-PNs (based on ICP-MS), this reduction in magnetization is expected. The 
presence of polymer or surfactant on the surface of SPIONs may also decrease the Ms 
due to a pinning of the surface spins and a related increase in the magnetic anisotropy 
energy constant (Berkowitz et al. 1980; Dresco et al. 1999). 
 
Figure 6-7 Field dependent magnetization at 25 oC for (a) pristine oleic acid-stabilized 
SPIONs and (b) Pt-Fe-PNs. 
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6.3.3 In Vitro Drug Release 
The release of cisplatin from carboxylate ligands can be triggered by the presence of 
chloride ions or low pH (Cheng et al. 2009; Lee et al. 2010; Huynh et al. 2011a; Zhu 
et al. 2011). The chloride ions will substitute the carboxylate ligand in the platinum 
complex, followed by cleavage of the cisplatin from the carriers. At low pH, the 
carboxyl groups are protonated and dechelated from the Pt centre, eventually leading 
to the release of cisplatin and inhibition of the rebinding of the released cisplatin 
(Huynh et al. 2011b; Ye et al. 2011). 
 
The release of cisplatin from Pt-Fe-PNs was assessed at 37 oC in DI water, PBS and 
artificial urine by a dialysis method. Experiments with free cisplatin have confirmed 
that the drug would not adsorb on the dialysis membrane. The cumulative release 
curves of cisplatin are shown in Figure 6-8. In general, the release profiles of Pt-Fe-
PNs in PBS and artificial urine are characterized by an initial burst release followed 
by a slower sustained release. In PBS, approximately 24% of cisplatin was released 
from Pt-Fe-PNs in the first 4 h and up to 32% released after 4 days. In artificial urine, 
approximately 30% was released in the first 4 h and up to 41% released after 4 days. 
Since the chloride ions concentrations in PBS and artificial urine are nearly the same, 
the higher release rate in artificial urine may be due to its more acidic nature (pH 6.1) 
resulting in the protonation of more free carboxyl groups. In contrast, only 4% of 
cisplatin was released in DI water over 4 days, indicating that the presence of chloride 
ions is important for ligand substitution of cisplatin from the carboxyls of PNs. The 
drug release from Pt-Fe-PNs can also be enhanced by an increase in temperature. 
After 10 h in artificial urine at 37 oC, ~31% of drug was released, and with further 
release occurring in a slow sustained mode. At this time point, when the temperature 
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was increased to 42 oC, approximately more than 10% of the drug was further released 
after 1 h of incubation (i.e. total release of ~40% of the drug). This is equivalent to the 
total additional amount released over the next few days at 37 oC. Since SPIONs can 
generate heat under an external alternating magnetic field, these Pt-Fe-PNs can 
potentially be utilized as a hyperthermia agent for cancer therapy as well as to control 
drug release. However, it may not be possible to release the drug completely since 
platinum may form strong bonds with sulfur-containing biomolecules. It has been 
reported that cisplatin may be coordinated with one carboxyl ligand and one sulfur 
ligand with possible involvement of the thioether (Huynh et al. 2011a). The presence 
of high number of bidentate dicarboxylate groups may also increase the probability of 
rebinding the released drug. This incomplete drug release has also been reported by 
others (Lee et al. 2010; Huynh et al. 2011b). 
 
Figure 6-8 Release profiles of cisplatin from Pt-Fe-PNs in DI water, PBS, and 
artificial urine at 37 oC. Inset shows the release profile in the first 10 h. 
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The mucoadhesiveness of Pt-Fe-PNs was verified by the mucin-particle method 
(Figure 6-9), since the hydrodynamic size of the mixed suspension of mucin and Pt-
Fe-PNs increased significantly (~34%) after 2 h of incubation at 37 oC. On the other 
hand, only a very slight increase in hydrodynamic size was observed with the pure 
mucin (~7%) or pure particle (2%) suspensions after a similar period. The release 
profiles together with the mucoadhesive property of Pt-Fe-PNs are advantageous for 
intravesical drug delivery since a sustained mucoadhesive drug delivery platform 
ensures a continuous presence of drug at the bladder wall for an extended period. 
 
Figure 6-9 Size increase of a mixture of Pt-Fe-PNs and mucin after incubation at 37oC 
for 2 h. Pure mucin and nanoparticle suspensions were used as controls. 
 
6.3.4 In Vitro Cytotoxicity Evaluation 
The in vitro cytotoxicities of free cisplatin, Fe-PNs (without drug) and cisplatin-
loaded Pt-Fe-PNs on UMUC3 bladder cancer cells were investigated by first 
incubating the cells with free cisplatin- or particles-loaded medium for 2 h and 
subsequently with fresh medium for 72 h. These incubation times were chosen to 
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imitate the typical intravesical instillation period. The amount of intracellular Pt after 
incubation of UMUC3 cells with free cisplatin at [Pt]  of 10 μM was 0.06 pg Pt/cell, 
whereas the equivalent amount when Pt-Fe-PNs was used at the same [Pt] was 1.15 
pg Pt/cell, which is 19 times higher than when free cisplatin was used. Since the 
release of the drug from the Pt-Fe-PNs in the medium during the 2 h incubation 
period was determined to be only 8.1% of the total drug, the intracellular Pt is mainly 
due to nanoparticles internalized by the cells via endocytosis. The internalization of 
nanoparticles by UMUC3 bladder cells was also investigated using fluorescent Pt-C6-
PNs instead of Pt-Fe-PNs. The presence of the nanoparticles inside the cells was 
confirmed by fluorescence microscopy (Figure 6-10).  
 
The in vitro cytotoxicities of the free cisplatin and nanoparticles are shown in Figure 
6-11. As can be seen from Figure 6-11b, Fe-PNs have very low or no significant 
toxicity towards UMUC3 bladder cancer cells since the cell viabilities are above 90% 
even at the highest concentration of 1 mg/mL. Both free cisplatin and cisplatin-loaded 
Pt-Fe-PNs demonstrate a dose-dependent cytotoxic effect on UMUC3 cells. As shown 
in Figure 6-11, the IC50 of free cisplatin was determined to be 12.1 μM, whereas the 
IC50 of cisplatin in Pt-Fe-PNs was calculated to be 32.3 μM (based on Pt wt% of Pt-
Fe-PNs as determined by ICP-Ms). The IC50 values of Pt-Fe-PNs and free cisplatin 
are different because in the former, the drug taken in by the cells was mainly 
conjugated to the nanoparticles (as mentioned above). After endocytosis of Pt-Fe-PNs, 
further release of the drug from Pt-Fe-PNs in the cells can occur with time, which 
may lead to increased cytotoxicity. The higher IC50 of cisplatin in Pt-Fe-PNs in 
comparison with that of free cisplatin is consistent with an earlier work using 
cisplatin-conjugated polymer nanoparticles at [Pt] of 20 μM in the incubation medium 
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which reported a ratio of 45 (Lee et al. 2010). Other researchers have found an 
increase in the IC50 and a decrease in potency of up to 100-fold (Malik et al. 1999; 
Uchino et al. 2005; Zhou et al. 2010). 
 
Figure 6-10 Fluorescence images of UMUC3 bladder cancer cells after 2 h incubation 
with Pt-C6-PNs at [Pt]=10 μM. The images were obtained from (a) FITC channel 
(green), (b) DAPI channel (blue), and (c) combined with FITC and DAPI channels. 




Figure 6-11 In vitro cytotoxicity profile of (a) free cisplatin, (b) Fe-PNs, and Pt-Fe-PNs 
against UMUC3 bladder cancer cells. Cells were exposed to the drug or nanoparticles 





















In summary, amphiphilic PCL-b-P(PMA-click-MSA-co-PEGMA) polymer with 
bidentate dicarboxylic groups was synthesized to encapsulate SPIONs and coordinate 
cisplatin. The resulting Pt-Fe-PNs contain 7.4% by weight of Pt and possess 
superparamagnetic and mucoadhesive properties. The superparamagnetic property 
(together with the use of an external magnetic field) and mucoadhesiveness will 
enable the localization of the nanoparticles on the bladder wall. The release profile of 
cisplatin from Pt-Fe-PNs in artificial urine shows a burst release in the first 4 h 
followed by a sustained release over 4 days, and the release rate can be enhanced by 
an increase in temperature. These nanoparticles can effectively induce cytotoxic 
effects in UMUC3 bladder cancer cells via a combination of drug released into the 
medium and further release of the drug inside the cells after endocytosis. Thus, these 
nanoparticles may serve as promising carriers for intravesical delivery of cisplatin for 




























The present research work has attempted to functionalize the surface of SPIONs for 
potential biomedical applications. In particular, cell targeting, MRI, and cancer 
therapy. Different functional polymers have been synthesized and used as surface 
coatings of SPIONs to target macrophages or cancer cells with high efficiency and 
specificity, and for potential cancer therapy. 
  
In the first part of the research, cellular uptake of SPIONs by macrophages was 
modulated by surface coating of poly(DL-lactic acid-co-malic acid) (PLMA) or 
PLMA-PEG. PLMA, synthesized via a two-step copolycondensation process, is an 
amphiphilic, biodegradable and biocompatible copolymer. The PLMA coated SPIONs 
(PLMA-SPIONs) are highly stable in aqueous medium and their anionic nature results 
in highly efficient uptake by macrophages. The extent of uptake can be modulated by 
incorporating PEG into the PLMA coating. The uptake of PLMA-PEG-SPIONs by 
macrophages is reduced with increasing PEG content of the PLMA-PEG copolymers. 
All these PLMA-SPIONs and PLMA-PEG-SPIONs are non-cytotoxic and exhibit a 
much higher value of r2/r1 in water than MRI contrast agents, Endorem and Resovist, 
due to the amphiphilic structure of the PLMA and PLMA-PEG coatings. The PLMA-
SPIONs-labeled macrophages in agarose show significantly higher R2* than R2 effect, 
and this would favour the detection of small amounts of labelled cells with high 
sensitivity in vivo. Thus, the PLMA-SPIONs would be a promising high contrast MRI 
probe for targeting macrophages and monitoring diseases associated with macrophage 
activity. On the other hand, PLMA-PEG-SPIONs can potentially be applied for in 




In the next part of the research, magnetic nanoparticles for targeting cancer cells were 
developed. For cancer targeting, it is important to minimize non-specific uptake by 
macrophages and enhance specific accumulation of SPIONs in cancer cells. Therefore, 
a highly efficient tumor-targeting ligand, folic acid (FA), was combined with the 
SPIONs. SPIONs were first modified with poly(glycidyl methacrylate) (PGMA) via 
atom transfer radical polymerization (ATRP) and then reacted with ethylenediamine 
to generate amino groups on the surface of SPIONs-PGMA for the conjugation of 
different amounts of FA. The as-synthesized folic acid conjugated SPIONs (SPIONs-
PGMA-FA) are highly stable in aqueous medium, have low cytotoxicity, and exhibit 
high MR enhancement effects with high T2 relaxivity and r2/r1 ratio. The combination 
of surface conjugated FA and the hydrophilic polymer coating results in rapid and 
selective internalization of these nanoparticles by KB cells while concomitantly 
minimizing uptake by macrophages and normal cells. 
 
To further improve the macrophages-evading and cancer targeting properties of 
SPIONs, another coating was developed. The strategy involves the ATRP of GMA 
and PEGMA from the surface of SPIONs followed by ‘click’ chemistry to conjugate 
controlled amounts of FA. These as-synthesized nanoparticles (SPIONs-P(GMA-co-
PEGMA)-FA) have excellent dispersibility and stability in aqueous medium, and 
exhibit good biocompatibility. The non-specific uptake of these nanoparticles by 3T3 
fibroblasts and macrophages is less than that of SPIONs-PGMA-FA, and the efficacy 
of SPIONs-P(GMA-co-PEGMA)-FA in targeting KB cancer cells is enhanced as 




The last part of the thesis explores the use of SPIONs for bladder cancer therapy. 
Non-specific uptake by macrophages is not a problem for bladder cancers, and folate 
receptors are also not over-expressed. However, the short residence time of drug 
carriers in the bladder is a problem. Therefore, in the last part of the research, 
amphiphilic poly(ε-caprolactone)-b-poly(propargyl methacrylate-click-
mercaptosuccinic acid-co-poly(ethylene glycol) methyl ether methacrylate) (PCL-b-
P(PMA-click-MSA-co-PEGMA)) were synthesized by a combination of ring-opening 
polymerization, reversible addition-fragmentation chain transfer (RAFT) 
polymerization, and thiol-yne ‘click’ reaction. The hydrophobic PCL core can be used 
to load SPIONs while the pendant dicarboxylic groups in the hydrophilic shell are 
used to coordinate cisplatin. These polymeric nanoparticles (Pt-Fe-PNs) are 
mucoadhesive and show a sustained release of cisplatin over 4 days in artificial urine. 
Moreover, they can effectively induce cytotoxicity against UMUC3 bladder cancer 
cells. The PCL hydrophobic core may also be used to encapsulate hydrophobic drugs 
(such as Paclitaxel) to obtain synergistic effects from multidrug therapy while the 
unreacted carboxylic groups may be used to attach targeting ligands such as the 
epidermal growth factor receptor for active targeting of bladder cancer cells. In 
addition, the SPIONs can possibly serve as a hyperthermia agent. Therefore, these 
nanoparticles may be a useful drug delivery system for bladder cancer therapy. 
 
In summary, this thesis has shown that polymer coatings can confer a range of 
desirable properties to SPIONs. Through proper design of these polymers, the 
inherent shortcomings and limitations of the SPIONs for biomedical applications can 
be overcome. Biodegradable and biocompatible polymers have been synthesized and 
applied as surface coatings for SPIONs in this research, and in vitro tests have 
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indicated that the SPIONs after modification with the respective polymer coating can 
achieve their intended applications, i.e. high MR contrast enhancement, modulation of 
uptake by macrophages, cancer cells targeting, or mucoadhesiveness for drug delivery 
in the bladder. 
 
7.2 Recommendations for Future Work 
Based on the work in this thesis, the following related research works are 
recommended for further study. 
 
In the present work, only in vitro tests were carried out. Although very encouraging 
results were obtained in these tests, the physiological conditions are much more 
complicated than the conditions in the in vitro test. Therefore, in vivo bio-distribution 
of PLMA-SPIONs (Chapter 3) and SPIONs-P(GMA-co-PEGMA)-FA (Chapter 5) 
after intravenous injection and their uptake by the targeted cells (macrophages for the 
former and cancer cells for the latter) should be investigated by MRI and compared 
with commercial formulation of SPIONs. For Pt-Fe-PNs (Chapter 6), adhesion and 
penetration into the urothelium after intravesical delivery in an animal model should 
be investigated.  
 
Secondly, the present work has focused on the superparamagnetic iron oxide 
nanoparticles. Recently, transition-metal-doped SPIONs (i.e. replacing the Fe2+ ions 
by Mn2+, or Zn2+, or Ni2+, etc.) have been reported to induce significant saturation 
magnetization values and MRI contrast enhancement effects that are superior to that 
of conventional iron oxide nanoparticles (Seo et al. 2006; Lee et al. 2007). For 
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example, (Zn0.4Mn0.6)Fe2O4 has been reported to have an extremely high 
magnetization value (175 emu g-1) and the largest MRI contrast effect (r2=860 mM-1s-
1), which corresponds to an eight- to fourteen-fold increase in MRI contrast compared 
to conventional iron oxide nanoparticles (Jang et al. 2009). In addition, these doped 
nanoparticles are reported to be nontoxic to healthy cells in an in vitro study (Jang et 
al. 2009). Therefore, these doped nanoparticles can be surface modified with PLMA-
PEG or P(GMA-co-PEGMA) to increase their blood circulation time. After 
conjugation with targeting ligand such as folic acid, these nanoparticles can be used 
for targeting cancer cells with high efficiency. 
 
Finally, the development of multifunctional nanomedical platforms for multimodal 
imaging, simultaneous diagnosis and therapy has recently gained significant attention 
(Kim et al. 2008). For example, the combination of SPIONs and fluorescent dye 
offers a combination of magnetic and optical imaging that would benefit disease 
diagnosis in vivo as well as monitoring of living cells in situ (Yang et al. 2008). 
SPION-based nanocarriers with a combination of anticancer drug and targeting ligand 
can be used as highly efficient and specialized carriers for the simultaneous diagnosis 
and treatment of cancers (Huh et al. 2007). Therefore, anticancer drugs (such as 
Herceptin, paclitaxel, and methotrexate) and fluorescent dyes (such as fluorescein 
isothiocyanate) can be either encapsulated or conjugated to the SPIONs-polymer 
hybrid to facilitate multimodality imaging and therapeutic functions from a single unit. 
Synergistic effects from chemotherapeutic drugs and magnetically-induced 
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